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In addition to conventional periodontal disease Human Immunodeficiency Virus (HTV)
seropositive patients can suffer from a range of periodontal diseases that are thought to
result from immunosuppression. These include HIV-associated gingivitis,
HTV-associated periodontitis and necrotising stomatitis. Furthermore, it has been
suggested that periodontal tissue breakdown may be one of the first indications ofHIV
infection (Winkler and Murray, 1987). To determine the association between site-
specific tissue breakdown and specific subgingival microorganisms a large number of
sites need to be investigated. However, previous studies of the subgingival microbiota
in HIV seropositive subjects have described data from only a few sites per subject. The
development of DNA probes for the identification of subgingival microorganisms
(French et al, 1986, Smith et al, 1988a, Gunaratnam et al, 1992) has allowed the rapid
analysis of large number of subgingival plaque samples compared to traditional
microbial identification techniques.
Twenty-nine HIV seropositive patients and 27 HIV seionegative patients were
examined during the course of this study. Clinical data was collected from a total of
14,244 sites and subgingival plaque samples were collected ffom 1,461 sites. A total of
6,804 hybridisations were successfully completed identifying over 16,000 colonies to
species level on nylon colony lifts.
On initial analysis, HIVseropositive subjects had a tendency for increased mean
attachment loss compared to the HIV seronegative controls in this sample. The
HIV seropositive subjects also harboured a higher mean percentage of P. gingivalis,
and had a higher mean percentage of sites with suppuration than HIV seronegative
subjects. A subgroup of nine HTV seropositive patients was identified with widespread
periodontal disease, after criteria described by Haffajee et al (1992). These patients
xv
differed in mean attachment loss, pattern of attachment loss, prevalence of clinical
indicators and microbiology of subgingival plaque from the remaining
20 HTV seropositive patients with localised periodontal disease. Furthermore, these nine
HIV seropositive patients with widespread periodontal disease were largely responsible
for the differences observed between HIV seropositive and HIV seronegative groups as
a whole. The incidence of HIV-associated periodontal diseases and the number of
active sites found during the study was low.
In conclusion, this study confirms that there exists a subgroup of
HTV seropositive patients who are at risk for an increased incidence of destructive
periodontal disease. However, so many potentially confounding factors associated with
HTV infection and treatment exist that identification of those patients who are at risk for
periodontal disease may be difficult. Periodontal predictors of increased
immunosuppression as HIV disease progresses are unlikely to be very powerful, even if
they prove to be reliable, as not every patient with HIV infection in this study suffered
from periodontal disease despite some patients having severe immunosuppression.
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1.1 CLINICAL DESCRIPTION OF PERIODONTAL DISEASE
In its broadest sense the term 'periodontal disease' may be used to describe any disease
arising within or involving the periodontal tissues. Usually, however, the term is used to
describe a range of clinical conditions that essentially involve two processes i.e.
gingivitis and periodontitis. Both conditions can exist concurrently at the same site, or
individually at different sites within the same mouth and are generally agreed to be the
result of host-bacterial interactions. The distinction between the two conditions depends
on whether apical migration of the periodontal attachment from the ACJ has occurred,
the definition of periodontitis. Although traditionally gingivitis and periodontitis have
been divided into acute and chronic conditions, in the majority of cases they are chronic
conditions, which can persist for many years (Williams et al, 1992).
1.1.1 Gingivitis
Clinically normal healthy gingiva has a pink appearance, firm consistency and a
scalloped gingival margin. The interdental papillae are firm, completely fill the
interdental space and do not bleed on gentle probing. (Lindhe, 1989). Histological signs
of inflammatory changes in gingival tissue develop within approximately 48 hours of
plaque accumulation and after 10 to 20 days, overt signs of gingival inflammation can
be observed clinically in most individuals in the continued absence of oral hygiene. If
microbial plaque is removed and adequate oral hygiene procedures instigated, then
these inflammatory changes are reversed and a clinically healthy appearance can be
restored after a few days (Loe et al, 1965; Theilade et al, 1966).
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1.1.2 Classification ofGingivitis
1.1.2.1 Chronic or adult gingivitis
Chronic gingivitis can be defined as inflammation of the marginal gingival tissues due to
the accumulation of dental plaque and is characterised clinically by redness, swelling,
and increased tendency to bleed on probing. Histologically, inflammatory changes do
not involve the underlying periodontal ligament and alveolar bone. The epithelial
attachment does not extend apically beyond its normal position at the amelocemental
junction. Chronic gingivitis is almost universally prevalent in the adult population,
however there is wide variation in the clinical signs of gingivitis between subjects.
Although the most obvious differences between individuals can be ascribed to levels of
dental plaque, either generally or specifically associated with local plaque traps,
different subjects appear to have different sensitivities to the effects of a given quantity
of dental plaque. Chronic gingitivis can remain unchanged for many years or may result
in the development of periodontitis.
1.1.2.2 Acute necrotising ulcerative gingivitis
ANUG mainly affects young adults with poor oral hygiene in conjunction with other
predisposing factors such as smoking, concurrent viral infections and a defective
immune response (Johnson and Engel, 1985; Williams et al, 1992). It is a destructive
inflammatory gingival condition characterised clinically by interproximal necrotic ulcers
in addition to those features described for chronic gingivitis. These lesions are
extremely painful and are often covered by a slough or pseudomembrane. Affected sites
commonly have a pre-existing chronic gingivitis. Other features can include, linear
erythema, bleeding, foetor oris, lymphadenitis, fever and malaise. (Lindhe, 1989). If
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untreated these ulcers may enlarge and spread rapidly to involve the marginal gingivae,
and occasionally the attached gingivae. The condition may resolve after a few days, but
is prone to recur. Alternatively, the acute phase of the disease can subside and chronic
necrotising gingivitis can ensue, which continues to destroy the periodontal tissues but
at a slower, less dramatic rate.
1.1.2.3 Childhood gingivitis
Although gingivitis is very rare before the age of six years, its prevalence increases
gradually until puberty when over 90% of children are affected These lesions are
reported to have a predominately T-lymphocyte infiltrate (Seymour et al, 1981;
Williams et al, 1992).
1.1.3 Periodontitis
Chronic periodontitis can be defined as plaque induced inflammation of the periodontal
tissues which results in the destruction and loss of the periodontal ligament and crestal
alveolar bone with concomitant apical migration of the epithelial attachment (Williams
et al, 1992). Over time this can result in the formation of a periodontal pocket produced
by the continued migration of the junctional epithelium on to the root surface.
Ultimately, the destruction of the supporting tissues may result in exfoliation of teeth.
This process is the major cause of tooth loss in adults (Listgarten, 1986a,b).
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1.1.4 Classification of Periodontitis
1.1.4.1 Adult periodontitis
Adult periodontitis is the most common form of periodontitis and is characterised by
inflammation and loss of periodontal attachment which usually starts after 30 years of
age. There is considerable variation in disease expression between subjects suffering
from disease classified as adult periodontitis. Patients with adult periodontitis that does
not respond to normal treatment procedures have been grouped into an additional
category called refractory periodontitis (Lindhe and Nyman, 1984; Adams, 1992).
1.1.4.2 Early onset periodontitis
Early onset periodontitis includes a number of clinical conditions that affect a small
percentage of young people who appear to be especially susceptible to periodontal
disease characterised by rapid progression.
1.1.4.2.1 Localised juvenile periodontitis
LJP is characterised by severe rapid periodontal disease of the permanent first molars
and incisor teeth with onset around puberty. Typically, it is not associated with gross
plaque deposits and the affected tissues show little inflammation clinically. The recovery
ofActinobacillus actinomycetemcomitans from a high proportion of affected sites from
patients with LJP has implied a specific aetiological role for this organism in the disease
process (Slots et al, 1980; Zambon et al, 1983a,b). Generalised juvenile periodontitis is
described as clinically more extensive than LJP, affecting several teeth in other
segments in addition to the first permanent molars and incisors. There is debate at
present regarding LJP and GJP. Some workers believe that LJP and GJP are separate
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disease entities, others that GJP represents a more aggressive form of LJP or is the
result of untreated LJP (Lindhe, 1989).
1.1.4.2.2 Rapidly progressive periodontitis
This subset was proposed in the light of longitudinal studies indicating that
approximately 10% of adult periodontitis patients developed a more rapidly progressing
form of the disease (Hirschfield and Wasserman, 1978; McFall, 1982; Page et al,
1983a) The age of onset tends to be after 20 years and the disease is characterised by
generalised severe periodontal destruction. During active phases the gingival tissues are
described as being very inflamed, exhibiting haemorrhage, exudation of pus and
proliferation of the marginal gingivae. Soft tissue destruction and alveolar bone loss can
occur very rapidly and may be accompanied by systemic signs i.e. general malaise,
weight loss and depression. Furthermore, defects in either neutrophil or monocyte
chemotaxis have been reported in some of these patients (Page et al, 1983a).
1.1.4.2.3 Prepubertal periodontitis
Destructive periodontal disease of the primary dentition is extremely rare, although
localised and generalised forms have been described (Page et al, 1983b). Generalised
prepubertal periodontitis is associated with severe gingival inflammation, gingival tissue
proliferation, gingival recession and widespread, rapid destruction of alveolar bone. It is
a rapidly progressive disorder that can lead to early loss of the deciduous dentition and
may involve permanent teeth. Localised prepubertal periodontitis only affects the
periodontal tissues at one or more primary molars and is associated with moderate
clinical signs of inflammation, deep periodontal pocketing and localised bone loss are
features of affected sites. (Page et al, 1983b; Lindhe, 1989).
6
1.2 DENTAL PLAQUE
Dental plaque has been defined as the bacterial aggregations that form on the teeth and
other solid oral structures (Lindhe, 1989). It consists of microbial cells and their
products together with host cells and compounds mainly derived from saliva
(MacFarlane and Samaranayake, 1989). Dental plaque present in the dentogingival area
can be classified as supragingival, being deposited on the clinical crowns of teeth, and
subgingival, located in the gingival sulcus or periodontal pocket (Lindhe, 1989).
Supragingival and subgingival plaque have different physical appearances that reflect
differences in the supragingival and subgingival environments and microbiota.
1.2.1 Supragingival Plaque
1.2.1.1 Early plaque formation
Plaque begins to re-establish supragingivally within a few minutes of cleaning teeth with
the formation of an organic film or pellicle on exposed tooth surfaces (Van Houte et al,
1971). The acquired pellicle is produced by the reaction of glycoproteins, lysozyme and
immunoglobulins present in saliva with the clean hydroxyapatite surface (Williams et al,
1992). After cleaning, bacterial recolonisation of the tooth surface is achieved by
organisms adhering to the pellicle from saliva and organisms that remained in less
accessible areas of the tooth surface. Early colonisers of the tooth surface are mainly
Gram-positive cocci and rods, for example Streptococcus sanguis, Actinomyces
viscosus and Actinomyces israelii. Early bacterial plaque contains few, if any, Gram-
negative species (Gibbons and van Houte, 1973).
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1.2.1.2 Plaque development
In a classic experimental model of gingivitis, Loe et al (1965) and Theilade et al (1966)
described three distinct phases of plaque formation in human volunteers. Following
professional plaque removal the volunteers abstained from normal oral hygiene
procedures for up to three weeks. The clinical and microbiological changes in Gram
stain and morphology of plaque bacteria were noted. The first phase, observed from day
zero to day two, was associated with a proliferation of Gram-positive cocci and rods,
with Gram-negative cocci and rods contributing up to 30% of species. These
proportions are similar to those found in whole saliva. The second phase, observed
from day one to day four, exhibited an appearance and increase of Fusobacteria and
filaments. Spirochaetes appeared during the third phase, observed from day four to day
nine, and were associated with clinically detectable gingivitis.
Cultural studies have revealed that an orderly succession of species is observed as
supragingival plaque matures. Initially, Streptococci and Actinomyces dominate but
during the next three weeks of plaque accumulation Fusobacterium, Veillonella,
Treponema and Bacteroides species appear (Socransky et al, 1977a,b; Syed and
Loesche, 1978). The microbiological development of supragingival plaque is believed to
be due to ecological changes in the local environment related to bacterial interactions
and the availability of nutrients (Socransky, 1977b).
Supragingival plaque organisms utilise dietary carbohydrates and salivary components
as their main source of nutrients (Williams et al, 1992). Several species produce an
extracellular polysaccharide matrix that can contribute up to 50% of total plaque bulk




Initially, subgingival plaque develops as an extension of supragingival plaque and is
believed to become established as early as four weeks after the onset of clinical
gingivitis (Williams et al, 1992). Initial colonisers are Gram-negative cocci, rods and
spirochaetes, however a diverse flora quickly develops that reflects different ecological
pressures present in the subgingival environment (Lindhe, 1989). Potential colonisers of
the subgingival area have to utilise nutrients that are derived from gingival crevicular
fluid as opposed to saliva, cope with a lower oxygen concentration and negotiate host
defence mechanisms (Williams et al, 1992). As subgingival plaque matures the
microbiota consists predominantly of obligate anaerobes or facultative anaerobes, many
of which are motile including Porphyromonas, Fusobacterium, Selenomonas,
Capnocytophaga, Eikenella, and Vibrio species. These organisms do not produce
extracellular polysaccharide matrix for support, but depend instead on interbacterial
adherence and attachment to the host (Williams et al, 1992). Subgingival plaque is
therefore generally less dense than supragingival plaque, although it can have both solid
and semi-liquid states (Christersson et al, 1991).
Over time the subgingival microbiota becomes more complex and over 300 species
have been isolated from subgingival plaque (Moore et al, 1985). In advanced
periodontal pockets the cultivable flora is dominated by anaerobic species, the majority
of which are Gram-negative rods including, Bacteroides spp., Fusobacterium




Histological and electron microscopic studies of gingivitis and periodontitis provide
valuable information about the cellular events that occur during these disease processes
and permit speculation about the pathogenic mechanisms that are responsible for the
observed tissue changes. Although the histological and ultrastructural features have
been divided into stages, the disease process represents a continuum and these stages
do not distinguish the sequence of signs and symptoms observed clinically.
Page and Schroeder (1976) summarised the histological and ultrastructural events
observed in the development of human and animal gingivitis and periodontitis. Their
work indicates a sequence of four stages in the pathogenesis of periodontal disease
beginning with the initial accumulation of supragingival plaque at previously healthy
sites.
1.3.1.1 Initial lesion
The initial lesion develops within two to four days of plaque accumulation and is
confined to the region of the gingival sulcus. During this stage vessels of the gingival
plexus become engorged and dilated, and large numbers of PMNL migrate into the
junctional epithelium and gingival sulcus. A few macrophages and blast-transforming
lymphocytes may appear in the connective tissue and junctional epithelium. Perivascular
collagen is lost and is replaced by fluid, serum proteins and inflammatory cells. These
changes are characteristic of an acute inflammatory response and are believed to be the
result of chemotactic and antigenic substances in the gingival sulcus region.
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1.3.1.2 Early lesion
The early lesion evolves from the initial lesion within four to seven days after the
beginning of plaque accumulation although there is no clear dividing line between the
two. As the growth of plaque continues, the features described above become more
marked and the inflammatory infiltrate becomes more extensive. There is an increase in
the number ofmacrophages and lymphocytes present, with initially both T and B cells
present, although T cells dominate towards the end of the second week of plaque
accumulation. In the early stages plasma cells are normally present only at the lateral
and apical periphery of the infiltrate. Fibroblasts begin to show signs of cell damage
including enlargement, swollen mitochondria, vacuolisation of the rough endoplasmic
reticulum and rupture of the cell membrane. Marked collagen loss is evident near the
junctional epithelium and may reach 60 - 70%. Rete peg proliferation can be observed
in the coronal part of the junctional epithelium.
The features of chronic inflammation begin to dominate the lesion as time progresses,
however the features of an acute inflammatory response, including crevicular fluid flow
and PMNL migrating into the gingival crevice persist
1.3.1.3 Established lesion
The established lesion develops within two to three weeks of plaque accumulation and
is characterised by a predominance of plasma cells within the inflammatory infiltrate.
The extent of the inflammatory infiltrate has increased both laterally and apically,
although it is still centered around the base of the gingival sulcus and junctional
epithelium. These plasma cells are actively engaged in the production of
immunoglobulins which are released locally and pass through the junctional epithelium
to enter the gingival crevice. Plasma cells are no longer confined to the reaction site but
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may also be found along blood vessels and between collagen bundles deep within the
connective tissues. The migration of PMNL into the gingival crevice becomes more
marked and as a consequence the junctional epithelium is heavily infiltrated with these
cells. Once in the gingival crevice they attach to the outer surface of the plaque to form
a layer between it and the junctional epithelium. The coronal portion of the junctional
epithelium and oral sulcular epithelium can show marked lateral proliferation into the
connective tissue although there is as yet no apical migration of the epithelial
attachment. The junctional epithelium may be thinned and detached from the tooth
surface in places and ulceration can occur. Continuing loss of collagen is evident
throughout the connective tissue in the zone of infiltration and in more distant regions,
however loss of alveolar bone or connective tissue attachment are not seen. In addition
to those described, features of the earlier stages of the lesion are also present, often in
an accentuated form. This stage represents a stable interaction between dental plaque
and host defences that may persist for months or even years without any signs of further
disease progression.
1.3.1.4 Advanced lesion
The advanced lesion as described by Page and Schroeder (1976) represents destructive
periodontitis and includes loss of alveolar bone and periodontal ligament, fibrosis of the
gingiva and pocket formation.
The lesion is no longer localised and features of the acute inflammatory response persist
in the presence of a chronic inflammatory infiltrate extending apically as well as
laterally. In addition, a dense infiltrate of plasma cells, lymphocytes and macrophages
are observed. At its deepest extent it is often focal and perivascular, separated by bands
of fibrous tissue. Lateral proliferation and ulceration of the junctional epithelium
continue to be a feature along with apical migration of the epithelial attachment. This
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event coincides with pocket formation and permits the extension of subgingival plaque
on to the root surface. Bone destruction begins along the crest of the interdental septum
around communicating blood vessels some distance from the inflammatory infiltrate,
often separated from it by trans-septal collagen fibres. Although these fibres appear to
be continuously regenerated as the lesion progresses apically, other collagen fibre
bundles loose their orientation and architecture completely. Collagen fibres are
practically absent within the hypercellular infiltrated connective tissue, whereas dense
fibrosis is evident in the surrounding area.
The advanced lesion can, like the established lesion, become stable. Active periodontal
destruction is believed to occur in an episodic manner, interspersed with period of
quiescence. This is discussed in section 1.7.
1.3.2 Plaque
1.3.2.1 Supragingival
The gross histological features of supragingival plaque were discussed in the previous
section.
1.3.2.2 Subgingival
Ultrastructural studies have revealed that subgingival plaques comprise a variety of
bacterial morphotypes and exhibit considerable variation between specimens
(Listgarten, 1976; Newman, 1976). In a recent study of patients with chronic
periodontitis, Vrahopoulos et al (1992) reported that established subgingival plaque
consisted of three to four layers, from the root surface to pocket epithelium. The first
layer nearest the cementum consisted of densely packed Gram-positive coccoid cells
13
arranged perpendicular to the root surface in palisades. Although Gram-negative cocci
and rods were predominant in the middle layers, Gram-positive filaments were also
common. Spirochaetes were usually close to the superficial layer, randomly distributed
among the other forms. The most superficial layer exhibited three general patterns
depending on the density of bacterial cell packing. The loose type of superficial layer
was the most common and comprised a variety of bacterial forms usually without
orientation, including spirochaetes, Gram-negative filaments, coccoid and rod-shaped
cells. Corn-cob, rosette and tooth brush forms were observed at the outermost level of
this layer. The dense type of superficial layer was restricted to Gram-negative and Gram
variable coccoid and rod-shaped bacteria with a few filaments and spirochaetes. A layer
of erythrocytes was frequently found at the pocket surface of these types of plaques.
The very dense type of superficial layer consisted of closely packed bacteria,
predominantly Gram-negative and Gram variable cocci, short rods and filaments, with
the occasional spirochaete. A feature of these plaques was a layer of PMNL lining the
pocket surface. Apically, subgingival plaque has been found to vary in its termination
ranging from a long gradual reduction in bacteria, to a series of bacterial islands of
Gram-negative cocci and short rods with occasional spirochaetes extending into a
plaque free zone (Vrahopoulos et al, 1992). In a recent SEM study of extracted healthy
and periodontitis-affected teeth, Friedman et al (1992) reported that microorganisms
were always present in the "plaque-free zone" and that in healthy specimens the apical
border plaque consisted mainly of cocci and short rods whereas in diseased teeth
spirochaetes predominated.
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1.4 ECOLOGY OF PERIODONTAL POCKET
1.4.1 Acquisition and Development of the Oral Microbiota
During the first few months of life an infant relies on passive immunity, acquired from
its mother, for protection against infection. Passive immunity is believed to exert a
strong influence on the composition of the resident microbiota that colonises the skin
and mucous membranes of the infant (Lehner, 1982). In turn, the acquired microbiota is
thought to influence some of the characteristics of the developing immune system. This
interplay between immune system and microbiota continues throughout the life of the
individual and results in the establishment of a commensal microbiota of skin and
mucous membranes that is a prerequisite for health (Listgarten, 1986a). There is
believed to be an element of chance involved in which organisms initially colonise a
particular site and thus fill the related niches in the ecosystem. These initial random
events thereby influence the sequence of subsequent ecological succession (Donoghue,
1990; Socransky et al, 1988a).
Using predominant cultivable microbiota techniques, Kononen et al (1992 a,b),
investigated the colonisation by several Gram-negative anaerobic bacteria in
30 edentulous infants and their mothers. These workers found that various bacterial
species readily colonise the oral cavity of edentulous infants, including Prevotella
intermedia, Fusobacterium nucleatum, Eikonella corrodens, Prevotella
melaninogenicus, Bacteriodes gracilis as well as Veillonella, Wolinella,
Capnocytophaga species and non-pigmenting Prevotella species. They also found that
the number of different anaerobic species in the same infant mouth increased in direct
proportion to age. They concluded that maternal saliva could act as a source of some
Gram-negative anaerobes and that these could become established in the oral
microbiota of edentulous infants (Kononen et al, 1992b).
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It has been known for some time that the newly formed gingival crevice is quickly
colonised, following the eruption of teeth, by organisms frequently isolated from the
oral cavity of adults (Gibbons and van Houte, 1975). However,
A. actinomycetemcomitans and Porphyromanas gingivalis are rarely detected in
edentulous infants (Kononen et al, 1992a), young children (Fisken et al, 1990) or
prepubertal children (Van Oosten, 1988). This observation has increased speculation
that A. actinomycetemcomitans and P. gingivalis may be exogenous pathogens in some
cases of destructive periodontal disease (Genco et al, 1988; van Oosten et al, 1988).
The hormonal events of puberty are believed to cause further shifts in the oral
microbiota. Van Oosten et al (1988) supported the theory that Bacteroides
melaninogenicus and Bacteroides intermedins were commensal organisms that were
given the opportunity to increase during puberty as a result of the hormonal imbalance
at this time.
Throughout the remainder of life, in addition to providing nutrients such as hemin,
long-chain fatty acids and serum proteins via the GCF, the immunologically competent
host is believed to exert ecological pressures on the periodontal pocket via non-specific
and specific defence mechanisms (Theilade, 1986). Non-specific mechanisms include
desquamation of pocket epithelial cells, PMNL, lysozyme and other bacteriocidal
enzymes and products in GCF. Specific defence mechanisms include the production of
specific antibodies that may aid phagocytosis of selected organisms or prevent them
from colonising the periodontal pocket. There is some evidence to suggest that the
composition of the oral microbiota and the incidence of some periodontal species
continue to develop throughout the life of the individual in response to these changes
(Savitt and Kent, 1991; Kononen et al, 1991).
16
A variety of mechanisms have been attributed to several periodontal bacteria that allow
them to colonise, evade host defences and cause tissue damage. These attributes have
been called virulence factors and will be discussed in section 1.6.4.1
1.4.2 Bacterial Interactions
The existence of an ordered structure to subgingival plaque (sections 1.2 and 1.3),
including the presence of formations such as palisading Gram-positive cocci, com cob,
rosette and toothbrush formations (Listgarten, 1976; Vrahopoulos et al, 1992),
supports the evidence that subgingival plaque contains a complex community of
organisms that are involved in commensal and antagonistic relationships. These range
from physical to nutritional and biochemical synergistic and antagonistic relationships
(Grenier and Mayrand, 1986; Ter Steeg and Van Der Hoeven 1989; Ohta et al, 1991;
Hillman and Socransky, 1982; Hillman et al, 1985). Some bacterial interactions could
be interpreted as potentially detrimental to the host by promoting the colonisation and
growth of suspected periodontal pathogens (Socransky et al, 1988b; Socransky and
Haffajee, 1991; Socransky and Haffajee, 1992). However, others may be of benefit to
the host. For example, a species may occupy a niche which would otherwise be
colonised by a pathogen, or may actively inhibit its growth. Alternatively, a species may
inhibit the action of or degrade virulence factors produced by a pathogen that would
otherwise have caused tissue damage (Socransky and Haffajee, 1992). One example of
interbacterial antagonism occurring between periodontal bacteria involves
A. actinomycetemcomitans and the following species, Streptococcus sanguis,
Streptococcus uberis and Actimomyces viscosus. Hillman et a!, (1985) showed that the
latter species produced hydrogen peroxide, either directly or via a host peroxidase
system that inhibited A. actinomycetemcomitans. Similarly, A. actinomycetemcomitans
was shown to produce a bacteriocin that specifically inhibited growth of S. sanguis,
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S. uberis and A. viscosus species, but not others (Hammond et al, 1987; Stevens et al,
1987) The effects of this mutual antagonism were observed by Socransky et al (1988a)
who reported decreasing odds of detecting A. actinomycetemcomitans across sites with
increasing levels of S. sanguis.
However, the oral cavity is an open ecosystem, and as such is continually exposed to
new microbial species and potential colonisers (Midtvedt, 1990). This means that in
addition to indigenous species comprising the normal resident flora, a transient flora can
also develop in a niche from time to time that comprises organisms "just passing
through" or temporarily filling a niche vacated by its normal resident. These organisms
are generally not ideally suited to the environment and usually disappear (Midtvedt,
1990). Therefore resident microbiota of the subgingival crevice is thought to be of
crucial importance in the defence against colonisation by possible periodontal pathogens
and potential extraneous colonisers (Preus, 1990). The property of resident species to
exclude potential extraneous colonisers can be termed colonisation resistance and arises
after the microbial population has become established, and inter-relationships have
developed, to produce a synergistically integrated microbial flora (Donoghue, 1990).
The effectiveness of colonisation resistance has been demonstrated in caries research,
with the ability of some dental plaques to resist colonisation by S. mutans (Perrons and
Donoghue, 1990).
As indicated above, the host plays an integral part in the development and maintenance
of the microbial environment and this is reflected in the observation that
immunocompromised hosts are prone to overgrowth of minor components of the flora
or colonisation by extraneous organisms (Samaranayake et al, 1984; Dreizen et al,
1986). Colonisation resistance may also be reduced in resident microbiota by the effects
of systemic broad-spectrum antimicrobials, the consequences of which have been well
documented (Gill and Pallach, 1981; Gordon et al, 1985). Indeed, Slots et al (1988,
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1990) and Rams et al (1992) concluded that the high percentage of Enterobacteraceae,
yeasts and Pseudomonas spp found in refractory sites from severe periodontitis patients
may be the result of prior systemic antimicrobial therapy. A recent study by Helovuo et
al (1993) reported that 42% of chronic periodontitis patients that had been prescribed
broad-spectrum antimicrobials, for the treatment of other diseases, developed a purulent
form of periodontal superinfection. These authors concluded that broad-spectrum
antimicrobials, in the absence of subgingival debridement and professional cleaning
could lead to a dramatic increase in the prevalence of enteric rods, staphylococci and
yeasts in the subgingival microbiota.
In summary, the oral cavity is initially colonised, at different sites, by a mixture of
various species largely by chance. Given time, the resident flora at a given periodontal
site develops, through host and bacterial inter-relationships, into a complex microbial
ecosystem. In health, the resident microbial flora in a subgingival crevice would be
expected to have the property of colonisation resistance and inhibit or prevent
colonisation by new or extraneous species.
The relationship between ecology and periodontal disease is discussed further in section
1.6.3.3
1.5 MICROBIAL IDENTIFICATION TECHNIQUES
1.5.1 Cultivation
Traditional methods of identification of organisms associated with periodontal diseases
have relied on culture of subgingival plaque samples. For example, the predominant
cultivable technique has been used in numerous studies at a limited number of centres to
characterise the predominant cultivable microflora associated with healthy sites (Slots,
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1977a), adult periodontitis sites (Slots, 1977b; Dzink et al, 1985, 1988; Moore et al,
1991), and juvenile periodontitis sites (Newman and Socransky, 1977; Haffajee et al,
1984; Moore et al, 1985). This technique involves the preparation of primary isolation
cultures of dispersed and diluted plaque samples, on non-selective media. After
anaerobic incubation, 30 - 50 colonies are chosen at random, subcultured to purity and
identified by Gram stain, biochemical tests and end product analysis e.g. gas liquid
chromatography.
In the early 1980's, existing concepts of disease activity were challenged and it was
proposed that periodontal destruction was not continuous and uniformly distributed as
once thought, but episodic and site-specific (Goodson et al, 1982; Socransky et al,
1984). The results of PCM studies of active and inactive periodontitis sites (Dzink et al,
1985,1988; Haffajee et al, 1988a,b), led to speculation that only a limited number of
species from several hundred that had been isolated from subgingival pockets (Moore et
al, 1985) were associated with episodes of periodontal disease activity. Furthermore, it
appeared that some species were beneficial to the health of the periodontium.
Although, the PCM provides a very wide picture of the subgingival microbiota, there
are several disadvantages to this approach that make it unsuitable for the detection of a
limited number of species in a large number of plaque samples. Subculture and
identification of randomly selected colonies on a primary isolation culture is time-
consuming, labour-intensive and depends ultimately on the viability of organisms in the
sample. For these reasons a number of rapid microbial identification methods have been





Immunofluorescence microscopy involves the use of either monoclonal or polyclonal
antibodies raised against specific periodontal species (Zambon et al, 1985, 1986; Gmtir,
1988). Typically, a subgingival plaque sample is spread on to a glass slide and fixed
before a species-specific or serotypically specific, monoclonal or polyclonal antibody is
added. This antibody can either be conjugated to a fluorescent substrate e.g. M lC or
TRTTC and fluorescence viewed directly, or it can be detected indirectly via
intermediate substrates which allow amplification of the signal before the fluorescent
substrate is added. A microscope with appropriate filters is used to view random fields
of plaque sample and count the number of cells exhibiting fluorescence. This count is
then compared to a total count of the same field viewed under phase contrast. Using
this approach Zambon et al, (1985), reported sensitivity of between 91 to 100% and
specificity of between 87% to 89%.
This approach has the advantage that the plaque sample is viewed directly and does not
rely on culture. However there are a number of disadvantages. Cross-reactivity of
monoclonal and polyclonal antibodies with several subgingival species appears to be a
common occurrence (Mouton et al, 1980; Gmiir and Guggenheim, 1983) and strict
testing of the specificity of the antibodies is advocated (Gmiir, 1988). The production
of both monoclonal and polyclonal antibodies is time-consuming and technically
demanding. Whole non-viable target cells can be included in the total count as they
continue to exhibit surface antigens after death. There is also concern that host-derived
antibodies to the same bacterial epitopes targeted by monoclonal and polyclonal
antibodies may cause masking and therefore lead to false negative results (Gmiir and
Guggenheim, 1990). Finally, microscopic examination ofmany plaque samples can be
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tedious, and require concentration and experience, factors which could limit the number
of samples assayed at one time (Gmtir, 1988).
1.5.2.2 Bacterial concentration fluorescence immunoassay
Wolff et al (1992) reported the development of a fluorescence immunoassay that is
performed in specially designed microtitre plates. The base of the wells in the microtitre
plate is a membrane filter that is situated above a waste reservoir. The washed and
resuspended plaque sample is added to a well along with species-specific FTTC-labelled
monoclonal antibody. After a short incubation, the well is washed and the contents
filtered through the base of the well into the waste reservoir under vacuum. This
removes unbound monoclonal antibody and allows the total bacterial bound
fluorescence to be determined by a fluorimeter. The relative bacterial cell equivalents
are determined by comparison to standard curves. This technique has the advantage of
being relatively fast. However many of the disadvantages of the use of
immunofluorescence microscopy noted above still apply. Sensitivity levels were
reported to be between 97% to 100%, and specificity ranged between 57% to 92%
(Wolff etal, 1992).
1.5.2.3 Chairside polyclonal assay - "Evalusite"
Polyclonal antibodies to specific suspected periodontal pathogens have been developed
by Eastman-Kodak into a chairside assay for the presence of P. intermedia,
P. gingivalis and A. actinomycetemcomitans. This system is based on a sandwich
enzyme immunoassay approach (Contestable et al, 1990). Discs of a porous membrane
are impregnated with polyclonal antibodies specific to the three organisms in three
distinct areas. A subgingival plaque sample is collected by sterile paper point and
deposited into an eluting solution. This is then added to one of the test discs and left to
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incubate at room temperature for a few minutes. During this time organisms expressing
these specific antigens are bound to the disc at the corresponding antibody dot site. A
second antibody, conjugated to horseradish peroxidase, is then added that binds to any
trapped antigen. Finally a colour development reagent is added that produces a
precipitate in the presence of the enzyme. The intensity of the colour precipitate at each
of the three sites is compared to a colour card supplied with the kit. The sensitivity of
this system is difficult to determine although the manufacturers claim a 90% specificity
(Contestable et al, 1990).
1.5.3 Restriction Enzyme Analysis
Restriction endonucleases can recognise and cleave double stranded DNA at the site of
specific base-pair sequences. The resulting fragments can be resolved by agarose gel
electrophoresis, ethidium bromide staining and visualised under ultra violet light
(Voytas, 1989). The number and size of DNA fragments obtained from a bacterial
strain constitute a specific fingerprint, which can be compared against other strains.
REA is especially useful in characterising the genetic heterogeneity within a species
(Loos et al, 1990; Chen et al, 1990; Han et al, 1991) and in epidemiologic studies to
investigate source and mode of transmission (Zambon et al, 1990; Genco and Loos,
1991). Furthermore, REA may be used to construct cloned DNA probes (see below).
1.5.4 Nucleic Acid Probes
Whole chromosomal (Savitt et al, 1988; Albandar et al, 1990; Lippke et al, 1991;
Gunaratnam et al, 1992; Haffajee et al, 1992), cloned (French et al, 1986; Savitt et al,
1988; Albandar et al, 1990; Zappa et al, 1990; DiRienzo and Slots, 1990) and
oligonucleotide (Dix et al, 1990; Maiden et al, 1992) nucleic acid probes have been
used for the detection of periodontal species in subgingival plaque samples. Isotopic
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and non-isotopic labels have been used in conjunction with the various probe types
listed above.
Whole chromosomal DNA probes are constructed by simply labelling whole
chromosomal DNA extracted from pure culture of the species under investigation.
However, there are potential problems with cross-reactions with genetically similar
organisms under conditions of low stringency (Savitt et al, 1990; Dix et al, 1990).
Whole chromosomal DNA probes have a lower limit of detection of 103 - 104
organisms (Savitt et al, 1990; Gunaratnam et al, 1992) with sensitivities and
specificities in the range 98% to 100% under strictly controlled conditions of high
stringency (Gunaratnam et al, 1992).
Cloned probes are produced by first isolating a specific DNA segment by restriction
endonuclease analysis and gel electrophoresis. Specific fragments are recovered,
integrated into a vector, e.g. plasmid DNA, and used to infect a rapidly multiplying and
easily cultured species such as E. coli. Multiple copies of the specific sequence are
produced which are then purified and labelled (French et al, 1986; DiRienzo and Slots,
1990; DiRienzo et al, 1990; Bolstad et al, 1991; DiRienzo et al, 1991). The sensitivity
of cloned DNA probes is comparable to that reported for whole chromosomal probes,
but they have the advantage that they can be species-specific and cross-reactions
between closely related species are avoided (French et al, 1986; Savitt et al, 1988).
Oligonucleotide DNA probes are typically 10-40 bases long and are synthesised base
by base to match species-specific sequences of nucleic acid, either in chromosomal
DNA or ribosomal RNA. These probes can have very short hybridisation times
compared to other probe types and are highly specific, however a disadvantage of their
size is that only one reporter molecule can be bound to each probe. If an
oligonucleotide probe has been synthesised to target regions of chromosomal DNA, it
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may not be as sensitive as whole chromosomal or cloned probes (Albandar and Olsen,
1990). This is due to the number of copies of target DNA sequence per cell and the
effect of probe size on the number of reporter molecules bound to each probe, although
strategies have been developed that can enhance the sensitivity of oligonucleotide
probes (Tenover, 1988).
Species-specific oligodeoxynucleotide probes synthesised to target regions of 16S
rRNA for periodontal organisms have been described (Chuba et al, 1988; Dix et al,
1990). This approach has the advantage that ribosomal RNA is present in cells in higher
amounts than DNA and so there are multiple copies of the target sequence contained in
each cell. Dix et al (1990) reported good specificity with sensitivity in the order of 103
cells for oligodeoxynucleotide probes directed against a range of ten periodontal
species. However, rRNA content of cells can vary enormously and make quantitation of
signals difficult (Savitt et al, 1990).
1.5.5 Polymerase Chain Reaction
Identification of different strains can also be achieved using products from the PCR
technique. Griffen et al (1992) described a technique that amplifies the highly variable
region between the 16S and 23S ribosomal genes by PCR and uses REA on the
products to differentiate between strains. This technique is claimed to be more precise
and reproducible than REA of whole chromosomal DNA noted above. Studies of 16S
rRNA genes retrieved directly from plaque samples using PCR products have recently
been reported (Wilson, 1993). The PCR technique can also be used to type bacteria by
amplifying whole chromosomal DNA with random primers and resulting products
compared by AGE (MacGowan et al, 1993).
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1.5.6 Enzymatic
Loesche et al (1987, 1990a) described the development of an enzymatic test to detect
T. denticola, P. gingivalis and B. forsythus in subgingival plaque samples. These
organisms can hydrolyse BANA (benzoyl-DL-arginine-naphthylamide), a synthetic
trypsin substrate. Decreased numbers of BANA positive sites have been demonstrated
following successful treatment of periodontal lesions, while clinical deterioration and
recolonisation of sites were associated with an increase in BANA positive sites (Bretz
et al, 1991). Sensitivity and specificity of the test have been reported to be 87% and
73% respectively (Loesche et al, 1990b). Although this technique has the advantage of
being rapid and assays the plaque sample directly, it cannot differentiate between these
three species and is therefore nonspecific. A commercial chairside kit for the rapid
detection of these three species in subgingival plaque samples has been developed
utilising BANA hydrolysis and is marketed under the name of "Perioscan".
1.5.7 Comparative Studies
A number of studies have compared the relative sensitivity and specificity of these rapid
methods of identification of organisms with traditional cultural techniques (Zambon et
al, 1985; Savitt et al, 1988; Maiden et al, 1991; Wolff et al, 1992; Loesche et al,
1992 a,b). A common finding is that the new methods were able to detect target species
in subgingival plaque where traditional cultural technique failed. This has prompted
calls for a review of cultural techniques as the reference or gold standard for the
identification of organisms in subgingival plaque samples (Loesche et al, 1992 b;
Loesche, 1992). These authors argue that cultural methods have multiple sources of
error inherent in the procedure that compromise the reliability of this technique, and
that DNA probes or immunological methods may prove to be more reliable reference
standards (Loesche, 1992).
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1.6 PATHOGENESIS OF PERIODONTAL DISEASE
1.6.1 Role of Dental Plaque in Periodontal Disease
It is well established that bacterial plaque forming on the teeth is the primary
aetiological factor of periodontal disease (Loe et al, 1965; Suomi et al, 1971). Whereas
there is excellent evidence linking dental plaque to gingivitis, the relationship between
plaque and periodontitis appears to be more complex (Williams et al, 1992). This
evidence has been derived from a variety of cross-sectional, longitudinal, human and
animal studies.
Longitudinal experimental gingivitis studies in humans (Loe et al, 1965; Theilade et al,
1966) and animals (Lindhe et al, 1973) have shown that complete withdrawal of oral
hygiene procedures results in a steady increase in plaque deposits and gingival
inflammation. Reinstitution of plaque control measures results in removal of plaque and
a return to gingival health within one week. Inhibition of plaque and gingivitis was
achieved in a group of volunteers, after the cessation of all oral hygiene procedures by
rinsing twice daily with a solution of 0.2% chlorhexidene gluconate. On discontinuation
of the mouthwash, plaque formed at normal rates with the development of gingivitis
again (Loe and Schi0tt, 1970). These results confirmed that dental plaque was
responsible for the production of experimental gingivitis in these volunteers.
Animal studies have also been important in establishing the role of dental plaque in the
aetiology of destructive periodontal disease. Longitudinal studies of ligature-induced
periodontal disease in beagle dogs revealed that gingivitis developed as a result of
plaque accumulation (Egelberg, 1965). If this gingivitis was maintained for five to seven
months, permanent destruction of the periodontal tissues ensued that was typical of
human periodontal disease (Saxe et al, 1967; Lindhe et al, 1973).
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Further evidence for the role of dental plaque in chronic inflammatory periodontal
disease comes from observations that improved oral hygiene procedures have been
shown to reduce gingivitis (Lovdal et al, 1961) and, in some cases, markedly retard the
progression of periodontitis (Suomi et al, 1971; Lindhe et al, 1984; Lindhe and Nyman,
1984).
1.6.2 Secondary Aetiological Factors
Secondary aetiological factors are recognised to contribute to the pathogenesis of
periodontal disease and can act either locally, and influence plaque accumulation or
systemically, and result in a modified host response to dental plaque.
1.6.2.1 Local factors associated with periodontal disease
Local factors that can influence periodontal disease can be divided into factors that
promote plaque accumulation and those that cause reduced salivary flow. Mechanical
plaque traps that promote plaque accumulation and therefore may predispose to
periodontal disease include calculus, carious cavities, margins of restorations and
crowns, partial dentures, orthodontic appliances, crowding and malocclusions and
anatomical variations of tooth morphology. Reduced salivary flow can be produced by
mouthbreathing or xerostomia, both of which may result in decreased antibacterial
actions of saliva. The resulting gingivitis has been attributed to accelerated plaque
accumulation (Williams et al, 1992).
1.6.2.2 Systemic factors associated with periodontal disease
A number of systemic factors have been proposed that are thought to modify the host
response to dental plaque in a variety of ways and result in different forms of
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periodontal disease. These can range from gingival hyperplasia seen in conditions
associated with hormonal changes i.e. pregnancy, and drug-induced hyperplasia i.e.
phenytoin, to increased or accelerated periodontal destruction which can result from
defects in tissue repair i.e. Ehlers-Danlos syndrome, or defects in host defences
(Williams et al, 1992).
1.6.2.2.1 Gingival hyperplasia
Increased progesterone levels, attributed to pregnancy, the contraceptive pill and
puberty, are thought to cause vascular changes in the gingival tissues that can result in a
hyperplastic, haemorrhagic gingivitis (Loe and Silness, 1963; Hugoson, 1970). The
effects of some drugs or their metabolites on gingival fibroblasts is believed to cause
gingival hyperplasia, however this may be reduced by good oral hygiene. The drugs
believed to contribute to hyperplasia include phenytoin, cyclosporin A and nifedipine
(Williams et al, 1992).
1.6.2.2.2 Defects in tissue repair associated with accelerated periodontal disease
Several nutritional and genetic disorders can result in defective collagen turnover, which
is believed to contribute to accelerated periodontal disease. These include ascorbic acid
deficiency (scurvy), protein deficiency (Kwashiorkor), hypophosphatasia and Ehlers-
Danlos syndrome (Williams et al, 1992; Wilton et al, 1988).
1.6.2.2.3 Defects in host defences associated with accelerated periodontal disease
Increased periodontal destruction can to be a feature of a number of systemic
conditions that often result from functional abnormalities of PMNL, although other
defects are also suspected in some diseases. Conditions that can be associated with
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increased periodontal disease include diabetes mellitus, acquired and genetic defects in
PMNL function, and HIV infection.
1.6.2.2.3.1 Diabetes mellitus
Changes in periodontal vasculature and impairment ofPMNL function have been
reported in relation to increased periodontal destruction seen in poorly controlled
insulin-dependent diabetes mellitus patients (Safkan-Seppala and Ainamo, 1992). Non-
insulin dependent diabetes mellitus patients are also thought to be at risk for periodontal
disease (Emrich et al, 1991).
1.6.2.2.3.2 Defects in PMNL function
Agranulocytosis, cyclic neutropenia and chronic idiopathic neutropenia have all been
associated with severe destructive periodontal disease (Zubery et al, 1991; Prichard et
al, 1984; Newman and Rule, 1983; Vaughan et al, 1990). The severe periodontal
destruction sometimes seen in patients with Down's syndrome, Papillon-Leferve
syndrome and Chediak-Higashi syndrome (Eklund et al, 1968; Clark and Kimball,
1971) is believed to be related to various defects in PMNL function associated with
these conditions (Wilton et al, 1988). A percentage of subjects infected with HTV can
suffer from a range of clinically distinct periodontal diseases. These range from a linear
gingivitis and ANUG to more destructive lesions i.e. HTV-periodontitis and necrotising
stomatitis (Winkler et al, 1988). These conditions will be discussed in section 1.8.4. and
the contribution of a suppressed or defective host response to periodontal disease will
be discussed in section 1.6.5
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1.6.3 Microbiology of Periodontal Disease
The study of the microbiology of periodontal diseases has been made difficult by an
array of problems, however, considerable progress has been made in the last twenty
years (Socransky et al, 1982, 1987).
1.6.3.1 Gingivitis
Although specific pathogens have been proposed for gingivitis (Loesche and Syed,
1978), most investigators agree that gingivitis is a non-specific inflammatory reaction to
indigenous bacteria. The composition of the oral microbiota may vary from person to
person and from site to site (Theilade, 1986).
1.6.3.2 Acute necrotising ulcerative gingivitis
Loesche et al (1982) isolated a constant flora comprising Treponema spp., Bacteroides
intermedius, Fusobacterium and Selenomonas spp. in addition to a highly complex
variable flora comprising of 70 taxonomic groups in plaque samples from sites of
ANUG. Although it is believed that these four bacterial groups contribute significantly
to the pathogenesis of ANUG, other factors including stress, fatigue, smoking, poor




1.6.3.3.1 Specific and non-specific plaque hypotheses
Traditionally, there exist two main theories of the microbial aetiology of destructive
periodontal disease, namely the non-specific and the specific plaque hypotheses
(Socransky et al, 1982). Historically, these two theories were diametrically opposed,
one or other dominating the opinion of oral microbiologists over the last 100 years.
Proponents of the specific theory believed that there existed a single pathogenic species
in destructive periodontal diseases and that treatment should be directed towards the
elimination of this species. Prevention of periodontal disease could be achieved by the
prevention of colonisation by the species (Theilade, 1986). Supporters of the non¬
specific theory of plaque believed that destructive periodontal diseases were caused by
indigenous microorganisms and that all plaque bacteria contributed to the pathogenesis
of the disease. Treatment of the disease should involve the elimination of plaque and
prevention would be achieved via adequate plaque control (Theilade, 1986).
Improvements in microbiology, sampling techniques and characterisation of subgingival
plaque samples from individual sites, as opposed to the analysis of pooled plaque
samples, have revealed great complexity and variability in microbiology of plaque
between individuals, between sites within the same individual and also from time to time
within the same site (Moore et al, 1984). A number of investigators proposed that
different microbial complexes were associated with different periodontal diseases
(Newman et al, 1976; Newman and Socransky, 1977; Slots, 1976; Tanner et al, 1979).
This idea was enhanced by the mounting evidence that A. actinomycetemcomitans had a
major aetiological role in both juvenile periodontitis and adult periodontitis (Newman et
al, 1976; Slots, 1976; Slots et al, 1980; Mandell and Socransky, 1981; Zambon et al,
1983b). Black-pigmenting Bacteroides and spirochaetes were also found to be
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associated with destructive periodontal disease in adults (Tanner et al, 1979, 1984;
Spiegel et al, 1979). Dzink et al (1985,1988) compared the predominant cultivable
microbiota from active and inactive sites and concluded that the likelihood of a site
showing activity increased dramatically if any, or a combination of any, of the following
species were present in increased numbers; A. actinomycetemcomitans, Bacteroides
forsythus, Bacteroides gingivalis, Bacteroides intermedius, Wolinella recta,
Peptostreptococcusmicros. These species were termed suspected periodontal
pathogens. These authors also found that the presence of Capnocytophaga ochracea,
Veilonella parvula, Streptococcus mitis, Streptococcus sanguis II, or Actinomyces spp.
appeared to lessen the chances of a site being active and so were termed beneficial
species. However, some authors pointed out that suspected periodontal pathogens were
not exclusive to active periodontal disease sites, but were also found in inactive
pockets, albeit in lower proportions (Theilade, 1986; Newman, 1990). Indeed, Dzink et
al (1988) were unable to demonstrate significant differences between the microbiota of
active and control sites when their data were corrected for multiple comparisons.
Furthermore, Moore et al (1991) failed to detect any significant differences between the
microbiota of active and control sites in adult periodontitis subjects, although the
microbiota associated with periodontitis patients differed from that in healthy subjects.
Theilade (1986) proposed modifications to the non-specific hypothesis and highlighted
the similarities between it and the modified specific plaque hypothesis (Socransky,
1977). There is general agreement that a limited number of the 300 or more potential
colonisers of the periodontal pocket play an important role in destructive periodontal
diseases and that the various ecological pressures within a subgingival pocket are
central to the aetiology of the disease. (Dzink et al, 1985,1988; Theilade 1986;
Socransky et al, 1987; Socransky and Haffajee, 1990; Newman, 1990). Some workers
believe imbalances or shifts in plaque ecology, perhaps from one that was host-
compatible to one containing an overgrowth of indigenous organisms having pathogenic
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potential, are responsible for active episodes of destructive disease (Theilade, 1986;
Newman 1990). This view is similar to the theory proposed by Socransky et al
(1988a,b, 1991). Using PCM and cluster analysis, these authors found evidence of
various microbial complexes that could be associated with healthy or diseased sites.
They proposed that interactions between host and resident subgingival microbiota, and
between different bacterial species could result in a series of selection pressures which,
over time, influenced the composition of the microbiota in the gingival crevice. This
could result in a spectrum of microbial complexes at different sites within the same
subject, ranging from host-compatible to pathogenic. Pathogenic microbial complexes
were generally combinations of suspected periodontal pathogens (Haffajee et al, 1988b;
Socransky et al, 1988a,b, 1991). Interestingly, colonisation of a site by a suspected
periodontal pathogen, although necessary, was not considered sufficient for active
disease, and it was proposed that a prolonged period of latency following initial
colonisation may result before it initiated active disease (Socransky et al, 1991).
Furthermore, whereas low levels of suspected periodontal pathogens may be tolerated
by the host, threshold levels had to be exceeded to initiate disease progression and that
these thresholds may be lower in patients who are susceptible to disease (Haffajee et al,
1991; Socransky and Haffajee, 1992) These authors also proposed that a carrier state
could exist with respect to the suspected periodontal pathogens in some patients,
making the identification of the aetiologic agents of periodontal disease more difficult
One of the differences between these two theories is that one refers to commensal
organisms with pathogenic potential, whereas the other to suspected periodontal
pathogens. However, the suspected periodontal pathogens appear capable of behaving
like commensal organisms for most of the time (Socransky et al, 1991).
In summary, it would appear that the basis for the controversy surrounding the non¬
specific and the specific plaque hypotheses has evaporated (Theilade, 1986; Newman,
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1990). The dominant theories of the microbial aetiology of destructive periodontal
diseases centre on the ecology of the subgingival pocket (Theilade, 1986; Socransky et
al, 1988a,b, 1991; Newman, 1990). For the majority of the time, the microbiology of
the subgingival pocket is compatible with periodontal health and may offer protection
against colonisation with possible pathogens (Socransky et al, 1991; Preus, 1990).
Episodes of active periodontal disease may be caused by shifts in the ecological balance
of subgingival plaque towards one with a pathogenic potential (Theilade, 1986;
Newman, 1990). Shifts in the ecological balance of subgingival plaque at a given site
could be caused by alterations of local enviroment such as increased supragingival
plaque accumulation (Theilade 1986; Katsanoulas et al, 1992), successful colonisation
and/or breach of tolerated threshold levels by specific species with pathogenic potential
(Socransky et al, 1991; Socransky and Haffajee 1992). However, as indicated in section
1.4, systemic factors may contribute to the pathogenesis of periodontal disease and
shifts in the ecological balance of the subgingival microbiota may also occur due to the
effects of systemic broad-spectrum antimicrobials (Slots et al, 1988; Rams et al, 1992;
Helovuo et al, 1993), or immunosuppression resulting from systemic disease or its
treatment (Samaranayake et al, 1984; Dreizen et al, 1986; Tenovuo et al, 1990; Slots
and Rams, 1991).
Whatever the cause of the change or shift in microbiology resulting in an active
periodontal disease site, some of the destructive processes are thought to be mediated
via the possession of virulence factors by periodontal bacteria (Theilade, 1986;
Socransky and Haffajee, 1991, 1992).
1.6.3.3.2 Exogenous pathogens
Genco et al (1988), proposed that two suspected periodontal pathogens could be
considered entirely exogenous pathogens, namely P. gingivalis and
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A. actinomycetemcomitans. These workers maintain successful prevention of at least
some destructive periodontal disease may be attained by prevention of the spread and
transmission ofA. actinomycetemcomitans. Although conclusive evidence has still to be
produced, there has been renewed interest in the acquisition and transmission of
A. actinomycetemcomitans and other periodontal bacteria (Fisken, 1990; Kononen et
al, 1992 a,b; Van Steenbergen et al, 1993).
1.6.4 Microbial Mechanisms in the Pathogenesis ofDestructive
Periodontal Diseases
1.6.4.1 Virulence factors
Virulence factors may be defined as the set of unique properties of a species which
permit colonisation, evasion of host defences and cause tissue damage (Slots and
Genco, 1984; Theilade, 1986; Socransky and Haffajee, 1991). Theilade (1986) argued
that all plaque bacteria contributed, more or less, to the destructive disease process by
the possession of various virulence factors, however, certain species played a larger role
than others because they increased in both number and proportion during active disease
in addition to virulence factors, mainly to evade host defences. Others proposed that
only pathogenic species would have multiple virulence factors (Socransky and Haffajee,
1991). In reviewing the literature, these authors listed a number ofmechanisms whereby
periodontal bacteria could contribute to the destructive process in periodontal disease.
Among the factors believed to aid colonisation are adhesins, which are specific
molecules on the surface of bacteria that allow attachment to host cells or the tooth
surface. These molecules are also thought to play a role in allowing bacteria to attach to
one another, a process called coaggregation. Evasion of the host defences by bacteria
could be mediated by the production of proteases to IgG and IgA, changing surface
antigens or mimicking host antigens. In addition to leukotoxin, produced by
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A. actinomycetemcomitans and the capsules produced by P. gingivalis, a number of
species have developed ways of disrupting phagocytosis and PMNL-mediated killing.
Mechanisms of suppression of the immune system involving both T and B lymphocytes
and activation of T-suppressor lymphocytes have been demonstrated. Invasion of host
tissues by bacteria in destructive periodontitis has been demonstrated, although it
remains a point of controversy and is not universally accepted as a common event in the
process of tissue damage (section 1.7). However, tissue damage could result solely
from the presence of specific bacteria or their products, or both, in the periodontal
tissues or from an immunological reaction to them. Virulence factors which cause tissue
damage can be divided in to those that cause damage directly ( e.g. hydrogen sulphide),
substances that cause host cells to release biologically active factors
(e.g. lipopolysaccharide) and substances that degrade the intercellularmatrix
(e.g. collagenase).
Socransky and Haffajee (1991) concluded that microbial virulence factors could
adversely affect virtually any cell or macromolecule present in the periodontium.
However, due to the fact that periodontal disease activity was rare, they suggested that
these substances are often not produced, do not react with their target or are prevented
from acting in the pocket environment. This suggestion would seem to gain support
from the observation that not all clonal types of a pathogenic species are virulent (Finlay
and Falkow, 1989). Clonal variants of periodontal pathogens with different virulence
have been isolated (Grenier and Mayrand 1987; McKee et al, 1988; Neiders et al,
1989) and have been proposed as a possible explanation to the observed variation in
disease between sites and between patients (Socransky and Haffajee, 1992). Another
possibility is that the production of virulence factors by pathogenic species may be
turned on or off in response to physical changes in the enviroment, for example,
temperature, osmolality or metal ion concentration, including Fe3+, Mg2+, and Ca2+.
Physical changes in the local enviroment may be produced by a traumatic event, such as
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food impaction and result in the production of virulence factors by these dormant
pathogens (Socransky and Haffajee, 1991, 1992). Finally, as mentioned above threshold
levels of suspected pathogens may be needed to initiate disease progression and these
thresholds may be lower in patients who are susceptible to disease (Haffajee et al,
1991).
1.6.5 The Host Response in Periodontal Disease
A number of studies published in the 1970's demonstrated the presence of host immune
and inflammatory cells in diseased periodontal tissues in response to bacterial plaque
e.g. Page and Schroeder (1976, section 1.3). Research by several groups has indicated
that an immune response, directed against specific bacteria present in the subgingival
pocket, is elicited by patients with periodontal disease. These responses vary between
individuals and are under genetic control (Seymour, 1991). Subgingival bacteria
together with soluble products (i.e. enzymes and toxins) and extracellular matrix are all
antigenic and, as with other bacterial diseases, mainly stimulate a humoral immune
response (Williams et al, 1992). There are a number of ways in which specific
antibodies to these elements can be produced. Antigens that penetrate the epithelial
barrier into the gingival tissues are recognised by macrophages, processed and taken to
local lymph nodes where they are presented to B-lymphocytes with the help of T-helper
lymphocytes (CD4+ T-cells). The B-lymphocytes that recognise each individual antigen
undergo blast transformation and differentiate into plasma cells. These cells remain in
the lymph node and secrete specific antibody into the blood stream which is then carried
back to the gingival tissues, passes into the gingival inflammatory exudate and into the
gingival crevice via GCF. Approximately 75% of the antibody produced in this way is
IgG with about 7% being IgM. However, some of the antibody is produced by local
plasma cells that remain in the gingival tissues and these cells account for approximately
15% of the total IgG produced (Ebersole et al, 1985; Tew et al, 1985). Although IgG
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subclasses predominate local antibody production (Mackler et al, 1978; Ogawa et al,
1989) some IgA and IgM producing cells have also been demonstrated (Mackler et al,
1977; Genco et al, 1974). There is also evidence that some bacterial products act as
polyclonal activators of B-cells which causes differentiation of these cells into plasma
cells and results in the production of irrelevant antibody that is secreted locally (Tew et
al, 1989). Another mechanism of specific antibody production involves Gut Associated
Lymphoid Tissue which recognises bacterial antigens swallowed with saliva and results
in the secretion of specific IgA with saliva. Specific antibodies can be effective against
periodontal bacteria by opsonisation, activating complement, activating PMNL enzyme
secretion, binding to bacteria and therefore inhibiting attachment to host surfaces and
inhibiting bacterial metabolism directly. They are also believed to be able to neutralise
toxins and inhibit enzymes produced by bacteria (Williams et al, 1992).
1.6.5.1 Bacterial factors
One of the most intensively studied examples of host-bacterial interaction in periodontal
disease is the association between A. actinomycetemcomitans and LJP. This organism
is detected frequently and often in high numbers in LJP lesions (Newman et al, 1976;
Slots, 1976; Zambon et al, 1983a,b), correspondingly the majority of LJP patients have
elevated serum antibodies to this species (Ebersole et al, 1980; Altman et al, 1982).
Furthermore, local antibody production has also been observed and antibodies have
been detected in gingival crevicular fluid (Murray and Genco, 1980; Ebersole et al,
1985; Tew et al, 1985).
A. actinomycetemcomitans is believed to have developed a number of strategies to
evade host responses (Slots and Genco, 1984; Socransky and Haffajee, 1991). It has a
capsule which resists opsonisation and phagocytosis and has its LPS with potent bone
resorbing activity. It also has a number of tissue degrading enzymes which are
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transported extracellularly in membrane vesicles. More importantly,
A. actinomycetemcomitans can also secrete a leucotoxin that is believed to effect
PMNL and macrophages (Baehni et al, 1979). However, there appears to be
considerable interplay between this species and the host defences (reviewed by Genco,
1992). The host is believed to overcome these difficulties by first producing specific
antibodies to neutralise the leukotoxin (McArthur et al, 1980; Tsai et al, 1981).
However as this is not sufficient to eliminate A. actinomycetemcomitans the host then
produces opsonic antibodies which fix complement and prepare the organism for
phagocytosis and intracellular killing by phagocytes (Baker andWilson, 1989). Zambon
et al (1983b) identified three distinct serotypes of A. actinomycetemcomitans, however
results of recent work by Gmiir et al (1993) have indicated that there may be as many
as five different serotypes. These serotypes are believed to have different virulence
potential with only certain strains possessing leucocidal activity and it is these strains
that are thought to predominate in UP subjects (Baehni et al, 1980; Asikainen et al,
1991b).
Many patients with advanced periodontal disease have been shown to elicit serum IgG
responses to P. gingivalis and P. intermedia (Mouton et al, 1981; Ebersole et al,
1986). P. gingivalis is also thought to possess a number of virulence factors (Slots and
Genco, 1984; Okuda and Takazoe, 1988; Socransky and Haffajee, 1991). It has a
capsule that resists opsonisation by complement, phagocytosis and killing by PMNL in
addition to LPS which inhibits chemotaxis and killing by leucocytes. However,
P. gingivalis has a wide range of tissue degrading enzymes including proteases,
fibrinolysins and phospholipases. Interestingly, it sheds small membranes vesicles,
containing protease, that are believed to be small enough to pass into host tissues (Slots
and Genco, 1984; Okuda and Takazoe, 1988). P. intermedia, however has a less
impressive array of virulence factors than P. gingivalis but it does have a capsule that
resists phagocytosis and LPS which is believed to affect immune cells (Williams et al,
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1992). Finally, prepubertal periodontitis patients have been found to have elevated
systemic antibody responses to C. sputigena, whereas post-pubertal periodontitis
patients had a reduced response to this organism (Vandesteen et al, 1984).
Longitudinal measurements of serum antibodies in periodontitis patients have indicated
changes in levels following treatment (Haffajee et al, 1984). Furthermore, Ebersole et
al (1985, 1986, 1987) demonstrated that the distribution of elevated GCF antibodies
and the presence of corresponding organisms at the same sites agreed in up to 78% of
samples. These authors also found a strong correlation between the isolation of specific
organisms from subgingival plaque at active sites with high levels of serum antibodies to
the same organisms (Ebersole et al, 1987). Recent work by Powell et al (1991)
demonstrated levels of IgG4 in GCF are elevated in GCF compared to levels in serum
and suggested that IgG4 production was induced locally. However, Gunsolley et al
(1987), found that levels of serum antibody to P. gingivalis and
A. actinomycetemcomitans were inversely related to disease level in a sample of
periodontitis patients, and postulated that a failure to mount a substantial antibody
response to these organisms could also result in more widespread disease in some
patients. Similarly, Kinane et al (1993) found GCF levels of specific IgG to
P. gingivalis were significantly lower in chronic periodontitis patients with deeper
pockets and more gingival inflammation.
Shenker (1987) questioned the effectiveness of the host's immune response, whether
humoral or cell-mediated, in periodontal diseases as infection with specific bacteria
seems to persist despite an apparently normal immune response. He and his colleagues
demonstrated that immunosuppressive characteristics, both B and T-lymphocyte
activation inhibition, were possessed by a number of suspected periodontopathogens
including T. denticola, A. actinomycetemcomitans, F. nucleatwn and several
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Bacteroides ssp (Shenker et al, 1982 a,b, 1984 a,b). The leucotoxic properties of
strains of A. actinomycetemcomitans have been mentioned above.
1.6.5.2 Polymorphonuclear leucocytes
Normal function and numbers of circulating PMNL are regarded as critical to the
maintenance of periodontal health (Miller et al, 1984; Page, 1990) as they possess a
considerable number of powerful antimicrobial mechanisms (Miyasaki, 1991). The
importance ofPMNL in the host response may be gauged by observations that patients
with neutrophil disorders i.e. agranulocytosis, cyclic neutropenia and chronic idiopathic
neutropenia suffer from severe periodontal disease (Aubrey and Hibbard, 1973; Zubery
et al, 1991; Baehni et al, 1983; Prichard et al, 1984; Vaughan et al, 1990).
Furthermore, patients with systemic diseases that can result in reduced neutrophil
function i.e. poorly controlled diabetes and Down's syndrome, have also been found to
be at risk for severe periodontal disease (Emrich et al, 1991; Safkan-Seppala and
Ainamo, 1992). Interestingly, several rare syndromes in which abnormal PMNL
functions are a feature can also suffer from severe periodontal disease i.e. Chediak-
Higashi Syndrome, Papillon-Leferve Syndrome, Lazy Leucocyte Syndrome. For
example, Chediak-Higashi Syndrome, which is transmitted by an autosomal recessive
gene, is associated with PMNL functional defects including reduced chemotactic
response and defective intracellular killing of bacteria. This syndrome is characterised
by an increased susceptibility to bacterial infections including advanced periodontal
disease (Eklund et al, 1968; Clark and Kimball, 1971).
There is also some evidence that patients with severe periodontal disease, but who are
otherwise healthy, can have altered PMNL function. PMNL function in LJP patients has
been studied extensively, however the exact nature of the defects in these patients
remain an area of considerable debate. Both defective phagocytosis and chemotaxis
42
have been demonstrated in PMNL from some LJP patients (Cianciola et al, 1977;
Suzuki et al, 1984; Clark et al, 1977). Van Dyke et al (1981, 1985a,b, 1987) reported
that the chemotactic defect is associated with reduced numbers of chemoattractant
receptors on the PMNL cell surface and produced evidence that this defect may be
familial. Interestingly, altered PMNL function is also thought to contribute to ANUG,
rapidly progressive periodontitis and refractory periodontitits (Cogan et al, 1983:
Genco et al, 1986; Leone et al, 1987; Van Dyke et al, 1985a; Van Dyke and Hoop,
1991). Nonetheless, PMNL and their contents are considered major contributors to the
acute inflammatory process observed in active adult periodontitis and may be
responsible for some host tissue damage seen in active periodontal disease (Kryshtalskyj
et al, 1986; Lamster et al, 1991).
1.6.5.3 Lymphocytes
Early phenotypic studies, using enzyme and cell surface antigen markers by Mackler et
al (1977) and Seymour and Greenspan (1979), reported that the majority of
lymphocytes present in active periodontitis lesions were B-lymphocytes, whereas stable,
gingivally confined lesions were dominated by a T-lymphocyte infiltrate, as seen in
gingivitis occurring in children (Seymour et al, 1981). The hypothesis that active tissue
destruction was associated with the conversion of a stable T-lymphocyte lesion to a B-
lymphocyte/plasma cell lesion was challenged by Page and Schroeder (1982) who
suggested that B-lymphocyte dominated lesions could also remain stable for prolonged
periods. However, recently Stoufi et al (1987) and Johannessen et al (1990) found that
whereas both T-cells and B-cells could predominate lesions, there was considerable
variation in the numbers of plasma cells present in individual active lesions.
Ivanyi and Lehner (1970, 1971) reported that peripheral blood lymphocytes (PBL) from
adult periodontitis patients underwent enhanced blastogenesis, compared to PBL from
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healthy controls, when stimulated by extracts of Veillonella alcalescens and
Actinomyces viscosus. However, later studies, found that PBL from periodontitis
patients behaved normally, in terms of blastogenesis, when presented with bacterial
antigens, mitogens or polyclonal activators (Kiger et al, 1974; Donaldson et al, 1982).
Interestingly, in a review of recent work, Tew et al (1989) proposed that polyclonal B-
cell activation is increased in some patients with periodontitis but estimated that
approximately 30% of subjects with severe periodontal disease do not have this
response. So at present the significance of polyclonal B-cell activation in the
pathogenesis of periodontitis, and whether it resolves after treatment, are still unclear.
Both T-helper (CD4+) and T-suppressor (CD8+) cell subsets are present in
periodontitis lesions (£elenligil, 1990) and their activity in periodontitis is inferred by
demonstrations of increased expression ofHLA-DR antigens and increased
concentrations of IL-1 in both GCF and gingival tissue extracts from periodontitis
patients (Reinhardt et al, 1988; Masada et al, 1990; Honig et al, 1989). However a
depressed CD4+: CD8+ ratio has been found in periodontal lesions compared to that
seen in health or in peripheral blood (Okada et al, 1982; Taubman et al, 1984; Manti et
al, 1984). This ratio is believed to be result of a local reduction in the numbers of CD4+
T-cells (Taubman et al, 1984; Stoufi et al, 1987) and it is thought that many of the
CD4+ T-cells that are present in periodontal lesions are in fact memory T-cells
(Taubman et al, 1991). These authors also proposed that local immunoglobulin and
antibody production could be suppressed by gingival CD8+ T-cells and aided by
gingival macrophages. Interestingly, Kinane et al (1989) observed significantly
depressed CD4+: CD8+ T-cell ratios in peripheral blood of 12 patients with early onset
periodontitis compared to age and sex matched controls. Collectively these studies
indicate that depressed CD4+: CD8+ T-cell ratio at a local level may contribute to the
pathogenesis of periodontal disease. The association between HIV infection,
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characterised by falling CD4+ and rising CD8+ T-cell numbers, resulting in depressed
CD4+: CD8+ T-cell ratios, and periodontal disease will be discussed in section 1.8.4.
Peripheral blood lymphocytes will undergo spontaneous proliferation after 5 to 7 days
in the absence of exogenous stimulants. This is called the autologous mixed lymphocyte
reaction (AMLR) and can be indicative of immunoregulatory activity by T-lymphocytes.
The AMLR has been shown to be depressed in patients with advanced periodontal
destruction in a number of studies (Tew et al, 1983; Suzuki et al, 1983, 1984).
However this returned to normal after treatment, suggesting that the depressed
response may be the result of disease activity, rather than the cause.
1.6.5.4 Monocytes and macrophages
It has been known for some time that macrophages play an important role in
phagocytosis and antigen presentation to lymphocytes, however, in addition it was
recently proposed that they may also help regulate local antibody production (Taubman
et al, 1991). In a recent study, McFarlane et al (1990) demonstrated that cultured
peripheral blood monocytes from periodontitis patients released greater quantities of
IL-lp and TNF-a than monocytes from healthy subjects when stimulated by bacterial
lipopolysaccharide (LPS). Whereas, Garrison and Nicols (1989) demonstrated
increased PGE2 release from monocytes of adult periodontitis patients stimulated by
LPS. These studies suggest that hyper-reactivity ofmonocytes to LPS may place
patients at risk for severe periodontal disease.
1.6.5.5 Inflammatory and immunologic mediators
The role of inflammatory and immunologic mediators in periodontal disease were
reviewed by Genco (1992). The identification of numerous cytokines, produced
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particularly by lymphocytes and macrophages, and the demonstration ofmany of these
cytokines in the GCF or gingival tissue, have led to intense speculation about their
contribution to the periodontal disease process (reviewed by Page, 1991). Although
there are a range of cytokines, IL-1 has attracted considerable attention after it was
demonstrated in GCF during periods of inflammation (Charon et al, 1982). Dewhirst et
al (1985) demonstrated that osteoclast activating factor was infact EL-1|3 and it has
since been localised in, and extracted from gingival tissue (Honig et al, 1989; Jandinski
et al, 1991). IL-1 is produced by activated macrophages and lymphocytes, platelets,
endothelial cells and fibroblasts and is also thought to be autostimulatory. However,
IL-1 is pleotrophic and in addition to stimulating osteoclastic-dependent bone
resorption, it is also believed to mediate many processes including antigen presentation,
PGE2 release from macrophages, attachment of PMNL and monocytes to epithelial
cells and induction ofmetalloproteinases e.g. procollagenase (Genco, 1992). IL-2,
previously known as T cell growth factor is produced by activated CD4+ T cells and
mediates T cell growth and proliferation, and TNF-a production by activated
macrophages. IL-6 is believed to regulate plasma cell infiltrate and preferentially
stimulates IgG-producing plasma cells, in addition to inducing IgG3 and IgG4
producing plasma cells (Genco, 1992). In addition to these individual properties many
cytokines including IL-1, TNF-a, IL-6 and TGF-(3 are thought to be important in bone
remodelling.
Page (1991) summarised the role of cytokines in a possible sequence of events leading
to periodontal tissue destruction: with the onset of vasculitis of small blood vessels
adjacent to the junctional epithelium, bacterial components and host cytokines induce
the expression of intercellular adhesion molecule, ICAM-1, on the surface of endothelial
cells. LTB4, TNF-a and activated complement components induce the expression of
adhesion molecules on PMNL and monocytes, which subsequently adhere to
endothelial cells via ICAM-1, then move into the surrounding connective tissue.
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Increased vascular permeability allows cells (PMNL, B and T-lymphocytes,
macrophages) to enter the tissues. Thus bacterial components appear to initiate a
sequence of events, but host factors are responsible for prolonging and amplifying the
process.
PGE2 has been the focus for research into the role of inflammatory mediators in
destructive periodontal disease for some time following the demonstration of this
arachnodonic acid metabolite to induce bone resorption in vitro (Genco, 1992).
Furthermore, Offenbacher et al (1986) demonstrated that PGE2 levels in GCF correlate
well periods of active periodontal disease.
Soft tissue degradation seen in periodontal disease are thought to be caused by both
bacterial and host derived enzymes i.e. plasmin, elastase and matrix metalloproteinases.
Matrix metalloproteinases include collagenase, stromalysins, gelatinase and their
production can be stimulated by bacteria directly or indirectly via the stimulation of host
cells to produce cytokines (Genco, 1992).
1.6.5.6 Complement system
The complement cascade when activated has a number of actions that are central to
control of the inflammatory response. There are two pathways in which the system may
be activated and result in the release of active components. The classical pathway
involves activation by antibody-antigen complexes i.e. antibody bound to the surface of
bacteria, or by the alternative pathway in which complement is activated by endotoxin
or by directly binding to a bacterial cell wall. Active components of complement are
important in opsonisation to enhance phagocytosis by PMNL and macrophages, causing
mast cells to degranulate thereby releasing histamine and other vasoactive molecules
into the area to affect the vascular response in inflammation and finally by causing lysis
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of some species directly. Several studies have shown that in most periodontal diseases
complement activation occurred via the alternative pathway, however in LJP
complement activation could have occurred via the classical and, possibly, the
alternative pathway (Genco, 1992).
1.6.5.7 Hypersensitivity reactions in periodontitis
Type I, II, and III immediate hypersensitivity reactions are antibody-mediated whereas
type IV hypersensitivity is cell-mediated. IgE-bearing mast cells are detected in very
low numbers in periodontal tissues and therefore Type I reactions are thought unlikely
to contribute to periodontal disease (Zachrisson et al, 1968; Nisengard, 1974). Type II
reactions, in which cell lysis is mediated by complement-fixing IgG or IgM antibodies,
have not been convincingly demonstrated in periodontal tissues (Ranney, 1991),
whereas, fixed immune complexes, characteristic of Type III reactions, have not been
observed (Genco et al, 1974). Type IV, cell-mediated delayed hypersensitivity reactions
are also thought to be unlikely because of the predominance of B-lymphocytes in many
periodontitis lesions (Ranney, 1991).
1.6.5.8 Autoimmunity in periodontal disease
Conclusive evidence of autoimmune tissue destruction in periodontal disease is lacking,
despite the existence of indirect evidence of this phenomenon. Hirsch et al (1989)
detected rheumatoid factor-producing cells in gingival tissue taken from adult
periodontitis lesions. Tew et al (1989) suggested that polyclonal B cell activators, such
as bacterial mitogens, might stimulate the proliferation of autoreactive B cell clones.
Local IgG antibodies to type I collagen were demonstrated in adult periodontitis
patients' tissues by Anusaksathien et al (1990). Singh et al (1990) could not
demonstrate a significant difference between autoantibody levels to 11 self-antigens in
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periodontitis patients and control subjects. Anusaksathien and Dolby (1991) reviewed
the literature on this subject and concluded that the autoantibodies found in diseased
periodontal tissue are derivatives of pre-existing natural antibodies (IgM class switched
to IgG) formed during the disease process in order to remove dead cells. However, in
certain circumstances this response may become excessive and lead to further tissue
damage.
1.6.6 Summary of Immune Responses in Different Forms of
Periodontitis.
1.6.6.1 Adult periodontitis
In his extensive review, Ranney (1991) concluded that patients with adult periodontitis
had normal immune functions which were fundamentally protective against local
invasion and septicaemia, since immunocompromised animals and humans often
experience severe periodontal tissue destruction. Some damage to the host tissues is
inevitable in the face of the inflammatory and immune mediators attracted to and
released into the periodontium. Ogawa et al (1989) postulate that chronic exposure of
B lymphocytes in gingival tissues to antigen during periodontitis induces a switch from
production of IgGi (which activates complement) to IgG4 (which does not), hence
host-mediated damage may be gradually reduced over time.
1.6.6.2 Early onset periodontitis
1.6.6.2.1 Localised juvenile periodontitis
A number of studies have produced conflicting evidence about the immune status of
patients with LJP (Lehner et al, 1974; Suzuki et al, 1984). The prevailing opinion now
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however, is that humoral and cell-mediated responses to A. actinomycetemcomitans are
normal, but PMNL function is abnormal in many, but not all, of these patients
(Cianciola et al, 1977; Clark et al, 1977; Van Dyke et al, 1981, 1984, 1985b; Page et
al, 1985). Infection by highly virulent organisms will also contribute to the disease
process. A good antibody response to A. actinomycetemcomitans seems to reduce the
extent and severity of EOP (Ranney et al, 1982; Gunsolley et al, 1987).
1.6.6.2.2 Rapidly progressive periodontitis and generalised juvenile
periodontitis
These disease categories do seem to be associated with immunological abnormalities in
the host. Engel et al (1984) demonstrated B lymphocyte hyper-responsiveness to
mitogens in cells from patients with severe, generalised EOP. Suzuki et al (1984)
found that a depressed AMLR was associated with generalised EOP and RPP, but not
with LJP. As mentioned above, this may be the result of disease, not a precipitating
factor. Low serum antibody titres to A. actinomycetemcomitans and P. gingivalis have
been associated with generalised EOP, as opposed to high titres to these species in
patients with localised disease (Gunsolley et al, 1987). This may be due to the
immunosuppressive abilities of certain isolates of these bacteria (Shenker, 1987). The
lack of an effective immune response seems to permit a much more rapid and
destructive process to occur.
1.6.6.2.3 Prepubertal periodontitis
Page et al (1983) reported chemotactic defects in both PMNL and monocytes in two
cases of generalised prepubertal periodontitis patients, whereas defects in chemotaxis
were reported to involve only PMNL in three cases of localised prepubertal
periodontitis.
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1.7 CURRENT CONCEPTS AND DIFFICULTIES IN THE STUDY OF
PERIODONTAL DISEASES
1.7.1 Indicators of Periodontitis
Although periodontal disease can be associated with a range of clinical signs, e.g.
gingival inflammation, bleeding, accumulation of plaque, these represent variable
responses between individuals. Of all the clinical signs associated with the disease only
two can be considered as a reliable indicators of periodontitis, namely localised
attachment loss and localised alveolar bone loss (Goodson, 1990). Methods of
measurement of attachment loss rely on the detection of the base of the periodontal
pocket and a fixed reference point i.e. the amelocemental junction. The degree of
periodontal attachment loss at a given site is assumed to be the distance between these
two points. However, a number of factors can influence this measurement including
probing force, shape and angulation of probe, degree of inflammation present at the site
together with the depth of the site to be measured (Blomqvist, 1986; Anderson et al,
1991; Mombelli et al, 1992; Atassi et al, 1992). The use of constant force manual
probes in combination with stents and the advent of automated probes have attempted
to address some of these problems (Van der Velden and de Vries, 1978; Jeffcoat et al,
1986; Gibbs et al, 1988; Espeland et al, 1991), however the accuracy and
reproducibility ofmeasurements varies greatly depending on the method used
(Goodson, 1990; Mintzer and Derdivanis, 1993). As a result of these developments,
error in measurement of attachment loss by traditional methods using a conventional
periodontal probe has been criticised as being unacceptably high (Best et al, 1990;
Espeland et al, 1991).
Methods of measurement of localised bone loss involve the use of radiographs and
there are a number of techniques that can measure height of alveolar bone on a
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radiograph including direct visual measurement, subtraction radiography and computer-
enhanced image analysis (Lamster and Karabin, 1992). However, variations in the
positioning and angulation of film, exposure and film processing can also produce
errors in these measurements (Webber et al, 1990; Hausmann et al, 1991).
A common problem with both direct measurement of attachment level and radiographic
assessment of alveolar bone loss is that a single measurement is indicative only of the
sum total of past periodontal disease experience at any given site. Two examinations are
required to determine whether further periodontal attachment loss has occurred
between the examinations. This implies that periodontal disease progression can only be
determined retrospectively using these methods ofmeasurement (Goodson, 1990,
1992).
1.7.2 Models of Periodontal Disease Progresion
Cross sectional epidemiological data from a variety of geographic locations (reviewed
by Goodson, 1990) indicated that the correlation between age and severity of
periodontal disease was linear. Although there were wide individual variations, the
mean rate of periodontal destruction was estimated between 0.1 and 0.2 mm per site
per year. The results of these studies gave rise to the continuous model of disease
progression in which periodontal attachment loss progressed in diseased sites in a slow,
inexorable fashion in the absence of treatment. However, a number of longitudinal
studies of periodontal attachment loss in individual sites in groups of patients with prior
evidence of periodontal disease challenged the continuous model of disease progression
(Goodson et al, 1982; Haffajee et al, 1982; Lindhe et al, 1983; Socransky et al, 1984).
These studies found that attachment loss occurred in only a small percentage of sites
monitored, but when observed the magnitude of loss was usually between 2-5 mm.
The majority of sites, despite the presence of inflammation showed no progression.
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These observations in conjunction with results from animal studies, prompted the
theory that disease progression was more likely to occur in rapid bursts of activity at
only a few sites, interspersed with long periods of quiescence (Socransky et al, 1984).
Furthermore, it was proposed that these bursts of activity could occur randomly
throughout adult life i.e. Random Burst Theory, or that they would be more likely at
certain periods of an individuals life i.e. Asynchronous Burst Theory. According to
these theories active disease is believed to be an uncommon event occurring in 5% of
sites of patients with untreated periodontal disease (Goodson et al, 1982; Haffajee et al,
1983). Long term periodontal health is associated with a stable host compatible
subgingival microbiota with infrequent active phases of the disease brought quickly
under control by host and/or microbial influences (Socransky et al, 1988a).
Recently, however, the use of automated probes, with the capacity to measure
attachment levels to an accuracy of 0.2 mm, have found that the prevalence of disease
progression is dependent on the threshold of attachment loss used to indicate active
disease (Jeffcoat and Reddy, 1991). These authors found that active disease occurred in
29% of sites measured when a threshold of 0.4 mm was used, compared to 2% of sites
deemed active when the threshold was over 2.4 mm. Similar results using subtraction
radiography (Deas et al, 1991) have resulted in renewed debate on the rate of active
disease and patterns of disease progression (Jeffcoat and Reddy, 1991; Goodson,
1992).
1.7.3 Tests for Periodontal Disease Activity
As indicated above, a single measurement of attachment level or bone loss cannot give
an indication if a site is undergoing active periodontal destruction at any one point in
time (Greenstein and Caton, 1990). Therefore there has been considerable interest in
recent years in developing a test, preferably chairside, that could indicate active
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periodontal disease. These were reviewed by Reddy and Jeffcoat (1993) and fall into
two categories. The first involves methods to identify putative periodontal pathogens
(reviewed in section 1.5), whereas the second involves the search for markers of
inflammation or tissue breakdown in gingival crevicular fluid. These include levels of
host-derived enzymes i.e aspartate aminotransferase, collagenase, (3-glucuronidase,
lactate dehydrogenase, arylsulphatase and elastase; tissue breakdown products i.e.
hydroxyproline and glycosaminoglycans, and inflammatory mediators i.e. TNF-a ,
EL-lp, PGE2 (Offenbacher et al, 1986; Rossomando et al, 1990; Stashenko et al, 1991;
Johnson, 1991). Recently, temperature of the gingival sulcus has been investigated as a
possible indicator of active periodontal disease (Haffajee et al, 1992b,c).
1.7.4 Risk Indicators for Periodontal Disease
There has also been interest in the possibility of identifying individual sites or subjects
that are at risk for destructive periodontal disease (Bader et al, 1990; Beck et al, 1990;
Grbic et al, 1991; Haffajee et al, 1991a,b). Some of these studies have shown that age
and history of previous disease are two important risk factors for progressive disease.
Other factors are thought to include tobacco use, immunosuppression, stress, oral
hygiene, genetics, poorly controlled diabetes and specific microbiology (Bader et al,
1990; Reddy and Jeffcoat, 1993).
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1.7.5 Microbiological
Difficulties in the search for pathogens of destructive periodontal disease were reviewed
by Socransky et al (1987).
1.7.5.1 Sampling strategy
Problems in detecting periods of disease activity will have a significant effect on the
timing of sampling a periodontal pocket for microbiological investigation (Socransky et
al, 1987). If active disease is an uncommon event and imbalances in subgingival
microbiota are quickly brought under control, then the chances of sampling a
periodontal site at the peak of disease activity will be low (Theilade, 1986; Socransky et
al, 1987; Sterne et al, 1990). Therefore, microbiological results of samples from sites of
uncertain disease status may lead to either an under estimation of the contribution of a
suspected periodontal pathogen to the disease process, or simply reflect the microbiota
of a recovering disease site (Socransky et al, 1987).
The choice of sampling technique and handling of the samples can have a profound
effect on the recovery of microorganisms from a subgingival pocket. The most common
methods of obtaining a subgingival plaque sample from a site involve either the use of a
sterile scaler or paper point. Some workers have reported better results with a scaler
compared to paper point (Tanner and Goodson, 1986; Baker et al, 1991), whereas
others have favoured the paper point (Dahlen et al, 1990; Renvert et al, 1992).
However, it is clear that caution should be exercised when comparing results from
papers that use dissimilar sampling methods (Tanner and Goodson, 1986, Baker et al,
1991; Wikstrom et al, 1991).
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These difficulties are superimposed on the concerns of some workers that dispersal
methods and selection pressures of non-selective media used in cultivable techniques,
distort the microbiological profile of a plaque sample leading to undue attention being
focused on the cultivable organisms only (Socransky et al, 1987; Theilade, 1986).
These factors, in addition to the increased sensitivity claimed by new rapid methods of
bacterial identification, have led to calls for the replacement of culture techniques as the
gold standard of bacterial identification in subgingival plaque samples (Loesche et al,
1992a,b,c).
1.7.5.2 Virulence
Asikainen et al (1991b) used indirect immunofluorescence microscopy to assess the
prevalence of different serotypes of A. actinomycetemcomitans between healthy, LJP,
EOP and adult periodontitis sites. They found various serotypes of
A. actinomycetemcomitans in 96 - 100% of the sample groups, however, the majority
of patients had only one serotype and this varied between the groups studied. Healthy
sites were more likely to colonised by serotype c and diseased sites were more likely to
be colonised by serotype b. These authors proposed that different virulence could be
attributed to the different serotypes ofA. actinomycetemcomitans. This is in agreement
with DiRienzo and Slots (1990) who proposed that varying virulence potential may
exist with different serotypes of A. actinomycetemcomitans.
1.7.5.3 Invasion of host tissues
Microscopic techniques have demonstrated the presence of bacteria within periodontal
tissues in ANUG (Listgarten, 1965; Courtois et al, 1983) in LJP (Saglie et al, 1982)
and in adult periodontitis (Allenspach-Petrzilka and Guggenheim, 1983). These findings
prompted speculation that active bacterial invasion could result in acute episodes of
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periodontal destruction (Allenspach-Petrzilka and Guggenheim, 1983). However, some
workers believe that, with the exception of ANUG and possibly LJP, active bacterial
invasion has still to be convincingly demonstrated in periodontal disease (Listgarten,
1986; Liakoni et al, 1987; Newman, 1990). They argue that the majority of previous
studies have shown only a haphazard distribution of a relatively small number of
bacteria in the periodontal tissues in a minority of adult periodontitis patients and
therefore invasion is unlikely to be a major factor in the pathogenesis of periodontitis.
These authors propose that it is more likely that bacteria were passively introduced into
the tissues for example as a result of minor trauma during mastication.
1.7.6 Statistical Analysis
The difficulties in statistical analysis of periodontal research data were reviewed by
Sterne et al (1990). One of the problems encountered is the site versus subject
controversy, which arises because periodontal data is hierarchical i.e. diseased sites
within subjects. On the one hand, periodontal disease is observed to occur at individual
sites, however site-based analyses are inappropriate because sites within an individual
are not independent. Furthermore, the number of measurements made for each subject
i.e. over 100 for attachment level alone, and the number of bacterial species being
investigated can create problems in analyses if corrections for multiple comparisons are
not made (Dzink et al, 1988; Sterne et al, 1990). Analyses could be made simpler if a
suitable summary statistic for each variable was found and statistical comparisons made
at a subject level. Although statistically acceptable, this approach results in a
considerable loss of detail and has been criticised for not being sensitive enough




1.8.1 AIDS and HIV
The Acquired Immunodeficiency Syndrome (AIDS) was first described in the USA in
1981 (CDC, 1981a). Early reports suggested the disease affected male homosexuals
and included opportunistic infections such as Pneumocystis carinii pneumonia and a
previously rare tumour, Kaposi's sarcoma (CDC, 1981a,b). It was already known that
such illnesses could occur in renal transplant patients and patients undergoing
immunosuppressive therapy, so an underlying immune deficiency was suspected as the
cause of these conditions in homosexual males. However it was not until 1984 that a
retrovirus was isolated from patients with AIDS and AIDS-related complex (ARC) and
recognised as the aetiologic agent of the syndrome (Gallo et al, 1984; Levy et al,
1984). Although the virus was given a number of different names, these were all
dropped in 1986 in favour of Human Immunodeficiency Virus (HTV).
HIV is believed to be a lentivirus which is a subfamily of human retroviruses (Levy et
al, 1985). Two main variants of the virus have been identified and are designated HTV-1
and HTV-2. It is estimated that 5-10 million people are infected with HIV-1 worldwide
which will lead to nearly 1 million cases of AIDS developing within the next few years
(Chin et al, 1990). HTV-2 is virtually endemic in certain West African countries (Clavel
et al, 1987) although isolated cases of HTV-2 infection have been reported in the USA,
Brazil and Central Africa (CDC, 1989; Cortes et al, 1989). In West African countries
the prevalence of HIV-2 in the same high risk groups that are at risk for HTV-1
worldwide, suggest that these viruses share similar modes of transmission. Indeed case
reports of co-infection with both variants have been reported in the literature (Rey et al,
1987). The abbreviation HIV used in the remainder of this thesis will refer to HTV-1.
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1.8.1.1 Transmission
HIV has three main modes of transmission: sexual, parenteral and vertical. Sexual
transmission includes homosexual, bisexual or heterosexual contact. Parenteral
transmission includes injection with contaminated needles and syringes, and transfusion
with infected blood or blood products. Vertical transmission may occur
transplacentally, intrapartum and via infected breast milk (Oxtoby, 1988; Falloon et al,
1989; Wofsy, 1990).
1.8.1.2 Epidemiology
There are three patterns ofHIV infection worldwide that are thought to have developed
as a result of global differences in the frequency of the various modes of transmission
and the rate of introduction of the virus to different areas. (From WHO after Greenspan
et al, 1990b). The first pattern affects mainly Western countries including the USA,
Western Europe, Australia and New Zealand. In these countries homosexual and
bisexual men, and intravenous drug abusers (IVDA) have been the main affected
groups, however recent years have seen a decline in the rate of infection of the
homosexual population and a rise in both heterosexual and perinatal transmission of the
virus. The second pattern affects Africa and South America, where both sexes are
infected to a similar degree with heterosexual and perinatal transmission being the most
common. The third pattern affects North Africa, Eastern Europe and Asia. In these
areas only a small number of AIDS cases have been reported and this is thought to be
due to the relatively late introduction ofHIV into these areas. Recently a rapid spread
ofHIV infection has been documented among female prostitutes and IVDA in some of
these regions.
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1.8.1.3 Natural history ofHIV infection
The natural history ofHTV infection has been studied mainly in homosexual men and
haemophiliacs, because these were the cohorts originally infected, although it is
believed that information gathered so far is applicable to the disease as seen in
heterosexuals (Moss and Bacchetti, 1989). However, some IVDA in New York appear
to die of non-ADDS causes before being diagnosed with AIDS. It is believed that many
of these other causes of death may in fact be associated with or exacerbated by HIV
infection and that current definitions are thought to underestimate the progression to
AIDS in this group (Moss and Bacchetti, 1989).
1.8.1.3.1 Primary infection with HIV
If exposure to HTV results in infection, seroconversion occurs between two to six
weeks later and may be associated with an acute clinical illness experienced by 50-90%
of adults (Tindall et al, 1988). The symptoms of the primary infection with HTV have
been described as resembling a mononucleosis-like infection and include; erythematous
maculopapular rashes, fever, sweats, malaise, myalgia, arthralgia, headache,
photophobia, diarrhoea, sore throat, lymphadenopathy and neurological manifestations
including aseptic meningitis (Cooper et al, 1985). The illness is characterised by sudden
onset and may last from three days to several weeks. The condition is self limiting and
the majority of patients become asymptomatic after a few weeks with persistent
antibodies normally developing within three months (Moss and Bacchetti, 1989). Long-
lasting symptomatic primary HIV infection has been reported to be strongly correlated
with subsequent risk of rapid progression to AIDS (Pedersen et al, 1989).
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1.8.1.3.2 Persistent generalised lymphadenopathy
In a number of patients who experience acute seroconversion illness, generalised
lymphadenopathy, established at primary infection, persists after remission of other
symptoms. This persistent generalised lymphadenopathy (PGL) can also develop in
some patients who were asymptomatic at seroconversion and typically involves two or
more extrainguinal sites (Tindall et al, 1988).
1.8.1.3.3 AIDS-related complex
There may then follow a period ofmany years after seroconversion where the infection
appears to be in a latent state and the patient is reasonably healthy. However
asymptomatic patients and those with PGL can progress to a range of clinical
conditions reflecting increased immunosuppression collectively referred to as AIDS-
related complex (ARC) (Seligmann et al, 1987). These symptoms include
multidermatomal herpes zoster (Melbye et al, 1987), oral candidiasis (Moss, 1988), oral
hairy leukoplakia (Greenspan et al, 1987), and lymphoma-like constitutional symptoms
of sustained weight loss, fatigue, night sweats and persistent diarrhoea (Moss et al,
1988).
1.8.1.3.4 AIDS
Full-blown fatal AIDS, characterised by opportunistic infections, Kaposi's sarcoma or
non-Hogkins lymphoma, can develop in previously asymptomatic patients, PGL or
ARC patients. It is unusual for patients to survive more than five years after contracting
full blown AIDS (Volberding and McCutchan, 1989). It has been estimated that the
average time from infection to AIDS is seven to ten years (Moss and Bacchetti, 1989).
Neurological dysfunction has been reported in up to 50% of patients in the terminal
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phases of AIDS, but may present at any time during the course of the disease (Wiley
and Nelson, 1990). Encephalopathy, myelopathy and peripheral neuropathy have been
reported in HIV seropositive patients, however the mechanisms of CNS damage remain
poorly understood (De Girolami et al, 1990; Wiley and Nelson, 1990).
1.8.1.4 Classification ofHTV infection
There are two commonly used classification systems for staging HIV infection. The
CDC system was initially proposed in 1986 and classifies manifestations ofHIV
infection into four mutually exclusive groups (Table 1). This classification system was
amended in 1987 and revised in 1992 to redefine asymptomatic HIV seropositive
patients and ARC patients with CD4+ T-cell counts of less than 200 mm3 as having
AIDS (CDC, 1986,1987,1992). This system applies only to patients diagnosed with
HTV infection (CDC, after Greenspan et al, 1990a). TheWalter Reed classification
system is based on a variety of clinical and laboratory markers of immunosuppression
(Table 2). This system relies on CD4+ T-cell count and function to stage HTV disease
(Redfield et al, 1986; Redfield and Burke, 1988).
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C.L. chronic lymphadenopathy
From Redfield et al (1986) after Greenspan et al (1990)
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1.8.1.5 Structure of HIV
The basic structure of HIV includes a central core consisting of two identical strands
of viral RNA intimately associated with enzymes known as reverse transcriptase
(Figure 1). Surrounding these elements are two protein layers, a core shell of protein,
p24, and an outer layer of another protein, pl7, that lies immediately below the viral
envelope. The envelope consists of a lipid bilayer that is traversed by a
transmembrane protein, gp41. This protein is associated with the external envelope
protein, gpl20, and gives the virus the appearance of small spikes or protrusions
under electron microscopy. The complete virion is estimated to be 100 nm










1.8.1.6 Life cycle of fflV
1.8.1.6.1 Attachment, fusion and entry
In vitro, the virus displays a tropism for host cells that express the CD4 antigen on their
surface, so it is thought that once inside the host the viral envelope protein, gpl20
attaches to the surface of cells that display the CD4 antigen e.g. helper T-lymphocytes
(Evans and Levy, 1989). Fusion of the virus to the cell surface is thought to be aided by
binding of the transmembrane protein, gp41, and a specific fusion receptor on the cell
surface (Levy, 1990).
Although clinical disease progression is related to HTV infection and depletion of CD4+
T-lymphocytes, expression of the CD4 antigen is not restricted to these cells and can be
expressed to varying degrees on a variety of cell types, including monocytes and
macrophages, Langerhans-dendritic cells, follicular dendritic cells of germinal centres,
B-lymphocytes transformed by Epstein Barr Virus, glial cells and neurones. All of these
cells have been reported to support viral replication (Levy, 1990). However, there may
be alternative modes of infection involving cells that do not have CD4 on their surface.
In vitro infection of brain astrocyte lines, human fibroblasts, and endothelial and
epithelial cells of seropositive patients with HIV has been demonstrated (Wiley et al,
1986; Nelson et al, 1988). Antibody-mediated enhanced infection, either complement-
dependent or complement-independent, has also been proposed. This mechanism would
probably involve Fc and complement receptors and could take place in peripheral blood
macrophages as well as T cells and established T cell lines (Robinson et al, 1988).
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1.8.1.6.2 Replication
Once inside the cell the reverse transcriptase produces a DNA copy of the viral genome
that is integrated into host chromosomal DNA in a double stranded circular form and
exists as proviral DNA (Evans and Levy, 1989). The infected cell can remain in this
latent state for long periods, producing little or no viral RNA or proteins, and so can
escape the host immune system. When active virus production begins the proviral DNA
is transcribed into viral RNA and messenger RNA, coding for structural proteins and
cell associated regulatory proteins (Levy, 1990). Assembly of progeny virions is
thought to occur in the cytoplasm and at the cell membrane. The virus can then be
spread by budding from the cell surface or by the process of fusion of an infected cell
with uninfected cells (Evans and Levy, 1989).
1.8.1.7 Serological events of infection
An HIV antigenaemia follows infection and specific antibodies to major structural
proteins ofHIV can be detected within a few weeks of the acute illness or 2 - 6 weeks
after initial exposure (Allain et al, 1986). HIV and p24 antigen become increasingly
difficult to isolate from serum soon after seroconversion and antibodies to core (p24)
and envelope proteins (gp41) appear (Pedersen et al, 1987). Although antibodies
produced by the host are not able to inactivate the virus, the infection appears to enter a
latent phase. These events coincide with resolution of the acute illness and the patient
may remain asymptomatic and reasonably healthy for several years (Tindall, 1990).
Eventually, however, p24 antigen reappears in the blood as antibodies to p24 begin to
disappear. These events have been associated with a deterioration of the clinical
condition of the patient with the occurrence of opportunistic infections and a
progression to AIDS (Pedersen et al, 1987). Production of antibodies to envelope
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proteins generally remains consistent throughout the course of the disease (Allain et al,
1987).
1.8.2 HTV Infection and Host Defences
Infection with HIV can lead to a range of abnormalities of inflammatory and immune
systems, some of which may be present without evidence of clinical illness. As the
patient progresses to full-blown AIDS, however, these abnormalities tend to become
more extreme (Sattentau, 1989).
1.8.2.1 T-lymphocytes
The alteration of CD4+ T helper/inducer and CD8+ T suppressor lymphocyte subsets is
one of the most consistent observations in patients infected with the virus. An inverted
CD4+: CD8+ ratio results from markedly reduced CD4+ T cell numbers and stable or
raised number of CD8+ T cells (Fauci et al, 1984). Soon after primary infection CD4+
T cell numbers fall from normal levels ofmore than 500/mm3 blood in the majority of
patients over the course of the disease. Most AIDS defining opportunistic infections
occur in patients with fewer than 200/mm3 CD4+ T cells (Volberding and McCutchan,
1989). In addition to a reduction in numbers of CD4+ T cells, HIV infection also results
in abnormalities of CD4+ T cell function. As these cells have a central role in the
immune system this can lead to a range of defects including decreased blast
transformation ofT and B lymphocytes to mitogens and antigens; diminished cytotoxic
T cell response and depressed helper function for B cell immunoglobulin production
(Bowen et al, 1985; Seligmann et al, 1987).
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1.8.2.2 Cytokines
HTV infection is also thought to affect cytokine production, which itself is intimately
associated with the function of T lymphocytes and their modulation of the immune
response. A reduction in IL-2 production and activity has been documented in HIV
infected patients. (Shearer et al, 1986). This phenomenon may be partly the result of
decreased CD4+ T cell numbers, as IL-2 is mainly produced by these cells (Sattentau,
1989). Increased levels ofTNF found in serum of HTV infected patients are believed to
stimulate HTV replication (Sattentau, 1989).
1.8.2.3 B-lymphocytes
It has been shown that B-lymphocytes are polyclonally activated in patients with HIV
(Seligmann, 1987). This results in elevated serum immunoglobulin levels of all isotypes,
circulating immune complexes, autoimmune disease and an inability of B cells to
respond normally to antigenic stimulation (Sattentau, 1989). Polyclonal activation of
B cells could be the result of either direct infection of these cells with HTV or the
mitogenic response of B cells to the virus.
1.8.2.4 Natural killer cells (NK)
The lack of IL-2 is thought to be responsible for the reduction in lysis by natural killer
cells observed in some HTV seropositive patients (Sattentau, 1989).
1.8.2.5 Monocytes and macrophages
Chemotaxis, Fc-dependant phagocytosis, intracellular killing, nonspecific cytotoxicity
and hydrogen peroxide release have all been shown to be abnormal in
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monocytes/macrophages in vitro (Smith et al, 1984; Pinching et al, 1983) Antigen
presentation by these cells is also thought to be impaired. Although some of these
defects are the direct result of lack of stimulation by CD4+ T-lymphocytes, direct
infection with HIV also impairs their function. (Sattentau, 1989)
1.8.2.6 Polymorphonuclear leucocytes
Kinne and Gupta (1989) reported deficient PMNL-mediated antibody-dependent
cellular cytotoxicity in HIV seropositive patients and suggested this as the cause of
increased predisposition to bacterial infections observed in some patients (Polsky et al,
1986). However, elevated phagocytosis and oxidative burst in PMNL has been
described in some HIV seropositive patients (Ryder et al, 1988), whereas serum from
homosexual HIV seropositive patients with HIV-associated periodontitis was found to
cause impairment of PMNL killing (Winkler and Hammerle, 1991). Interestingly,
Lazzarin et al (1986) found defective migration of PMNL from non-IVDA HIV
seropositive patients, but defective phagocytosis and killing in PMNL from a group of
IVDA HIV seropositive patients.
1.8.3 Cofactors and Predictors of Disease Progression
In order to explain the apparent differences in disease progression between individuals
infected with HIV there have been attempts to identify possible cofactors (Polk et al,
1987). Several clinical markers have been proposed as predictors of disease
progression, but they differ widely in predictive power (Greenspan et al, 1987; Moss,
1988: Moss et al, 1988; Fahey et al, 1990). Although Herpes zoster, oral candidiasis
and oral hairy leukoplakia were found to be mid-range predictors of progression to full¬
blown AIDS i.e. unlikely to occur until 3 - 5 years after primary infection with HIV,
they varied widely in predictive power. However, lymphoma-like constitutional
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symptoms were regarded as highly predictive for imminent progression to AIDS (Moss
and Bacchetti, 1989).
A number of laboratory markers have also been shown to predict disease progression in
HTV seropositive asymptomatic patients (Moss et al, 1988). In a comparison of several
cellular and serological markers ofHIV infection, CD4+ T lymphocytes expressed as an
absolute number, percentage of lymphocytes, or a ratio of CD4+ to CD8+ T cells was
found to be the best single predictor of progression to AIDS. However, increased
serum levels of neopterin, a metabolite produced by stimulated macrophages, and
(32-microglobulin, a non-covalently linked protein component of the major
histocompatibility complex, were found to have almost as much predictive power.
Levels of IgA, IL-2 and p24 antigen were found to have less predictive value (Fahey et
al, 1990). These authors, along with Moss and Bacchetti (1988), concluded that the
progression to AIDS was most accurately predicted by the level of CD4+ T cells in
combination with serum levels of either neopterin or (^-microglobulin.
1.8.4 Periodontal Disease and HIV infection
1.8.4.1 History
Winkler et al (1986) reported an aggressive periodontitis and an atypical gingivitis
occurring in patients infected with HIV. These authors described the appearance of a
rapidly progressive periodontitis, named AIDS-virus associated periodontitis (AVAP)
in 8 HTV seropositive, 9 ARC and 21 AIDS patients (Winkler et al, 1987). AVAP was
originally described as having a similar clinical appearance to ANUG. However,
spirochaetes were absent from these lesions (Winkler et al, 1986), and rapid destruction
of periodontal attachment and bone were common clinical features of the lesion
(Winkler et al, 1987). Other clinical features included rapid onset, interproximal soft
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tissue necrosis, ulceration and cratering, marked oedema and intense erythema of the
attached and marginal gingivae. Patients commonly complained of severe pain and
spontaneous nocturnal bleeding from the gingivae (Winkler et al, 1986, 1987, 1988).
Response to conventional treatment was noted to be slow and some lesions remained
unresolved after several weeks (Winkler et al, 1986).
The atypical gingivitis was reported in 24 homosexual men previously unaware of
exposure to HIV (Winkler et al, 1986). The distinguishing clinical features of this lesion
were a red linear-type border extending from the attached gingiva and red petechia-like
patches occurring on the attached and unattached gingiva (Winkler et al, 1986, 1987).
This lesion was also found to be unresponsive to conventional oral hygiene procedures.
Subsequent HTV antibody testing of these patients found all but one to be HIV
seropositive. This finding prompted speculation by the authors that the atypical
gingivitis may be a early intra-oral expression ofHIV infection (Winkler et al, 1987).
Both lesions were frequently found adjacent to apparently clinically healthy gingiva and
periodontium. The AVAP and the atypical gingivitis were subsequently renamed HTV-
associated periodontitis (HIV-P) and HIV-associated gingivitis (HTV-G) respectively
(Winkler et al, 1988).
In 1990, a further disease entity involving the periodontal tissues ofHIV seropositive
subjects was observed and termed necrotising stomatitis (Williams et al, 1990). This
severe condition has been described as originating from the periodontium and can result
in widespread and rapid destruction of the periodontium, as well as adjacent hard and
soft tissues. Several case reports of this lesion are have been recorded (Williams et al,
1990; SanGiancomo et al, 1990; Felix et al, 1991).
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1.8.4.2 Classification
There have been several attempts to classify periodontal diseases occurring in HIV
seropositive patients (Winkler et al, 1989; Axtill et al, 1991; Challacombe et al, 1991;
Smith etal, 1993).
The classification systems proposed by Winkler et al (1989, 1992) have several
disadvantages. For example there is no provision for non-HIV periodontal diseases in
HTV seropositive patients. Inappropriate nomenclature suggests involvement of HIV in
the aetiology of periodontal diseases and creates the potential for breaches in
confidentiality (Smith et al, 1993). Recently, Masouredis et al (1992) proposed two
sets of clinical criteria for the diagnosis of HIV-G and HIV-P based on whether or not
probing was included in the assessment. However, the system described byWinkler et
al (1988, 1992) has been the most frequently used and, in the absence of a universally
agreed classification system, was adopted for use in the present study.
1.8.4.2.1 HIV-associated gingivitis
HTV-G has been described as a profound erythema of the gingivae that in the majority
of cases presents as a red linear band extending two to three millimetres apically from
the gingival margin. Punctate and diffuse erythema may be accompanying features of
this condition and can involve the entire attached gingivae extending from the gingival
margin to the alveolar mucosa. Lesions generally affect the whole mouth and are evenly
distributed throughout all quadrants. It has been reported that 15% of HTV-G sites




HTV-P includes all the clinical features of HTV-G in addition to soft tissue necrosis with
accompanying gingival bleeding and rapid destruction of periodontal attachment
Severe pain is a common complaint being described as a 'deep aching' pain localised to
the 'jaw bone' which may herald the onset of an acute phase of the disease before other
clinical signs. Bleeding on probing is a consistent feature with 50% of lesions exhibiting
spontaneous bleeding that may result in nocturnal bleeding with patients complaining of
blood clots on pillows or in their mouths on awakening (Winkler et al, 1986). The rapid
progression of soft tissue necrosis can result in exposure of crestal and interseptal
alveolar bone which may sequestrate. HIV-P is usually a localised lesion often resulting
in the appearance of a severely affected site adjacent to sites with signs ofHIV-G or
relatively normal tissue occurring round the same tooth (Winkler et al, 1988, 1992).
1.8.4.2.3 Necrotising stomatitis
Case reports ofHIV seropositive patients with necrotising stomatitis have appeared
recently in the literature (Williams et al, 1990; SanGiancomo et al, 1990; Felix et al,
1991). This lesion is characterised by rapid destruction of affected tissues resulting from
ulceration and subsequent necrosis. Originating from the gingivae, the lesion extends
into adjacent tissues including the oral mucosa and underlying bone, and can result in
denudation and sequestration of bone. Necrosis of confluent tissues is a distinguishing
feature of necrotising stomatitis (Winkler and Robertson, 1992).
1.8.4.2.4 Acute necrotising ulcerative gingivitis
Cases of ANUG occurring in HIV seropositive patients have been documented
(Pindborg, 1986; Pindborg and Holmstrupp, 1987) and also in homosexual males whose
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HTV status was unknown (Dennison et al, 1985). The clinical features of ANUG in
HIV seropositive patients are essentially indistinguishable from the disease occurring in
HTV seronegative subjects, however it may be unusual in extent, severity or age
distribution (Sch0idt and Pindborg, 1987; Smith et al, 1993).
Although HIV-P was initially described as being similar to ANUG (Winkler et al, 1986,
1987) clinical and microbiological features can help distinguish between the two lesions
(Winkler and Murray, 1987; Winkler et al, 1986, Murray et al, 1988). For example,
HIV-P is associated with rapid destruction of both soft and hard tissues, whereas
ANUG only results in loss of bone after multiple episodes over several years (Winkler
and Murray, 1987). Furthermore, the levels of spirochaetes present in lesions ofHIV-P
are variable and the microbiota of these lesions is not consistent with that associated
with ANUG (Murray et al, 1988).
1.8.4.2.5 Conventional periodontal diseases
Non-specific gingivitis and adult periodontitis are thought to occur in HIV-seropositive
patients in the same way as in HTV-seronegative patients and may be established long
before HIV infection. Furthermore, it is suspected that rare periodontoses, such as
prepubertal periodontitis and localised juvenile periodontitis can also occur in HIV
seropositive patients (Smith et al, 1993).
1.8.4.3 Prevalence
The prevalence of periodontal disease in HIV seropositive patients has been reported in
numerous studies of the oral manifestations ofHIV infection and AIDS and in studies
concerned with HIV-associated periodontal diseases (Silvermann et al, 1986; Phelan et
al, 1987; Roberts et al, 1988; Schulten et al, 1989; Porter et al, 1989; Tukutuku et al,
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1990; Barone et al, 1990; Laskaris et al, 1992; Gillespie and Marino, 1993; Murray et
al, 1991a; Friedman et al, 1991; Swango et al, 1991; Masouredis et al, 1992).
However, results from studies of the oral manifestations of HTV infection vary with
respect to prevalence of gingivitis, from 1% to 66% of subjects, and prevalence of
periodontitis which varied from 0% to 91% of subjects studied (Phelan et al, 1987;
Tukutuku et al, 1990; Roberts et al, 1988; Barone et al, 1990; Klein et al, 1991).
Prevalence of HTV-associated periodontal diseases, from periodontal research papers,
range from 0% to 50% of subjects affected by HIV-G and from 0% to 22% of subjects
with HIV-P (Apaiza et al, 1991; Freidman et al, 1991; Swango et al, 1991; Murray et
al, 1991a: Masouredis et al, 1992).
Variations in the prevalence of periodontal diseases reported by these studies have been
attributed to geographic variation (Gillespie and Marino, 1993), selective sampling,
improper diagnostic criteria and poor study design (Robinson, 1993). Standardised
diagnostic criteria will have to be established before accurate prevalence rates of
periodontal diseases in HIV seropositive patients can be determined (Robinson, 1993;
Smith et al, 1993).
1.8.4.4 Histology
Few reports on the histology of HIV-associated periodontal disease have been
documented in the literature. One report was concerned with the histological features of
HIV-G from a single biopsy of an HIV seropositive patient complaining of bleeding
gums. The main features were of gingival tissue engorged with blood vessels, but the
absence of any inflammatory infiltrate (Glick et al, 1990). Steidley et al (1992)
attempted to characterise T cell subpopulations in gingival tissue from eight HIV
seropositive patients and compare to six HIV seronegative controls. The gingival tissue
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for all patients was collected during routine periodontal surgery as part of the treatment
for periodontal disease. Using monoclonal antibodies to CD4+ and CD8+ T cells they
found that the gingival tissue from the HIV seropositive patients exhibited a complete
absence of T cells in all but one patient. All tissue taken from the controls had these
cells present (Steidley et al, 1992).
1.8.4.5 Microbiology
A number of studies have investigated the microbiology of subgingival plaque samples
from HIV seropositive patients using a variety of sampling and identification techniques
(Murray et al, 1988, 1989, 1991b; Zambon et al, 1990; Lucht et al, 1991; Gornitsky et
al, 1991; Rams et al, 1991; Moore et al, 1993). Some of these studies have
characterised the subgingival microbiota of HIV seropositive patients and have
investigated HIV-associated periodontal disease in only a few patients (Zambon et al,
1990; Lucht et al, 1991). Others have attempted to characterise the microbiota
specifically associated with HTV-G and HIV-P (Murray et al, 1988, 1989, 1991b;
Gornitsky et al, 1991; Rams et al, 1991).
The subgingival microflora ofHIV seropositive patients would appear to be
qualitatively similar to that of HIV seronegative patients. Zambon et al (1990), using
the predominant cultivable microbiota technique and immunofluorescence microscopy,
found many of the Gram-negative anaerobic microorganisms associated with
conventional periodontitis. Similarly, Lucht et al (1991), also using predominant
cultivable techniques, detected no significant differences between the subgingival
microflora found in saliva or gingival crevice in 10 HIV seronegative, 10 seropositive,
10 ARC and 10 AIDS patients. A recent study by Moore et al (1993) found that the
only difference in the subgingival microbiota between HTV seropositive and
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seronegative patients, both with adult periodontitis, was a statistically significantly
elevated levels ofMycoplasma salivarium in HIV seropositive subjects.
Murray et al (1988, 1989, 1991b) have used a variety of techniques including
predominant cultivable microbiota, indirect immunofluorescence, indirect ELISA and
DNA probes to determine the subgingival microbiota associated with HIV-G and
HIV-P. These workers have found the microbiota of both of these lesions to contain
similar subgingival species that are found in conventional periodontitis including
A. actinomycetemcomitans, P. gingivalis, P. intermedia, F. nucleatum, C. rectus,
E. corrodens . However, using DNA probes C. rectus was found in higher proportions
in HIV-P sites than in HIV-G sites (Murray et al, 1991).
Using the predominant cultivable microflora technique Rams et al (1991) compared the
subgingival flora for 3 clinically healthy and 3 HIV-P sites in 14 HIV seropositive
patients. The HIV-P sites harboured Gram-negative anaerobic species similar to those
found in conventional periodontitis including A. actinomycetemcomitans, P. intermedia
and C. rectus and concluded that the microbiota of HIV-P sites was similar to that
found in progressing periodontal lesions in systemically healthy adults (Rams et al,
1991). Gornitsky et al (1991), reported no differences in the microbiological profile
between HIV-P sites and periodontitis sites from healthy HIV seronegative patients,
using darkfield and immunofluorescent microscopy techniques directed towards a
limited number of organisms.
Interestingly, a number of studies investigating subgingival plaque samples from HIV
seropositive patients have reported finding microorganisms not usually associated with
the subgingival microflora and others at higher levels than previously detected in
healthy adults with severe periodontitis (Murray et al, 1988; Slots et al, 1988; Zambon
et al, 1990; Rams et al, 1991). Murray et al (1988) found a significantly elevated
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percentage of sites harbouring C. albicans in HIV-P and HIV-G lesions than in healthy
sites from HIV seropositive subjects or sites from seronegative controls. Both Rams et
al (1991) and Zambon et al (1990) reported recovering microorganisms not normally
associated with adult periodontitis from subgingival plaque samples from HIV
seropositive patients including, Bacteroid.es fragilis, Fusobacterium necrophorum,
Fusobacterium varium, Eubacterium aerofaciens, Candida albicans, Pseudomonas
aeruginosa, Klebsiella oxytoca, Enterobacter cloacae, Enterobacter agglomerans,
uncommon Clostridium species and enterococci. Felix et al (1991) reported high levels
of Enterobacter cloacae, Enterococcus and coliforms from a lesion of necrotising
stomatitis.
Schmidt-Westhausen et al (1990), in a retrospective study of routine oral swabs,
detected Enterobacteriaceae in 5% ofHIV seropositive patients and in 4.8% of a
control group of HIV seronegative patients. However, closer inspection of the control
group revealed that of those with Enterobacteriaceae all were predisposed to
opportunistic infections as they were either diabetics or had undergone irradiation.
In summary, using a variety of sampling and identification techniques the majority of
studies analysing the subgingival microbiota ofHIV seropositive and HIV-associated
periodontal lesions are in agreement. The subgingival microbiota of HIV seropositive
patients harbours a similar range of organisms found in the subgingival microbiota of
HIV seronegative healthy adults (Lucht et al, 1991; Zambon et al, 1990; Moore et al,
1993). The range of organisms isolated from HIV-associated periodontal lesions is
similar to that found in conventional adult periodontitis (Murray et al, 1988, 1989,
1991b; Rams et al, 1991; Gornitsky et al, 1991). However, a number of studies have
detected microorganisms not previously regarded as common subgingival colonisers, in
low or moderate levels, from healthy and diseased sites in HIV seropositive patients
(Murray et al, 1988; Zambon et al, 1990; Rams et al, 1991).
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1.8.4.6 Immunology
The most consistent feature of infection with HIV is the progressive loss and
deterioration in function of CD4+ T cells, combined initially with a relative rise in
CD8+ T cells. As a result of this there has been considerable interest in the levels of
CD4+ and CD8+ T cells in peripheral blood and local tissue ofHIV seropositive
patients with HIV-associated periodontal diseases (Winkler et al, 1988; Lucht et al,
1991; Steidley et al, 1992; Barr et al, 1992). Winkler et al (1988) found in patients with
HTV-G the CD4+: CD8+ ratio was at the low end of the normal range, but patients
with HTV-P had significantly lower CD4+: CD8+ ratios than normal. Steidley et al
(1992) reported that low CD4+ T cell counts in peripheral blood correlated well with
severity of HTV-P observed. In another study, significantly more attachment loss was
observed in HTV seropositive patients with CD4+ T cell counts of less than 200/mm3
blood compared to HIV seropositive patients with CD4+ T cell counts of greater than
200/mm3 blood (Barr et al, 1992).
To date only one study has reported levels of CD4+ and CD8+ T cells in gingival tissue
taken from HIV seropositive patients with HIV-P. Steidley et al (1992) reported that
no CD4+ or CD8+ T lymphocytes observed in gingival tissue from all but one of 8 HIV
seropositive patients with HIV-P. The HTV seropositive patient with some CD4+ and
CD8+ T cells present had near normal levels of serum CD4+ T cells.
1.8.4.7 Pathogenesis
Winkler et al (1988) demonstrated CD4+: CD8+ ratios within the low normal range in
patients with HIV-associated gingivitis, but significantly below normal ratios in patients
with HIV-associated periodontitis. This group of patients had elevated serum antibodies
to P. gingivalis, P. intermedia, F. nucleatum, E. corrodens and
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A. actinomyceiemcomitans relative to HIV-negative heterosexual and homosexual
controls. These authors proposed that the pathogenesis of HIV-associated periodontal
diseases was the result of the compromised immune system of the HIV infected patient
allowing shifts in virulence potential of the oral microbiota. Therefore tissue destruction
would result from an overgrowth of specific pathogens during periods when the tissue
defence mechanisms were compromised. This same group also reported altered PMNL
function in HIV seropositive patients, including increased phagocytosis and oxidative
burst, compared to HIV seronegative controls (Ryder et al, 1988). They proposed that
hyper-responsive PMNL, primed by bacteremia of oral origin and in the absence of
normal functioning lymphocytes and macrophages, could contribute to the severe
periodontal disease observed in some HIV seropositive subjects. Lucht et al (1991) also
found increasingly severe periodontal disease with progressing HIV infection,
exemplified by an inverse relationship between peripheral blood CD4+ T-lymphocytes
and both gingivitis and pocket depth. However, these authors concluded that non¬
specific accumulation of dental plaque or potential specific pathogens were unlikely to
play a major role in the development of periodontal diseases in HIV seropositive
patients, rather that the severity of periodontal disease was correlated with
immunosuppression and progression of HIV infection. Steidley et al (1992) proposed
that a reduction in CD4+ T-lymphocytes in ginigval tissue could contribute to the
development of the severe periodontal diseases seen in HIV seropositive patients.
Robinson (1992) in a review of HIV-asociated periodontal diseases, concluded that
several explanations for the aetiology of periodontal diseases in HIV seropositive
patients were possible. They could either be the result of infection by the subgingival
species currently associated with conventional periodontitis whose virulence is
increased with the diminished immune response in HIV or, unusual species found
colonising the subgingival area in HIV seropositive subjects, found by some workers,
contributing to the disease.
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In summary, similarities in clinical appearance and microbiota associated with HIV-G
and HIV-P have prompted speculation that HIV-G may be a precusor to HIV-P and
represents an earlier stage of the same disease process (Murray et al, 1989; Winkler and
Robertson, 1992). Furthermore, case reports of necrotising stomatitis indicate that this
lesion may be a further stage ofHIV-P (Williams et al, 1990; SanGiancomo et al, 1990;
Felix et al, 1991). Therefore, HIV-associated periodontal diseases may represent a
spectrum of the same disease process and that the particular periodontal lesion seen in a
patient may depend on the subgingival microbiota that emerges during periods of
immunosuppression, which in turn will depend on the degree, duration and type of
alteration of the immune response (Winkler and Robertson, 1992).
1.8.4.8 Management
Due to the recognition that HIV-G may be an early stage of HIV-P, prompt and
vigorous treatment of HIV-G lesions with aggressive scaling and root planing in
addition to 0.12% chlorhexidine mouthwash has been advocated (Grassi et al, 1988;
Murray et al, 1989).
The management of severe periodontal disease in HIV seropositive patients was
outlined by Winkler and Robertson (1992). Treatment ofHIV-P and necrotising
stomatitis should involve removal of plaque and calculus and thorough debridement of
necrotic tissue with removal of exposed necrotic bone sequestra. These authors also
recommended the use of povidone-iodine irrigation during debridement as it helps to
relieve pain and reduce bleeding. Chlorhexidine mouthwash, twice daily, should be
started as soon as possible and may be continued throughout long-term maintenance.
Immediate follow-up care should involve quadrant-by-quadrant scaling and root planing
with removal of necrotic tissue as required in addition to instruction in oral hygiene
procedures, with follow-up visits every month. Once the condition is stabilised, recall
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visits can be arranged at three monthly intervals. Winkler and Robertson (1992) also
suggest that the use of systemic antimicrobials be restricted to the immediate phase of
treatment and depend on the rate of destruction of the lesion and systemic
manifestations. Metronidazole is the drug of choice with a short course, low dose
regimen of 250 mg four times a day for 4 - 5 days advocated. The use of broad-
spectrum systemic antimicrobials is not recommended, however, due to the potential for
candidiasis to develop. Indeed, these authors advise that patients should be monitored
for candidiasis throughout the period of metronidazole therapy and antifungals used if
required.
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1.9 OBJECTIVES OF STUDY
Previous studies of the subgingival microbiota ofHIV seropositive subjects have
reported data from only a few sites per subject. However, to determine the association
between site-specific tissue breakdown and specific subgingival microorganisms, a large
number of sites need to be investigated. The development and validation of whole
chromosomal digoxigenin-labelled DNA probes for the rapid identification of a
selection of periodontal bacteria (Gunaratnam et al, 1992), has allowed the analysis of a
larger number of subgingival plaque samples than previously possible with traditional
cultural identification techniques. The objectives of this thesis were
1) To establish a procedure for the enumeration of selected periodontal bacteria in
a large number of plaque samples using non-isotopic whole chromosomal DNA
probes.
2) To compare the prevalence of periodontal disease between HIV seropositive
and HTV seronegative subjects in the Edinburgh area.
3) To compare the prevalence of these selected periodontal bacteria between HTV
seropositive and HIV seronegative patients.
4) To assess the incidence of HTV-associated periodontal diseases in the HTV
seropositive group on a longitudinal basis.
5) To characterise the microbiology associated with these lesions in terms of those
species selected for enumeration.
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6) To investigate whether periodontal breakdown or any of the
clinical or microbiological parameters studied could be used as
predictors ofHIV disease progression.
Therefore, the objectives of the study comprised of cross-sectional and longitudinal
components. Initially, baseline clinical measurements and analysis of subgingival plaque
samples allowed an assessment of the clinical and microbiological status in HIV
seropositive and HIV seronegative subjects from the Edinburgh area. Longitudinal
monitoring of HTV seropositive subjects would provide an indication of the incidence of
severe periodontal disease in these patients and give an opportunity to characterise the
microbiota associated with these lesions in terms of the periodontal species selected for
enumeration. Furthermore, longitudinal data collected from the HIV seropositive
subjects would provide information on the relationship between periodontal breakdown







All chemicals quoted in Materials and Methods were obtained from Sigma (U.K.)
unless otherwise stated.
2.1.1 Bacterial Strains
The following species and strains were chosen for enumeration in subgingival plaque
samples; Actinobacillus actinomycetemcomitans FDC Y4; Prevotella intermedia FDC
581; Porphyromonas gingivalis FDC 381; Bacteroides forsythus ATCC 33277;
Capnocytophaga ochracea NCTC 11545; Veillonella parvula NCTC 11463;
Campylobacter rectus NCTC 11489; Fusobacterium nucleatum NCTC 10562;
Streptococcus sanguis NCTC 7863. These species were obtained as lyophilized
specimens from the various sources given.
2.1.2 Culture Media
Bacteria above were cultured anaerobically in Bacteroides medium cooked meat broth
(BM CMB, Holbrook et al, 1978), with the exception of B. forsythus, and C. rectus
which were cultured in special broths (Dr Anne Tanner, personal comminucation,
Appendix 1).
2.1.3 Solid Media
All species were grown anaerobically on Trypticase soy agar supplemented with 5%
horse blood (TSBA) plates, with the exception of P. gingivalis, B. forsythus, and
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C. rectus, which were grown special solid media (Dr Anne Tanner, personal
comminucation, Appendix 1).
2.1.4 Anaerobic Cabinet
A Don Whitley mark IE Anaerobic Workstation (DonWhitley Scientific Ltd, Shipley,
England) was used to achieve and maintain an anaerobic enviroment containing 80%
nitrogen, 10% hydrogen and 10% carbon dioxide at a temperature of 37'C.
2.1.5 Reduced Transport Fluid
Reduced Transport Fluid (RTF) was proposed by Syed and Loesche (1972) as a
suitable means of transporting subgingival anaerobic bacteria (Appendix 1). Freshly
prepared RTF was filter-sterilised 24 h prior to use under a vacuum through a cellulose
acetate filter (pore size 0.22 mm) in a Nalgene 500 ml filter holder with a 1000 ml
receiver (Nalgene, New York, U.S.A.) and left in the anaerobic cabinet overnight.
2.1.6 Sonication Experiment
2.1.6.1 Aim
The aim of this experiment was to assess the possible detrimental effect of sonic energy
on the nine species listed above, as it was intended to disperse plaque samples in closed
bijoux immersed in an ultrasonic waterbath (Weiner et al, 1979). Of particular concern
were the Gram-negative species, known to be more vulnerable to sonication.
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2.1.6.2 Materials and methods
Pure broth cultures of the nine species listed above were anaerobically incubated for
two days in the anaerobic cabinet. Aliquots of 0.5 ml of the broths were diluted in
4.5 ml RTF in plastic 7 ml disposable bijoux (Sterilin Medical, U.K.) and sonicated for
various times by immersion in the ultrasonic waterbath (Decon FS 100b, Decon
Laboratories Ltd, Sussex, England.). After 15s, 30s, 60s and 90s sonication, 100 ml
aliquots of the diluted broths were spread onto TSBA plates and anaerobically
incubated for 5 - 7 days. A colony counter (Dept. of Medical Microbiology, University
of Edinburgh) was used to enumerate the colonies present on the agar plates and assess
the effect of sonication on the nine species.
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igure 2 Effect of Sonication on Viability of Bacterial Strains Selected
for Enumeration
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2.1.6.3 Results and Conclusion
The logio counts for nine strains are plotted against time sonicated in Figure 2. The
results of this experiment indicate that these bacterial strains ^ould withstand exposure
to sonication in a ultrasonic waterbath for up to 60s without dramatically affecting the
total colony counts recovered. It was decided that a plaque sample would be sonicated
for 60s to achieve dispersal using this method.
2.1.7 DNA Extraction Methods
A number of DNA extraction methods were used to obtain fragments of whole
chromosomal DNA from the nine species based on the rapid DNA extraction method
reported by Smith et al (1989b).
2.1.7.1 Method A
After anaerobic incubation for 5 - 7 days, growth from the surfaces of
2 - 3 appropriate agar plates of each species were scraped using a disposable plastic
loop (Sterilin Medical, U.K.) and resuspended in 567 (il TE buffer (10 mM Tris,
pH 7.6, 1 mM EDTA) in sterile 1.5 ml Eppendorf microcentrifuge tubes (Elkay, U.K.).
Cells were throughly dispersed by repeated pipetting through a sterile glass Pasteur
pipette. Then 30 |al of 10% sodium dodecyl sulphate (SDS) and 3 (il of a 20 mg/ml
solution of proteinase K were added. Cell lysis was completed by incubation in a water
bath at 37°C for 60 min. After the addition of 150 |al 5 M NaCl to adjust salt
concentration, the contents of the Eppendorf were mixed thoroughly, then 85 ql
CTAB/NaCl solution (Appendix 1) was added, the reagents mixed again and incubated
at 65°C, with occasional mixing, for a further 20 min. An equal volume of
chloroform : isoamyl alcohol (24 : 1, v/v) was added, and the contents of the Eppendorf
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mixed by shaking vigorously for 5 min to remove cellular proteins and polysaccharides,
and then centrifuged for 15 min at 12,000g in a microcentrifuge (Micro Centaur
Centrifuge, MSE Scientific Instruments, U.K.). The upper aqueous phase was removed
using sterile wide-mouthed Pasteur pipette and transferred to a new sterile Eppendorf
tube. An equal volume of phenol: chloroform : isoamyl alcohol (25 : 24 : 1, v/v/v.
Appendix 1) was added to this aqueous solution and mixed by vigorous shaking for
5 min. The Eppendorfs were centrifuged for a further 12 min and the upper aqueous
phase removed by wide-mouthed Pasteur pipette transferred to a new Eppendorf and
mixed with 0.6 volumes of isopropanol to precipitate nucleic acids. Following
centrifugation for 2 min and removal of the aqueous solution the precipitate was
redissolved in 300 |il 10 : 1 TE buffer. From stock solution, 2 fil RNase A was added
(Appendix 1) and incubated for 60 min at 50°C. Suspensions were then mixed with
30 p.1 3 M sodium acetate, pH 7.6 and re-extracted by adding an equal volume of
chloroform : isoamyl alcohol (24 : 1, v/v) as before. Following centrifugation for 6 min,
the upper aqueous phase was removed and transferred to a new Eppendorf by sterile
wide-mouthed Pasteur pipette. Two volumes of ice cold 95% ethanol (approximately
660 p.1) were added and mixed by shaking. The DNA was precipitated by putting the
Eppendorf in a freezer at - 20°C for 30 min, and then centrifuged for 5 min. The
aqueous solution was removed with a long drawn-out Pasteur pipette and the
precipitate washed twice with ice cold 70% ethanol. Following the removal of the last
ethanol wash the precipitate was dried in a 37°C incubator for 20 min and dissolved at
37°C overnight in 200 |il 10 : 0.1 TE buffer (10 mM Tris, pH 7.6, 0.1 mM EDTA).
2.1.7.2 Method B: Modified DNA extraction method for Gram-negative species
Confluent growth from 2-3 agar plates was scraped into a sterile 1.9 ml Eppendorf
microcentrifuge tube containing 310 p.1 of 50 mM Tris HC1, pH 8.0, 20 mM EDTA
(HTE). Each pellet was well dispersed by repeated passage through a sterile glass
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Pasteur pipette to achieve a homogeneous suspension. Lysis was achieved by adding
350 pi of a 2% solution of sarcosyl in HTE and vortexing briefly (Whirlimixer, Fisons
Scientific Equipment, U.K.) before adding 5 pi RNase A (Appendix 1) and incubating
for 15 min at 37°C. Lysis was completed by adding 35 pi pronase and incubating for
90 min at 50°C. Salt concentration was adjusted by adding 175 pi of 5 M sodium
chloride and mixing the contents of the Eppendorf by vigorous shaking. Following the
addition of 85 pi CTAB/NaCl the Eppendorf was vortexed briefly before incubation for
20 min at 65°C, with occasional mixing. An equal volume of chloroform : isoamyl
alcohol (24 : 1, v/v) was added, the contents of the Eppendorf vortexed briefly and
centrifuged for 15 min. The upper aqueous phase was transferred with a sterile wide-
mouthed Pasteur pipette to a fresh Eppendorf tube and an equal volume of phenol:
chloroform : isoamyl alcohol (25 : 24 : 1, v/v/v) was added. The contents were mixed
by vortexing briefly before centrifugation for 12 min. The upper aqueous phase was
transferred to a new Eppendorf as before and 600 pi of isopropanol was added. The
Eppendorf was mixed by gently rocking back and forth in the hand until a white DNA
precipitate formed. DNA was recovered by centrifugation for 2 min followed by
removal of the supernatant with a long drawn-out Pasteur pipette. The pellet was
washed twice with 200 pi of 70% ethanol at room temperature and allowed to air dry
for 15 - 20 min after removal of the last ethanol wash. The DNA was then allowed to
dissolve in 200 pi 10 : 0.1 TE buffer, pH 7.6 overnight at 37°C. This solution
containing the DNA was then stored at - 40"C until required.
2.1.7.3 Method B: Modified DNA extraction method for Gram-positive species
In order to achieve successful lysis of Gram-positive species, additional steps to the
above protocol were neccessary. After the growth scraped from the agar plates had
been dispersed into a homogeneous suspension, 10 pi of 10 mg/ml of lysozyme and
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10 |il of 10 mg/ml of achromopeptidase were added, vortex briefly, and the Eppendorf
incubated in a waterbath for 30 min at 37°C. Then 350 p.1 of a 2% solution of sarcosyl
in HTE was added and the Eppendorf vortexed briefly, incubated at 75°C for 10 mins.
After this stage the contents were cooled to 37 °C before 5 |il RNase was added and the
extraction procedure continued as described above.
2.1.8 DNA Assay
The purity and concentration of DNA extracted from the reference strains were
measured at several wavelengths using a spectrophotometer (Pye-Unicam, SP-6,
550 UV/VIS). Two quartz microcuvettes with a total volume of 500 |il and a 1 cm
pathlength were used to perform the readings and the instrument was blanked using
10 : 0.1 TE buffer, pH 7.6. A 10 |il aliqout of the solution containing bacterial DNA
was mixed with 490 ql of 10 : 0.1 TE buffer and pipetted into the microcuvette.
Readings of absorbance at 260 nm and 280 nm were recorded for each sample
(Sambrook et al, 1989).
2.1.9 Protein Assay
The amount of protein contaminating DNA sample following the extraction protocols
outlined above was assessed using Coomassie protein assay (Pierce Chemical Company,
Illinois, USA). The spectrophotometer (Pye Unicam, Unicam SP600 Series 2) was
blanked for absorbance at 595 nm using 100 (il 10 : 0.1 TE buffer, pH 7.6 and 5 ml of
protein assay reagent in a 5 ml plastic disposable cuvette. A standard curve was
established using 100 |4l of the following concentrations of Bovine serum albumin,
1 mg/ml, 5 mg/ml, 10 mg/ml and 5 ml of assay reagent and absorbance read at 595 nm.
The amount of protein contaminating a sample of extracted DNA, as outlined in the
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above protocols, was measured by mixing 100 |il of sample DNA solution with 5 ml of
protein assay reagent and reading absorbance versus blank at 595 nm (Bradford, 1976).
2.1.10 Agarose Gel Electrophoresis
The size of the DNA fragments extracted was determined using a minigel kit (Bethesda
Research Laboratories, Maryland, USA) and agarose gel electrophoresis (Voytas,
1989). A gel of 0.8% agarose was prepared from 0.64 g agarose granules melted in
80 ml of 1 x Tris-acetate buffer (0.04 M Tris-acetate, 0.001 M EDTA) freshly prepared
from a stock solution of 50 x TAE buffer. The agarose was dissolved in 1 x TAE buffer
by heating and swirling the flask occasionally until all the granules had disappeared. The
melted agarose was cooled to 55°C in a water bath and ethidium bromide added to a
final concentration of 0.5 (Xg/ml. The melted agarose was poured into the gel former
complete with gel comb and left to solidify. When set, the gel comb and walls of the gel
former were removed and the gel was covered to a depth of 1 mm with 1 x TAE buffer.
The molecular weight marker chosen was a Hind III digest of phage Lambda DNA.
Following the addition of 1 (il of 10 x loading buffer to 1 fig of bacterial DNA orDNA
marker, the solution was made up to 10 p.1 with sterile distilled water. The 10 x loading
buffer contained 0.1% bromophenol blue, 30% sucrose and 5% SDS in 10 : 1 TE
buffer, pH 7.6. Bacterial DNA samples were loaded into the wells in the gel using a
20 p.1 micropipette with one well being reserved for the molecular weight marker.
When all the DNA samples had been loaded, including the marker, the gel was run at
65 V for 2 hours or until the bromophenol blue dye had migrated three quarters along
the length of the gel. The DNA was visualised directly by transilluminating the gel with
254 nm UV light (UV transilluminator, model TS-36, UVP inc, California, U.S.A.).
Gels were photographed using Polaroid type 667 film and a Polariod MP4 camera
equiped with a Kodak 23A Wratten filter (Voytas, 1989).
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2.1.11 DNA Probe Construction
Whole chromosomal DNA extracted from the reference strains was labelled with the
steroid hapten digoxigenin in one of two ways.
2.1.11.1 Method A
A random priming technique (Feinberg and Vogelstein, 1983) was used to label DNA
extracted and purified as detailed above with digoxigenin. Unless otherwise stated, all
reagents used in the labelling procedure were supplied by Boehringer Mannheim (U.K.).
An aliquot of whole chromosomal bacterial DNA was denatured by heating in a boiling
waterbath for 10 min and then cooling quickly on ice for a further 5 min to prevent re-
annealing of complementary strands. The following were added to a small sterile
Eppendorf tube on ice: 1 pg freshly denatured bacterial DNA, 2 pi of random
hexanucleotide mixture, 2 pi of dNTP mixture containing dCTP, dATP, dGTP (1 mM
each), dTTP (0.65 mM) and digoxigenin-dUTP (0.35mM). This solution was made up
to 19 |Xl with sterile distilled water then 1 pi of Klenow fragment (DNA polymerase 1,
large fragment) was added and the mixture incubated in a waterbath at 37°C. The
reaction was stopped after 20 hours by the addition of 2 pi 0.2 M EDTA, pH 8.0 and
the labelled DNA precipitated with 2.5 pi 4 M lithium chloride and 75 pi prechilled
70% ethanol. This mixture was then left for 80 min at - 40 °C. Labelled DNA was
recovered by centrifugation for 5 min, washed with 50 pi cold 70% ethanol, centrifuged
for a further 5 min before drawing off the final ethanol wash with a long drawn-out
Pasteur pipette. The Eppendorf tube was placed in a 37°C incubator for 20 min or until
no ethanol smell could be detected. The pellet was allowed to dissolve in 50 pi
10 : 1 TE buffer, pH 7.6 for one hour at 37°C.
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2.1.11.2 Method B
The modification to the above protocol involved labelling the same quantity of template
DNA but in a larger reaction volume. Approximately 1 pg of heat denatured DNA was
added to a small sterile Eppendorf on ice as before. To this was added; 20 pi of random
hexanucleotide mixture, 20 pi of dNTP mixture containing dCTP, dATP, dGTP (1 mM
each), dTTP (0.65 mM) and digoxigenin-dUTP (0.35 mM). This solution was made up
to 190 pi with sterile distilled water before the addition of 10 pi of Klenow fragment
and then incubated overnight in a waterbath at 31°C. The reaction was stopped after
20 hours by the addition of 20 pi 0.2 M EDTA, pH 8.0 and the labelled DNA
precipitated with 25 pi of 4 M lithium chloride and 750 pi prechilled 70% ethanol. This
mixture was then left for 80 min at - 40°C. Labelled DNA was recovered as before by
centrifugation for 5 min, washed with 500 pi cold 70% ethanol, centrifuged for a
further 5 min before drawing off the final ethanol wash with a long drawn-out Pasteur
pipette. The Eppendorf tube was placed in a 37°C incubator for 20 min or until no
ethanol smell could be detected and the pellet finally allowed to dissolve in 50 pi
10 : 1 TE buffer, pH 7.6, for one hour at 37°C (Boehringer Mannheim, 1993a).
2.1.12 Colony Lift
The following method was reported by Gunaratnam et al, (1992). A nylon membrane
82 mm in diameter (Nytran filter, NY 13 N, 0.45 mm pore size, Schleicher and Schuell,
U.K.) was placed on the surface of an agar plate containing bacterial growth and left for
2-5 min. It was removed and placed colony-side up on Whatman No. 1 filter paper
soaked in 20% SDS for 10 min. The membrane was then placed colony-side up on fresh
filter paper soaked in lysing/denaturing solution (1.5 M sodium chloride; 0.5 M sodium
hydroxide) for a further 10 min. Following blotting on fresh filter paper, the membrane
was again placed colony-side up on filter paper soaked in neutralising solution (1.5 M
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sodium chloride; 0.5 M Tris hydrochloride, pH 7.6) for 5 min. The membrane was
transferred to fresh filter paper soaked in proteinase K solution (100 mg/ml in 0.5%
SDS) and incubated for 30 min at 37°C. The membrane was then immersed in
chloroform : isoamyl alcohol (24 : 1, v/v) for 15 min with gende agitation and washed
in running distilled water for 10 min followed by three, 2 min washes in 95% ethanol.
After air drying for 20 - 30 min, the membrane was exposed to ultra violet light 254 nm
for 1 min by placing it on top of a transilluminator (model TS-36, UVP inc, California,
U.S.A.) to achieve covalent bonding of the single stranded DNA to the nylon fibres
(Cannon et al, 1984; Boeringher Mannheim, 1993b) Membranes were then stored
at - 20°C until required.
2.1.12.1 Modifications to the colony lift protocol for Gram-positive species
Following lifting of colonies, the membrane was placed colony-side up on Whatman
No. 1 filter paper soaked in a mixture of achromopeptidase and lysozyme, each at
100 mg/ml in HTE pH 8.0, prewarmed to 37°C for 30 min at 37°C. The colony lift
protocol was then followed as described above, although the proteinase K step was
increased from a 30 min soak to one hour.
2.1.13 Prehybridisation and Hybridisation
The prehybridisation, hybridisation and stringency washes were maintained as described
by Gunaratnam et al, 1992. Prehybridisation and hybridisation stages were completed
by placing the filters in hybridisation bags (Gibco Ltd. Paisley, U.K.) containing the
appropriate solution and placing the bags in a waterbath (W14, Grants, U.K.) at the
required temperature. Hybridisation bags were sealed using a plastic bag sealer (Salton
Vacuum Bag Sealer, Model No. 1101, Pifco Ltd., U.K.).
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After being marked with pencil to indicate patient number and site the membranes were
washed briefly in 2 x SSC, prepared from 20 x SSC (Appendix 1). They were then
prehybridised for 2 - 4 hours at 42*C in a solution containing 50% formamide, 5 x SSC,
5 x Denhaidt's solution (Appendix 1), 25 mM sodium phosphate, pH 6.5 and 0.5 mg/ml
freshly denatured herring sperm DNA. Twenty ml of prehybridisation solution was used
per 100 cm2 filter. The filters were then sectioned and incubated overnight at 42*C with
one of the whole chromosomal DNA probes labelled with digoxigenin (at a final
concentration of 100 - 250 ng/ml labelled DNA) in hybridisation solution containing
45% formamide, 5 x SSC, 1 x Denhardt's, 20 mM sodium phosphate, pH 6.5 and
0.2 mg/ml freshly denatured herring sperm DNA. A volume of 2.5 ml of hybridisation
solution was allowed for every 100 cm2 filter. After 16 hours of hybridisation the filters,
were subjected to two sets of stringency washes. Firstly in 2 x SSC, 0.1 % SDS (w/v)
for two washes of 5 min at room temperature with gentle shaking (Rotating Table,
Stuart Scientific, U.K.). Filters were then immersed in 0.1 x SSC, 0.1% SDS (w/v) at
65°C for two washes of 15 min. The membranes were then ready for detection of
digoxigenin labelled hybrids with anti-digoxigenin antibody and colour substrates.
2.1.14 Detection ofDigoxigenin-Labelled Probe
All volumes given in the detection protocol are calculated for 100 cm2 of nylon
membrane and were adjusted accordingly. Membranes were washed briefly in maleic
acid solution (0.1 M maleic acid, 0.15M NaCl, pH 7.5; buffer 1) before being incubated
for 30 min at room temperature with 100 ml of 1% blocking solution (buffer 2). This
was made from a concentrate of autoclaved 10% blocking reagent in buffer 1.
(Boehringer Mannheim, U.K.) Membranes were then incubated for a further 30 min
with freshly diluted 150 mU/ml (1:5000) anti-digoxigenin antibody conjugated to
alkaline phosphatase in 1% buffer 2. Unbound conjugate was removed by washing with
100 ml buffer 1 for two 15 min washes. The procedure from this point depended on
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whether detection of bound anti-digoxigenin antibody conjugate was to be
accomplished with nitro blue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl
phoshate (BCIP) or with diazonium salts and naphthol-AS phosphate compounds (West
etal, 1990).
2.1.14.1 NBT/BCIP detection
The membranes were equilibrated for two minutes in 20 ml of the following solution:
0.1 mM Trisma base, 0.1 mM NaCl, 50 mM MgCl2, pH 9.5 (buffer 3). Detection of the
presence of alkaline phosphatase was achieved by placing membranes in 10 ml of freshly
prepared NBT/BCIP solution which contained; 10 ml buffer 3, pH 9.5; 45 JJ.1 NBT
solution (from stock solution, Appendix 1) and 35 p.1 BCIP solution (from stock
solution, Appendix 1). The membranes were left immersed in this solution for 3 hours
in the dark at 37°C. The colour reaction was stopped by immersing the membrane in
10 : 1 TE (Tris 10 mM; EDTA 1 mM, pH 8.0) for 5 min and could be enumerated
immediately prior to reprobing.
2.1.14.2 Reprobing protocol used with NBT/BCIP
After enumeration of brown colony forms on the section, the membrane was placed
immersed in heated N,N-dimethylformamide (DMF) at 48°C in a sealed glass jar under
a fumehood for 15 min. If neccessary, this step was repeated several times to remove
most of the coloured precipitate. The membrane was then rinsed thoroughly in distilled
water for 5 min before being soaked in a solution of 0.2 M sodium hydroxide for
30 min at 37°C to complete probe removal. After a brief rinse in 2 x SSC, sections of
membrane were prehybridised again as described above for hybridisation with another
DNA probe (Boehringer Mannheim, 1993b).
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2.1.14.3 Diazonium salt and naphthol-AS-phosphate detection
The membranes were equilibrated for two minutes in 20 ml of the following solution:
0.1 mM Trisma base, 0.1 mM NaCl, 50 mM MgCl2, pH 8.2 (buffer 3). Detection of the
presence of alkaline phosphatase was achieved by placing membranes in 10 ml of freshly
prepared red or blue colour substrate solution depending on the probe that the section
ofmembrane had been hybridised with. Red colour substrate solution comprised 10 ml
buffer 3, pH 8.2 with 0.006% fast red TR and 0.02% naphthol-AS-phosphate, whereas
blue colour substrate solution comprised 10 ml buffer 3, pH 8.2 with 0.03% fast blue
BB and 0.02% naphthol-AS-phosphate. All colour substrate chemicals were prepared
from 10% stock solutions (Appendix 1). Colour substrate was initially left in contact
with the membranes for 45 min at 37°C in the dark and replaced with fresh substrate
solution and allowed to develop for a further 45 min. The colour development was
stopped by washing the membranes briefly in 10 : 1 TE buffer, pH 8.0 for 5 min.
Membranes were then dried at room temperature and stored. Colours did not fade, but
were best seen when the membranes were rehydrated in 2 x SSC.
2.1.14.4 Alkaline phosphatase inactivation between colour detections
Alkaline phosphatase was inactivated between subsequent hybridisations by washing the
membranes briefly in 10 : 1 TE buffer, pH 8.0 followed by a 10 min incubation in 0.2 M
EDTA, pH 8.0 at 85°C. The membranes were finally washed twice for 5 min in buffer 1
to complete removal of EDTA. The membrane was the immediately hybridised with
another DNA probe and detected with a different set of colour substrates.
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2.1.15 Simultaneous Hybridisation
2.1.15.1 DNA extraction and probe construction
Whole chromosomal DNA was extracted as described in Modified DNA Extraction
Method (2.1.7.2) above from the following strains, P. intermedia FDC 581,
A. actinomycetemcomitans FDC Y4 and C. ochracea NCTC 11545. Extracted DNA
was finally dissolved in 200 fil 10 : 0.1 TE buffer, pH 7.6 and stored at - 20°C. A
random priming technique was used to label DNA from these three strains with one of
the following labels: digoxigenin, biotin and fluorescein. Protocols for labelling DNA
with each of these labels were as described above and required 1 fig bacterial DNA. All
reagents were supplied by Boehringer Mannheim (U.K.). DNA was denatured by
heating in a boiling waterbath for 10 min and then cooling quickly on ice for a further
5 min to prevent re-annealing. The following were added to a sterile Eppendorf tube on
ice: 1 fig freshly denatured whole chromosomal bacterial DNA, 2 fil of random
hexanucleotide mixture, 2 jil of dNTP mixture containing dCTP, dATP, dGTP (1 mM
each), dTTP (0.65 mM) and one of the following depending on the label desired;
digoxigenin-dUTP, biotin-16-dUTP, fluorescein-12-dUTP (0.35 mM each). This
solution was made up to 19 fil with sterile distilled water and 1 fil of Klenow fragment
added before incubation in a waterbath at 37°C. The reaction was stopped after
20 hours by the addition of 2 fil 0.2M EDTA, pH 8.0 and the labelled DNA precipitated
as before with 2.5 fil of 4M lithium chloride and 75 fil prechilled 70% ethanol. This
mixture was then left for 80 min at - 40 °C. Labelled DNA was recovered by
centrifugation for 2 min, washed with cold 70% ethanol, dried and dissolved in 50 ftl
10 : 1 TE buffer, pH 7.6.
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2.1.15.2 Preparation of colony lifts
Pure cultures of the three strains were incubated for two days in pre-reduced BM CMB,
as given above, in the anaerobic cabinet with 80% nitrogen, 10% hydrogen and 10%
carbon dioxide at 37 °C. Aliquots of 500 ml were taken from these broths and serial
dilutions made in RTF. One set of dilutions comprised a mixture of equal amounts of all
three broths, the remaining dilutions each contained growth from only one of the
broths. Aliquots of these were then spread on TSBA plates and anaerobically incubated
for 7 days at 37°C. Mixed TSBA plates at 10"4 dilution were selected because colony
counts were estimated to be in the region of 300 to 500. Colony lifts of the mixed
growth plates were prepared using nylon filters as described by Gunaratnam et al
(1992) and single stranded DNA covalently bound to the filters following air drying by
crosslinking for 3 min with 254 nm UV light from a transilluminator. Filters were then
stored at - 20°C prior to hybridisation. The TSBA plates containing pure growth from
the BM CMB at 10"4 dilution were used for colony counting to estimate the number of
colony forming units of each of the three species at this dilution.
2.1.15.3 Prehybridisation and hybridisation
The colony lifts were prehybridised as described above for 2 hours at 42°C. The filters
were then incubated overnight at 42°C in hybridisation solution, as described above,
containing 45% formamide, 5 x SSC, 1 x Denhardt's, 20 mM sodium phosphate, pH 6.5
and 0.2 mg/ml freshly denatured herring sperm DNA, to which had been added the
following freshly denatured DNA probes: C. ochracea DNA labelled with digoxigenin,
A. actinomycetemcomitans DNA labelled with biotin and P. intermedia DNA labelled
with fluorescein. Probes were at a final concentration of 50 ng/ml labelled DNA and a
volume of 2.5 ml was allowed for every 100 cm2 filter. Filters were then subjected to
stringency washes, first in 2 x SSC, 0.1% SDS (w/v) for two washes of 5 min at room
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stringency washes, first in 2 x SSC, 0.1% SDS (w/v) for two washes of 5 min at room
temperature and then in 0.1 x SSC, 0.1% SDS (w/v) at 68°C for two washes of
15 min. As multiple detections were to be performed, the filters were subjected to UV-
crosslinking for 3 min with 254 nm UV light to fix the DNArDNA hybrids and avoid
melting of the hybrids at later stages of the protocol (Boehringer Mannheim, 1993c).
2.1.15.4 Detection
The detection of the DNA hybrids was in three stages, each detecting the presence of
one of the three probes at a time and resulting in a different colour being deposited at
the sites of hybridisation, indicating the position of complementary target DNA at the
site of the original colony. Volumes are given for each 100 cm2 filter and colour
substrate chemicals obtained from Sigma, U.K.
2.1.15.4.1 Detection of digoxigenin-labelled probe
Filters were washed briefly in maleic acid solution (0.1 M maleic acid, 0.15 M NaCl, pH
7.5. buffer 1) before being incubated for 30 min at room temperature with 100 ml of
1% blocking solution (buffer 2). This was made from a concentrate of autoclaved 10%
blocking reagent in buffer 1. (Boehringer Mannheim, U.K.) Filters were then incubated
for a further 30 min with freshly diluted 150 mU/ml (1:5000) anti-digoxigenin antibody
conjugated to alkaline phosphatase in 1% buffer 2. Unbound conjugate was removed by
washing with 100 ml buffer 1 for 2 x 15 min. The filters were equilibrated for two
minutes in 20 ml of the following solution: 0.1 mM Trisma base, 0.1 mM NaCl, 50 mM
MgCh , pH 8.2 (buffer 3). Detection of the presence of alkaline phosphatase was
achieved by placing filters in 10 ml of freshly prepared 'green' colour substrate solution.
This comprised 10 ml buffer 3, pH 8.2 with 0.03% fast blue BB and 0.02% naphthol-
AS-GR-phosphate for 45 min at 37°C (Appendix 1). Colour substrate was replaced
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with 10 ml of fresh substrate solution after this time and allowed to develop for a
further 45 min. Alkaline phosphatase was inactivated as above (2.1.14.4).
2.1.15.4.2 Detection of biotin-labelled probes
Filters were washed briefly in buffer 1, pH 7.5 before being incubated for 30 min at
room temperature with 100 ml of 5% buffer 2. Then incubated for a further 30 min with
freshly diluted 150 mU/ml (1:5000) streptavidin-alkaline phosphatase conjugate in 5%
buffer 2. Unbound conjugate was removed by washing with 100 ml buffer 1 for two
washes of 15 min. The filters were equilibrated for two minutes in 20 ml of buffer 3.
Detection of biotin-streptavidin-alkaline phosphatase complexes was achieved by
placing filters in 10 ml of freshly prepared 'red' colour substrate solution. This
comprised 10 ml buffer 3, pH 8.2 with 0.006% fast red TR and 0.02% naphthol-AS-
phosphate for 45 min at 37°C (Appendix 1). Colour substrate was replaced with 10 ml
of fresh substrate solution and allowed to develop for a further 45 min. Alkaline
phosphatase was inactivated as above (2.1.14.4).
2.1.15.4.3 Detection of fluorescein-labelled probes
Filters were washed briefly in buffer 1, pH 7.5 before being incubated for 30 min at
room temperature with 100ml of 1% blocking solution (buffer 2) and then incubated for
a further 30 min with freshly diluted 150 mU/ml (1:5000) anti-fluorescein antibody
conjugated to alkaline phosphatase in 1% buffer 2. Unbound conjugate was removed by
washing with 100 ml buffer 1 for two washes of 15 min. The filters were equilibrated
for two minutes in 20 ml of buffer 3. Detection of alkaline phosphatase complexes was
achieved by placing filters in 10 ml of freshly prepared 'blue' colour substrate solution.
This comprised 10 ml buffer 3, pH 8.2 with 0.03% fast blue BB and 0.02% naphthol-
AS-phosphate for 45 min at 37°C (Appendix 1). Colour substrate was replaced with
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10 ml of fresh substrate solution and allowed to develop for a further 45 min. The final
colour reaction was stopped by washing the filters in 10 : 1 TE buffer, pH 8.0. Filters
were then dried at room temperature and stored. As before, colours did not fade, but
were best seen when the membranes were rehydrated in 2 x SSC.
2.2 CLINICAL PROCEDURES
2.2.1 Patients
Patients who were seropositive for the Human Immunodeficiency Virus (HTV)
participating in the study were referred to the Edinburgh Dental Hospital from a variety
of sources. Patients were referred from the Department ofGenito-Urinary Medicine at
the Royal Infirmary of Edinburgh and the Infectious Diseases Unit at the City Hospital
ofEdinburgh, either for specific treatment of oral conditions due to their
immunodeficiency or for regular observation should any oral conditions associated with
HTV infection arise. Other patients were self-referred, seeking general dental treatment
as a result of difficulties in finding a general dental practitioner. The nature of
periodontal disease in HIV seropositive subjects and the aims of this study were
explained to the patients, after which they were invited to participate.
Control patients, assumed to be HIV seronegative, responded to a poster displayed in
the Edinburgh Dental Hospital requesting volunteers to take part in a study of
periodontal disease. The Edinburgh Dental Hospital is primarily a teaching hospital
although it does provide a specialist consultant service for referrals from general dental
practitioners. It also serves as an acute care centre for the local population that may not
have a general dental practitioner of their own.
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2.2.2 Initial Visit
Each patient was randomly assigned to one examiner at baseline and continued to see
that clinician on all subsequent visits. A medical and social history was taken for all
patients at the initial visit (Appendix 2). Following a thorough oral examination,
dichotomous indicators of plaque, redness, necrosis, sequestration and suppuration
were recorded at six sites for all teeth present with the exception of third molars
(Haffajee et al, 1984). Supragingival plaque was removed from the mesiobuccal
surfaces of all teeth by means of Gracey curettes and a subgingival plaque sample taken
from the mesiobuccal site of all teeth with the exception of third molars. Each plaque
sample was deposited in 5 ml of RTF contained in a plastic disposable bijou marked
with patient number and site. Once all the plaque samples were collected the bijoux
were taken to the laboratory for dispersal, dilution and plating as outlined below.
Pocket depth measurements and position of the amelocemental junction were recorded
with a Williams probe at six sites for all teeth with the exception of third molars.
2.2.3 Laboratory Procedure
Due to the nature of the samples it was decided not to use a sonicating tip to achieve
dispersal of the plaque sample, but instead immerse the sealed bijoux containing the
plaque samples in a ultrasonic waterbath. This would remove the health risk posed by
the formation of a potentially harmful aerosol if a sonicating tip and open containers
were used.
The bijou containing the plaque sample was placed in an ultrasonic water bath, until the
level of the RTF inside the bijou was beneath the level of water in the bath, and
sonicated for 60s. After mixing by inverting the bijou several times, the dispersed
plaque sample was serially diluted in 10-fold dilutions of RTF. Using a 1 ml
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micropipette (Gilson Ltd., U.K.), 500 pi of the dispersed plaque sample was transferred
under a continuous flow of oxygen-free nitrogen to a fresh bijou containing 4.5 ml RTF.
The top of this bijou was secured and it was inverted several times before 500 pi of this
dilution was removed and transferred under oxygen-free nitrogen to another fresh bijou
containing 4.5 ml RTF and again the contents mixed thoroughly by inverting. Plaque
samples taken from the mesiobuccal sites of molar teeth were diluted one stage further
to allow for larger samples from these teeth. Aliquots of 100 pi of the neat, 10"1, 10~2
and 10~3 dilutions of plaque samples, were spread on TSBA plates marked for patient
number and site. These plates were then incubated in the anaerobic cabinet at 37°C.
When confluent growth was established on the agar surface after a period of between
5 to 7 days, the growth from agar plates with a total colony count of between 100 and
2000 was lifted on to nylon membranes using method A described in Materials and
Methods above. The colony lifts were then stored at -20°C until required. When a
number of patient samples had been collected and colony lifted, hybridisations were
completed as described above, at first using NBT/BCIP substrates to detect alkaline
phosphatase and subsequently naphthol-AS phosphates and diazonium salts.
2.2.4 Recall and Subsequent Visits
HIV seropositive patients were instructed to return immediately if they suffered any
gingival discomfort, pain, bleeding or had any concerns regarding their periodontal or
oral health between recall visits. Recalls were arranged initially only for HIV
seropositive patients on a three monthly basis. At these visits, clinical measurements and
dichotomous indicators of periodontal disease were recorded for the same six sites of
teeth present with the exception of third molars as before. A subgingival plaque sample
was collected only from those sites calculated to have lost 3 mm or more of attachment
between visits (see Calibration study, 2.2.5). These sites were deemed to have been
active in the intervening period. A subgingival plaque sample was also taken from any
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site that had the same final attachment level but that had suffered no additional loss
between visits, this site was designated as a control site. Recall visits were later
organised on 9 to 18 month basis for HTV seronegative patients and all measurements
were repeated as detailed above for HTV seropositive patient recalls. Two clinicians
were responsible for collection of all clinical measurements and plaque samples from
both the HIV seropositive and HTV seronegative patients.
2.2.5. Calibration Study
2.2.5.1 Aim
This study was undertaken to calibrate both clinical examiners and give estimates of
false positive rates when using a Williams probe to determine attachment level loss.
2.2.5.2 Design
The calibration study was conducted in two parts and comprised cross-sectional and
longitudinal measurements. The cross-sectional measurements were intended to give an
estimate of intra- and inter-examiner correlation and were conducted on two patients.
Both examiners measured pocket depths and levels of ACJ, of the maxillary teeth only,
in the same two patients on two separate occasions. The time between paired
measurements by one examiner was one hour and, as no real change in attachment level
could occur within this period, analysis of the data would also reveal a false positive
rate. The longitudinal measurements were analysed retrospectively on a total of three
patients who had attended each examiner on at least three occasions within a six month





Cross-sectional data is given in Table 3. The examiners in this study were in absolute
agreement in 70.5% of sites measured in the cross-sectional measurements. Inter-
examiner agreement of attachment level was 98-100% at + 2 mm.
2.2.5.3.2 Longitudinal data
The longitudinal data is given in Table 4. Total number of sites reviewed over three
visits was 498 and the total number of comparisons was 1498. From the results the
intra-examiner agreement was 90% + 1 mm and 98% + 2 mm. The number of sites
found in these three patients to have lost 3 mm attachment was six therefore the rate of
activity found in these patients from 1498 measurements was 0.6%. Results reported by
Best et al (1990) are included for comparison.
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Table 3 Calibration Study Cross-sectional Data
Best et al, 1990
Mean % Mean %
Absolute agreement 70.5 44.3
Difference of 1mm 27.7 40.9
Difference of 2mm 1.8 11.5
Difference of 3mm - 2.3
Difference of 4mm - 1.0
Number of sites 168 4963
Table 4 Calibration Study Longitudinal Data
Best et al, 1990
Range % Mean % Mean 1
Absolute agreement 38-63 48 41.6
Difference of 1mm 34-47 42 44.0
Difference of 2mm 3-11 8 11.7
Difference of 3mm 0-3 1.3 2.2
Difference of 4mm 0- 1 0.7 0.5
Number of sites 498 3604
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2.3 STATISTICAL ANALYSES
All statistical analyses were achieved by using a SPSS statistical package available on
Edinburgh University mainframe computer. In the majority of cases the data of
parameters studied were not normally distributed and transformations proved







3.1.1 DNA Extraction and Spectrophotometer Assay
Table 5 gives details of bacterial DNA extracted from reference strains using method B,
with modifications for the Gram-positive species used for S. sanguis.
Spectrophotometer readings of absorbance at 260 nm and 280 nm are also included, as
are the ratios of 260 : 280. These extractions were chosen to construct DNA probes
because of good 260 : 280 ratios, indicating highly purified preparations ofDNA.
Table 5 DNA Assay
Absorbance
260 nm 280 nm ratio yield (fig)
A. actinomycetemeomitans 0.134 0.077 1.74 67.0
P. gingivalis 0.347 0.205 1.69 173.5
P. intermedia 0.042 0.025 1.68 21.0
C.rectus 0.240 0.144 1.67 120.0
B. forsythus 0.069 0.042 1.64 34.5
C. ochracea 0.094 0.057 1.65 47.0
V. parvula 0.037 0.021 1.76 18.5
F. nucleatum 0.193 0.11 1.75 96.5
S. sanguis 0.096 0.057 1.68 48.0
3.1.2 Protein Assay
Using the Pierce Coomassie protein assay, negligible quantities of protein were found in
bacterial DNA extracted using method B.
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3.1.3 Agarose Gel Electrophoresis
The size of bacterial DNA fragments extracted was estimated using AGE. The bulk of
DNA extracted was found to be in the region of 23.1 kb or larger. This is in agreement
with previous results reported by Smith et al (1989b). Figure 3 shows results from an
AGE to estimated the size of DNA fragments after shearing. Extracted DNA was
sheared by passing through a 25 gauge needle four times. Lane 1 contains a Hind III
digest of phage X-DNA with eight bands that represent DNA fragment sizes of
23.13 kb, 9.42 kb, 6.56 kb, 4.36 kb, 2.32 kb, 2.03 kb, 0.56 kb and 0.13 kb
respectively. Lanes 2 through 9 contain DNA extracted from the following
A. actinomycetemcomitans, C. ochracea, B.forsythus, C. rectus, V.parvula,
P. gingivalis, F. nucleatum and P. intermedia. The results of this experiment indicate
that the size of the DNA from these organisms after shearing is generally 2.32 kb or
smaller. Figure 4 is a photograph of a gel containing digoxigenin-labelled C. ochracea
DNA and the phage X-DNA marker as before. This shows that the size of the
digoxigenin-labelled DNA is comparable to unlabelled DNA after shearing, being 2 kb
or less. The absence of RNA fluorescence at or beyond the gel front is a further











Lane 1 Hind HI digest of phage Lambda DNA,
Lane 2 A. actinomycetemcomitans, Lane 3 C. ochracea,
Lane 4 B.forsythus, Lane 5 C. rectus, Lane 6 V. parvula,














Figure 4 AGE ofDigoxigenin-labelled DNA
Lane 1 Hind HI digest of phage Lambda DNA,
Lane 2 digoxigenin-labelled C. ochracea DNA
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3.1.4 DNA probes
Figure 5 shows ten-fold dilutions of labelled DNA in concentrations from 100 ng to
10 pg detected with a range of colours possible by altering the combination of napthol-
AS-phosphates and diazonium salts. The colours produced are from the left Fast Red,
Green, Fast Blue, and Fast Brown. This experiment also compared the colours
produced by reducing the pH of the colour substrate buffer from 9.5 to 8.2. Improved
definition and clarity can be achieved by lowering the pH from 9.5 (right hand strip of
each pair) to 8.2 (left hand strip). Figure 6 shows the result of a labelling reaction which
was detected with napthol-AS-phosphate and fast red TR diazonium salt.
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Figure 5 Range of Colours using Colour Substrates
1. Fast Red TR and Naphthol-AS-phosphate
2. Fast Blue BB and Naphthol-AS-GR-phosphate
3. Fast Blue BB and Naphthol-AS-phosphate
4. Fast Brown and Naphthol-AS-phosphate
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Figure 6 Labelling Reaction Detected with Fast Red TR and Naphthol-AS-
phosphate
1. A. actinomycetemcomitans, 2. B.forsythus, 3. C. ochracea,




Control colony lifts were included with every hybridisation reaction and detected with





Figure 7 Colony Lifts Detected with NBT/BCIP
1. A. actinomycetemcomitans, 2. C. ochracea, 3. P. gingivalis,







5 6 7 8
Figure 8 Colony Lifts Detected with Colour Substrates
1. A. actinomycetemcomitans, 2. P. gingivalis, 3. B.forsythus,
4. V. parvula, 5. P. intermedia, 6. C. ochracea, 7. F. nucleatum
8. C. rectus.
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3.1.5.1 Selection of periodontal species to be enumerated
Only species that had been validated by Gunaratnam et al (1992) were considered for
use in this study and every attempt was made to purchase equivalent strains to those
validated by these authors. Due to restrictions of time and manpower, it was originally
decided to limit the number of species investigated to those nine detailed in Materials
and Methods. These species were selected because they featured prominently in the
literature as currently suspected periodontal pathogens or beneficial species. However
during test hybridisations it became apparent that 5. sanguis colonies were not lysed
consistently using the colony lift protocol described by Gunaratnam et al (1992). This
was attributed to the resilience of the Gram-positive cell wall possessed by this
organism. Although lysis ofGram-positive bacteria could be improved by additional
steps to the colony lift, this resulted in elution from the surface of the filter of Gram-
negative species on a mixed growth colony lift. It was therefore decided to concentrate
only on the Gram-negative species selected. Test hybridisations with F. nucleatum
gave inconsistent results, although the colony lift method was not believed to be at fault
in this case. Colony lifts of patient samples were hybridised with the F. nucleatum
probe, however detection of F. nucleatum measured by the strength of signal on the
positive control colony lifts during these hybridisations remained inconsistent and at
best very weak. For these reasons the results reported do not include S. sanguis or
F. nucleatum and are for the remaining seven Gram-negative species only.
3.1.6 Stripping Procedure
Figure 9 shows a colony lift that demonstrates some of the problems caused by
reprobing when alkaline phosphatase is detected with NBT/BCIP. This colony lift was
prepared from an agar plate that contained a mixture of A. actinomycetemcomitans and
C. ochracea growth and was first hybridised with a digoxigenin-labelled
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A. actinomycetemcomitans DNA probe and detected with NBT/BCIP. After
enumeration of colony forms the brown precipitate and probe were stripped using the
protocol outlined in Materials and Methods. The lift was then hybridised with a
digoxigenin-labelled C. ochracea DNA probe and detected with NBT/BCIP. Whereas
the brown precipitate produced at sites of hybridisation with the C. ochracea probe is
clearly visible, blue ghost colony forms from the first detection remain visible after
stripping. It is also possible to make out the effect that light can have on a colony lift
detected with NBT/BCIP. An area exposed to light during the detection has lightened,
leaving dark outlines of two separate lifts overlying the one photographed.
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Figure 9 RgmQval Qf NBT/BCIP Precipitate with DMF
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3.1.7 Patient Samples
Detection of the probe species on colony lifts prepared from primary isolation plates
using colour substrates is illustrated in Figure 10. These two quadrants of filter were
first hybridised with C. rectus digoxigenin-labelled DNA probe and detected with 'fast
red' colour solution then hybridised with P. intermedia digoxigenin-labelled DNA probe
and detected with 'fast blue'. The remaining quadrants from these sites were hybridised
with one of the following pairs of digoxigenin-labelled DNA probes
A. actinomycetemcomitans and P. gingivalis, C. ochracea and V. parvula,
F. nucleatum and B.forsythus.
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Figure 10 Patient Samples Detected with Colour Substrates
Red colony forms represent areas where the C. rectus DNA probe has
hybridised and blue colony forms represent areas where the
P. intermedia DNA probe has hybridised.
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3.1.8 Simultaneous Hybridisations
After anaerobic incubation for seven days, TSBA plates with growth from aliquots of
the 10'4 dilution of pure and mixed dilutions of CMB, were selected for colony
counting and colony lift respectively. Triplicate TSBA plates containing growth of
separate species at the 10~4 dilution of the CMB were counted using a colony counter.
From these results mean total colony counts and standard error for each species at this
dilution were calculated (Table 6). The mean total colony count represents the mean
number of CFU's for each species contained in a 100 ji.1 aliquot of a 10"4 dilution of
each CMB. The estimated total colony count was calculated by adding these three
means to give an estimate of the total colony count of all three species on a mixed
growth TSBA plate (Table 6). Mixed TSBA plates at 10~4 dilution, were colony lifted,
simultaneously hybridised and colour detected as described in Materials and Methods.
Coloured colony forms on the lifts represented areas where the DNA probes to these
species had successfully hybridised with single-stranded target DNA fixed to the nylon
colony lift (Figure 11 a,b). Total colony counts of mixed growth TSBA plates with
green, blue and red colony forms, representing C. ochracea, P. intermedia and
A. actinomycetemcomitans colonies respectively, are given in Table 7. The mean total
colony count of all coloured colony forms on each lift, together with mean total colony
count and standard error for each species are also given.
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C. ochracea 146 132 125 134.3 6.18
P. intermedia 40 61 48 49.7 6.12
A. actinomycetemcomitans 24 31 34 29.7 2.94
Estimated total colony count 213.4
Table 7 Colony Counts for Mixed Growth TSBA Plates Enumerated bv
Simultaneous Hybridisation and Multicolour Detection
plate mean SE
1 2 3 4 5 6
C. ochracea 152 127 114 175 163 131 143.7 9.56
P. intermedia 36 39 39 43 59 36 42.0 3.56
A. actinomycetemcomitans 29 19 16 31 32 30 26.2 2.80
Mean total colony count 217 185 169 249 254 197 211.8 14.10
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Figure 11 a Simultaneous Hybridisation and Multicolour Detection
Green colony forms represent C. ochracea DNA
Red colony forms represent A. actinomycetemcomitans DNA
Blue colony forms represent P. intermedia DNA
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Figure 11b Simultaneous Hybridisation and Multicolour Detection
(Higher power view of colony lift in Figure 11a)
Green colony forms represent C. ochracea DNA
Red colony forms represent A. actinomycetemcomitans DNA
Blue colony forms represent P. intermedia DNA
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3.2 PATIENT POPULATION
A total of 29 HTV seropositive patients were recruited from the Department of Genito¬
urinary Medicine at the Royal Infirmary of Edinburgh and the Infectious Diseases Unit
at the City Hospital of Edinburgh to take part in this study. All patients were diagnosed
HTV antibody positive by ELISA and confirmed by Western Blot This group
comprised 23 males and 6 females, with a mean age of 33.2 years, s.d 8.47 (Table 8).
Twenty patients had acquired HTV by homosexual or bisexual contact, five by
heterosexual contact and four patients during IVDA. The median number of years since
diagnosis ofHIV infection at baseline examination was three, although this ranged from
a few months to eight years. Twelve patients had a CDC classification of stage II and
seventeen stage IV (Table 9). Many of these patients were on a wide range of
medication and presented with a number ofHIV-related and unrelated illnesses. Table
10 gives the occurrence of systemic and oral conditions believed to be related to
immunosupression caused by HTV infection. Five HTV seropositive subjects gave a
history of Herpes zoster which was the most common systemic manifestation ofHIV
infection in this sample representing 17.4% of the population studied. Four patients had
a history of Herpes simplex, three Pneumocystis carinii pneumonia and two subjects
had a history of Kaposi's sarcoma. Other systemic conditions recorded at first visit for
these patients included appendicitis, peptic ulcer and diabetes insipidus. The most
common oral manifestation of HTV infection was oral hairy leukoplakia which occurred
in eleven (37.9%) of HIV seropositive subjects. Of the seven cases of candidiasis
reported five were pseudomembraneous candidiasis, one was atrophic candidiasis and
one patient had both pseudomembraneous and atrophic candidiasis at the same time.
Other oral signs believed to be related to HIV infection included four cases of recurrent
oral ulceration, two with Herpes simplex and one oral Kaposi's sarcoma. Table 11 gives
the percentage of HIV seropositive subjects on antimicrobial, antiviral and antifungal
medication at first visit. Fifteen patients were recieving azidothymidine, three acyclovir
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and one patient was taking dideoxyinosine. A total of sixteen patients were receiving
antimicrobial therapy at the first visit, eleven subjects were taking pentamidine either
prophylactically or for the treatment of Pneumocystis carinii pneumonia. Twelve
patients were on a single course of antimicrobials, eight on pentamidine only, and four
patients were taking a single course of either penicillin V, metronidazole, trimethoprim
or doxycycline. Four patients were on a combination of antimicrobials at first visit, two
patients were receiving pentamidine and metronidazole, one patient pentamidine and
penicillin V, and one patient was taking metronidazole and erythromycin. Of those
patients on antifungals, four were taking fluconazole and one amphoteracin. Other
medications recorded included three subjects on methadone with Valium, temazepam,
codeine, aspirin, Tagamet, dapsone and Lotomil being taken by one patient each.
Twenty-seven patients volunteered to act as a control group and comprised 18 males
and 9 females. Two male subjects were homosexuals, but had recently tested negative
for HIV. The remaining 25 patients were assumed to be HIV negative. The mean age of
this group was 35.5 years (s.d 11.06) (Table 8).
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Table 8 Patient Statistics 1
HIV + HIV -
n AGE sd n AGE sd
Male 23 35.2 8.37 18 34.4 9.12
Female 6 25.7 2.80 9 37.7 14.59
Total 29 33.2 8.47 27 35.5 11.06
Table 9 Patient Statistics 2
HIV + HIV + HIV
n % n % n %
homo/bi 20 69.0 CDC II 12 41.4
hetero 5 17.3 CDC IV 17 58.6
IVDA 4 13.7 smoking 14 48.3 15 55.6
non smoking 15 51.7 12 44.4
homo/bi homosexual/bisexual CDC II CDC stage II
hetero heterosexual CDC IV CDC stage IV
IYDA intravenous drug abuser










Oral Hairy Leukoplakia 11 37.9
Candida 7 23.3
Recurrent Oral Ulcers 4 13.8
Herpes simplex 2 6.9
Kaposi sarcoma 1 3.4
Table 11 Medication taken bv HIV Seropositive Subjects at First Visit
n % n %
Antimicrobials 16 55.2 Antivirals 17 58.6
pentamidine 11 37.9 azidothymidine 15 51.7
metronidazole 4 13.8 acyclovir 3 10.3
penicillin V 2 6.9 dideoxyinosine 1 3.4
erythromycin 1 3.4





3.2.1 Baseline and Subsequent Visits
At baseline examination both groups had a similar mean number of teeth, i.e. 25.9 (s.d.
2.3) in the HIV seropositive group, 25.1 (s.d. 3.1) in the HIV seronegative group.
Clinical data were collected on 4500 sites from the HTV seropositive patients and 4068
sites from the HIV seronegative patients at baseline examination. Subgingival plaque
samples were taken from a total of 750 sites from HIV seropositive subjects and 678
sites from HIV seronegative subjects at this visit Tables 12 and 13 give the number of
HTV seropositive patients that attended recall appointments. Eighteen patients were
seen on a second visit, 16 males and two females, comprising 14 homosexuals or
bisexuals, two heterosexuals and two IVDA. Details of HTV seropositive patients
attending third, forth, fifth and sixth visits are also given in Table 13. The mean interval
between appointments was 3.6 months (s.d 0.80).
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Table 12 Subsequent Visits ofHIV Seropositive Subjects
number of visits
1 2 3 4 5 6
HIV +
patients 29 18 9 5 3 1
sites 4500 2814 1404 792 498 168
HIV -
patients 27 4
sites 4068 672 ....



































































3.3.1 Attachment Loss and Clinical Indicators
Individual histograms ofmean attachment loss for each patient presented highly
positively-skewed data. Logio > log 10 (x + 1) and square root transformations failed to
correct for skewness and a normal distribution could not be obtained. However, if a
log io (x + 1) transformation of the mean attachment loss of the worst 10% of sites is
plotted, abbreviated to CTENP (Imrey, 1986), a normal distribution is attainable for the
HIV seronegative patients (Figure 12). This same transformation failed using data from
the HIV seropositive group (Figure 13). It was therefore decided that untransformed
mean attachment loss for each patient would serve as a summary statistic of attachment
loss for these two patient groups. Comparisons of attachment loss between groups was
achieved using mean attachment loss and a Mann-Whitney U test. Clinical indicators of
periodontal disease were also not normally distributed for either groups and therefore




Figure 12 Frequency Distribution for Logju^x + 1) Transformation
of CTENP for HIV Seronegative Subjects
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Figure 13 Frequency Distribution for Logui(x +1) Transformation
of CTENP for HIV Seropositive Subjects
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3.3.2 Comparisons ofMicrobiological Data Between Patient Groups
Both prevalence and mean percentage of each of the species enumerated varied widely
between patients of both groups. The mean percentage of any one of the species was
not normally distributed in either the HIV seropositive or HIV seronegative group and
transformation of the raw data also proved unsuccessful. Comparisons between HTV
seropositive and seronegative groups were achieved using a Mann-Whitney U test. The
median is included in the Tables ofmicrobiological data as a summary statistic for the
groups, and the interquartile range is given as an indication of the range of the mean
percentages for the species enumerated.
3.3.3 Periodontal Parameters as Possible Predictors of HTV Disease
Progression
Baseline clinical and microbiological data collected from both HIV seropositive and
HIV seronegative subjects were analysed using a Kruskal Wallis test, non-parametric
one way analysis of variance, to find out ifHIV disease progression could be related to
any of the parameters studied. Other tests used in statistical analyses are described with




Figures 14 and 15 plot the mean attachment loss at baseline examination against age for
HIV seronegative and HIV seropositive patients. Mean attachment loss for HIV
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seronegative patients increased with age, however two HIV seronegative patients had a
greater mean attachment loss for their corresponding age compared to the rest of the
HIV seronegative patients in this sample (Figure 14). The relationship between mean
attachment loss and age for HIV seropositive patients was considerably more complex
(Figure 15), whereas some HIV seropositive patients had a similar distribution ofmean
attachment loss for age compared to the HIV seronegative patients in this sample, as
many as fourteen HTV seropositive patients had an increased mean attachment loss for
their age (Figure 16). When these two groups were compared using a Mann-Whitney U
test, the HIV seropositive patients tended to have a greater mean attachment loss than
HTV seronegative patients (p = 0.099, Table 14).
Table 14 Comparison of Mean Attachment Loss At Baseline Visit ofHIV
Seropositive and HIV Seronegative Subjects
(Mann-Whitney U Test).
Median Interquartile Range p-value
HIV + 1.40 0.68 - 2.48
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Figure 14 Mean Attachment Loss in HIV Seronegative Subjects
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Figure 16 Mean Attachment Loss in HIV Seropositive and HIV
Seronegative Subjects
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Figures 17 and 18 plot the number of sites and their location within the mouth that had
attachment loss of 3 mm or more at baseline examination in both HIV seronegative and
HTV seropositive groups. The HIV seronegative group had 295 sites with attachment
loss of 3 mm or more at the baseline visit, which represents 7.3% of all HIV
seronegative sites examined at baseline (Figure 17). The HTV seropositive group
yielded 818 sites with this degree of attachment loss or greater, which represented
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The pattern of attachment loss in the HIV seronegative group can be seen in Figure 17.
Posterior teeth had increased prevalence and degree of attachment loss of 3 mm or
more when compared to the anterior teeth for both upper and lower arches. Figure 18
shows the pattern of attachment loss in HTV seropositive patients as seen at baseline
visit is different from that observed in HTV seronegative subjects. Whereas the pattern
of loss in the upper arch was similar to that seen in the HIV seronegative group, the
lower incisor teeth in HTV seropositive patients exhibited a markedly higher prevalence
and degree of attachment loss when compared to other sites in the mouth. Furthermore,
a large percentage of these sites had attachment loss of 5, 6 or 7 mm.
3.4.1.2 Widespread and localised periodontal disease
Patients were divided into those exhibiting widespread or localised disease on the basis
of the percentage of sites with 3 mm or more of attachment loss (Haffajee et al, 1991).
These authors decided that a patient would be categorised as having widespread
periodontal disease if 30% or more of all sites had 3 mm or more of attachment loss.
Localised periodontal disease patients would have less than 30% of all sites with this
degree of attachment loss. According to these criteria, nine of 29 HIV seropositive
patients and two of 27 HIV seronegative patients fell into the widespread disease
category, with the remainder of both groups in the localised or no disease category. A
chi-squared test was used to find if this difference in disease pattern between the groups
was statistically significant (Table 15). Although showing a marked tendency, the
difference between these two groups with respect to pattern of periodontal disease fell
short of statistical significance (p = 0.059).
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Table 15 Distribution ofWidespread and Localised Periodontal Disease
Categories Among HIV Seropositive and HIV Seronegative
Subjects (Chi-square Test)
HIV + HIV - p-value
Widespread 9 2
Localised 20 25 0.059
The pattern of attachment loss of 3 mm or more in the nine HTV seropositive patients
with widespread periodontal disease is shown in Figure 19, whereas Figure 20 plots the
same for the remaining 20 HIV seropositive patients with localised or no disease. The
nine HTV seropositive patients with widespread periodontal disease contributed a total
of 636 sites with this degree of attachment loss, representing 48.2% of the total number
of sites for these patients. The remaining 20 HIV seropositive patients had 182 sites
with 3 mm or more of attachment loss, or 5.7% of the total number of sites for this
group. The nine patients with widespread disease showed a marked tendency for
moderate to severe attachment loss throughout the mouth, especially in the lower
incisor region (Figure 19). Figure 20 shows that the 20 HIV seropositive patients with
localised disease had a similar distribution to that seen in the HIV seronegative patient
group as a whole (Figure 17). When mean attachment loss was compared between the
widespread and localised periodontal disease patients of the HIV seropositive group,
not surprisingly, the widespread patients had a statistically significantly higher mean
attachment loss than localised periodontal disease patients (p = 0.001, Table 16). Eight
of the widespread periodontal HTV seropositive patients were males, seven of whom
were homosexuals or bisexuals and one IVDA. Further details of these patients are








Figure 19 Location of Sites with 3 mm or More of Attachment Loss for Nine
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Figure 20 Location of Sites with 3 mm or More of Attachment Loss for 20
HIV Seropositive Subjects with Localised Periodontal Disease
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Table 16 Comparison of Mean Attachment Loss ofHIV Seropositive





2.78 2.48 - 3.06
0.97 0.523 - 1.57
p-value
0.001
Table 17 Details ofHIV Seropositive Widespread and Localised
Periodontal Disease Subjects
widespread localised widespread
n % n % n %
male 8 89 15 75 CDC II 4 44
female 1 11 5 25 CDC IV 5 55
homo/bi 7 78 13 65 smoking 6 66
hetero 1 11 4 20 non smoking 3 33












Table 18 compares the mean attachment loss of 20 HIV seropositive and 25 HIV
seronegative patients with localised periodontal disease. No difference of statistical
significance could be found for mean attachment loss between these two groups.
Table 18 Comparison <?fMean Attachment Loss ofHIV Seropositive
and HIV Seronegative Subjects with Localised Periodontal
Disease (Mann-Whitney U Test)
n Median Interquartile Range p-value
HIV + 20 0.97 0.52 - 1.57
HIV- 25 0.88 0.75- 1.16 0.802
3.4.1.3 Dichotomous clinical indicators
Raw clinical data, including percentages of sites of individual patients with bleeding on
probing, plaque, redness and suppuration, were not normally distributed for either HIV
seropositive or HIV seronegative groups. To compare the presence or absence of any
of these clinical indicators of periodontal disease across HTV seropositive and HIV
seronegative groups, a Mann-Whitney U test was used (Table 19). No significant
differences were found between these two groups with respect to bleeding on probing,
plaque or redness. However, HIV seropositive patients had a statistically significantly
higher percentage of sites exhibiting suppuration at baseline than HIV seronegative
patients (p = 0.025).
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Table 19 Comparison of Presence of Clinical Indicators Between HIV
Seropositive and HIV Seronegative Subjects
(Mann-Whitney Test)
Status Median Interquartile Range p-value
% BOP + 10.70 3.75-25.30
8.30 5.10-52.40 0.446
% PLQ + 60.30 41.55 - 78.60
60.00 33.30 - 67.90 0.350
% RED + 59.30 43.40 - 90.70
54.20 34.00-75.30 0.412
%SUPP + 2.60 0.00-8.30
0.00 0.00 - 1.40 0.025
% BOP = percentage of sites exhibiting bleeding on probing
% PLQ = percentage of sites with plaque
% RED = percentage of sites with redness
% SUPP = percentage of sites with suppuration
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In an attempt to investigate the nine widespread periodontal disease patients further, a
Mann-Whitney U test was used to compare the incidence of the dichotomous clinical
indicators between HIV seropositive patients with widespread and localised periodontal
disease (Table 20). Although no differences of statistical significance were found
between the percentage of sites with bleeding on probing or plaque between these two
groups, the widespread periodontal disease group exhibited a statistically significantly
higher percentage of sites with redness (p = 0.030) and suppuration (p = 0.010) than
the HIV seropositive patients with localised periodontal disease.
Table 20 Comparison of Presence of Clinical Indicators in HIV
Seropositve Subjects with Widespread and Localised
Periodontal Disease (Mann-Whitney U Test)
Disease Median Interquartile Range p-value
% BOP wide 13.70 7.60 - 17.35
local 9.05 1.65- 39.18 0.396
% PLQ wide 75.00 46.45 - 92.85
local 51.85 41.48-74.63 0.195
% RED wide 96.70 41.35- 100.00
local 53.45 42.25 - 70.73 0.030
% SUPP wide 13.60 3.00 - 19.05
local 0.90 0.00 - 4.30 0.010
% BOP = percentage of sites exhibiting bleeding on probing
% PLQ = percentage of sites with plaque
% RED = percentage of sites with redness
% SUPP = percentage of sites with suppuration
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Interestingly, no differences of statistical significance were found with respect to the
dichotomous clinical indicators recorded for the 20 HTV seropositive and 25 HIV
seronegative subjects with localised periodontal disease (Table 21).
Table 21 Comparison of Presence of Clinical Indicators in HIV
Seropositive and HIV Seronegative Subjects with Localised
Periodontal Disease (Mann-Whitney U Test)
Status Median Interquartile Range p-value
% BOP + 9.05 1.65-39.18
7.70 4.70-51.20 0.293
% PLQ + 51.85 41.48 -74.63
56.90 32.05 - 67.75 0.640
% RED + 53.45 42.25-70.73
53.60 33.35-75.70 0.936
%SUPP + 0.90 0.00-4.30
0.00 0.00- 1.30 0.158
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3.4.2 Subsequent Visits
Eighteen HIV seropositive patients were seen at a second visit, and nine of these
returned for at least a third visit (Tables 22 and 23). Wilcoxon matched pairs signed
ranks test was used to compare the changes in attachment loss and pocket depth as well
as changes in the percentage of sites with clinical indicators of periodontal disease of
each patient between baseline and visit two and between visits two and three (Tables 22
and 23).
Table 22 Comparison of Attachment Loss and Pocket Depth for HIV
Seropositive Subjects Returning on Subsequent Visits
(Wilcoxon Matched Pairs Signed Ranks Test)
n Median Interquartile Range p-value
pocket depth
visit 1 18 2.23 1.72 - 2.75
visit 2 18 2.10 1.69 - 2.39 0.011
visit 2 9 2.23 1.87-2.62
visit 3 9 2.06 1.65 - 2.67 0.139
attachment loss
visit 1 18 1.71 0.80 - 2.38
visit 2 18 1.40 0.97 - 2.36 0.118
visit 2 9 1.97 1.15-2.44
visit 3 9 1.91 0.86 - 2.42 0.066
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Table 23 Comparison of Clinical Indicators for HIV Seropositive
Subjects Returning on Subsequent Visits
(Wilcoxon Matched Pairs Signed Ranks Test)
n Median Interquartile range p-value
% BOP
visit 1 18 15.10 6.13-42.73
visit 2 18 11.05 3.55-21.48 0.001
visit 2 9 8.30 3.05-20.25
visit 3 9 10.80 1.65- 18.8 0.767
% PLQ
visit 1 18 53.95 36.30-76.18
visit 2 18 67.30 46.88 - 74.10 0.055
visit 2 9 65.50 55.65-75.65
visit 3 9 66.70 39.00-82.60 0.441
% RED
visit 1 18 57.09 46.88-82.53
visit 2 18 73.45 58.48-94.45 0.124
visit 2 9 62.30 52.65-95.80
visit 3 9 75.00 44.40-85.50 0.779
% SUPP
visit 1 18 3.45 0.45-9.85
visit 2 18 2.05 0.00- 8.15 0.856
visit 2 9 6.50 0.60-9.15
visit 3 9 1.90 0.00- 11.25 0.441
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3.4.2.1 Attachment loss and pocket depth
Mean pocket depth decreased in 14 HIV seropositive patients between baseline and
visit two (p = 0.011). No statistically significant differences were observed for mean
pocket depth between visit two and three. There was a tendency for the mean
attachment level to improve between visits two and three in seven of the nine HIV
seropositive patients but this was not statistically significant (p = 0.066, Table 22).
3.4.2.2 Dichotomous clinical indicators
Of a total of 18 HIV seropositive patients seen at visit two, 16 had fewer sites with
bleeding on probing on the second visit compared to the baseline examination
(p = 0.001), but a tendency for increased plaque on the second visit was seen in
13 patients (p = 0.055). There were no statistically significant differences in the
percentages of sites with redness or suppuration between these two visits. There were
no statistically significant differences between the percentages of the various clinical




The baseline microbiological data reported below is for 20 HTV seropositive patients
and 23 HIV seronegative patients. This represents 445 sites in the HTV seropositive
patients and 497 sites in the HIV seronegative patients or 86% of the total number of
sites for both groups. Tables 24 and 25 give the details of these 43 patients.
Table 24 Microbiology Data Patient Statistics 1
HIV + HIV -
n AGE sd n AGE sd
Male 16 37.0 10.9 15 34.5 9.6
Female 4 26.0 3.6 8 38.3 15.5
Total 20 34.8 10.8 23 35.9 11.8
Table 25 Microbiology Data Patient Statistics 2
(HIV + only)
n % n %
homo/bi 14 70 CDC II 11 55
hetero 4 20 CDC IV 9 45
IVDA 2 10 smoking 11 55
non smoking 9 45
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3.5.1 Lower limit of detection
The lower limit of detection of the colony lift method was dependent on the total
colony count for each site and therefore varies from site to site within a patient. The
mean total colony count for the HIV seropositive sites was 651.5 (s.d. 218.00)
compared to 657.3 (s.d. 221.32) for HIV seronegative sites. The mean lower limit of
detection of colony lifts prepared from HIV seropositive sites was 0.58% (s.d. 0.18)
compared to a mean lower limit of detection of 0.60% (s.d. 0.25) in sites from HIV
seronegative patients.
3.5.2 Prevalence
Table 26 gives the percentage of patients in both groups positive for the species
enumerated. V. parvula and W. recta were detected in at least one site in all 43
patients, whereas P. gingivalis was detected in 18 of the 20 HIV seropositive patients
and 19 of 23 HIV seronegative patients. Included in the table are the results of the
study by Haffajee et al (1992) of adult/chronic periodontitis patients for comparison.
The percentage of sites positive for each of the species enumerated is given in Table 27.
V. parvula was detected in 50.1% of the HIV seropositive sites and 55.3% of the sites
from HIV seronegative patients. This table also includes data from Gunaratnam et al
(1992) for percentage of sites positive for these strains in 90 periodontitis patients
whose HIV status was unknown.
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Table 27 Percentage of Sites Positive for Probe Species Enumerated
HIV + HIV - Gunaratnam et al, (1992)
A. actinomycetemcomitans 25.8 27.0 13.0
P. gingivalis 32.4 18.3 37.0
P. intermedia 24.3 27.2 36.0
C.rectus 38.4 41.0 48.0
B. forsythus 32.8 36.8 22.0
C. ochracea 24.3 25.2 42.0
V. parvula 50.1 55.3 59.0
Number of Sites 445 497 700
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3.5.3 Comparison Between HIV Seropositive and HIV Seronegative
Subjects
A Mann-Whitney U test was used to compare the difference between HIV seropositive
and HTV seronegative patients on the basis ofmean percentage of the species
enumerated. Table 28 gives the median for each species for both groups as well as the
interquartile range and the p-value for the Mann-Whitney U test for each species. No
differences of statistical significance were found between groups with regard to the
mean percentage of six of the seven species. However, P. gingivalis was found at a
higher mean percentage in the HTV seropositive patients compared to the HIV
seronegative controls (p = 0.030).
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Table 28 Comparison ofMean Percentages of Probe Species Enumerated











Median Interquartile Range p-value
0.21 0.04-1.99
0.53 0.19-0.87 0.798
0.73 0.28 - 1.58
0.22 0.02 - 0.72 0.030
0.44 0.07 - 1.03
0.42 0.09 - 1.08 0.807
0.65 0.26 - 1.91





2.08 0.64 - 5.53
I.86 1.23- 3.59 0.865
II.21 6.37-19.13
9.79 5.81 - 13.25 0.295
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3.5.4 Widespread and Localised Disease in HIV Seropositive Subjects
Microbiological data were available for only seven of the nine HTV seropositive patients
with widespread periodontal disease. These patients were compared to the remaining
13 patients with localised or no disease. Widespread periodontal disease patients
exhibited a higher mean percentage of these seven probe species than the HIV
seronegative patients. This difference was statistically significant (p = 0.005, Table 29).
The HTV seropositive patients with widespread periodontal disease had a median mean
total of 19.18% compared to the localised disease group with a median mean total of
9.34% (Table 29). Furthermore, these seven HIV seropositive patients also had a
tendency for a higher mean percentage of P. gingivalis (p = 0.063), P. intermedia
(p = 0.088), C. ochracea (p = 0.066) and V. parvula (p = 0.081) (Table 29). No pattern
of colonisation of any one of the probe species could be associated with the lower
incisor region of the seven widespread disease patients.
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Table 29 Comparison of Mean Percentages of Probe Species Enumerated
in HIV Seropositive Subjects with Widespread or Localised
Periodontal Disease (Mann-Whitney U Test)
Disease Median Interquartile Range p-value
A. actinomycetemcomitans wide 2.09 0.05 - 3.41
local 0.12 0.02 - 0.95 0.111
P. gingivalis wide 1.38 0.68 - 1.68
local 0.43 0.21 - 1.00 0.063
P. intermedia wide 0.45 0.28 - 1.71
local 0.24 0.02 - 0.76 0.088
C. rectus wide 1.39 0.14-2.04
local 0.62 0.30 - 2.70 0.843
B. forsythus wide 1.40 0.90 - 3.36
local 0.88 0.43- 1.30 0.166
C. ochracea wide 1.21 0.10-4.53
local 0.29 0.00 - 0.66 0.066
V. parvula wide 3.87 1.32- 11.90
local 1.32 0.43 - 4.53 0.081
Total wide 19.18 12.95-24.51
local 9.34 4.86-14.15 0.005
HIV+ widespread = 7, localised =13.
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3.5.5 HIV Seropositive Subjects and HIV Seronegative Subjects with
Localised Periodontal Disease
Table 30 compares the mean percentages of the species enumerated in the localised or
no disease group of 13 HIV seropositive and 21 HIV seronegative subjects. Using a
Mann-Whitney U test no differences of statistical significance could be found between
these two groups with respect to any of the species enumerated.
Table 30 Comparison of Mean Percentages of Probe Species Enumerated in HIV
Seropositive and HIV Seronegative Subjects with Localised Periodontal
Disease (Mann-Whitney U Test)
Status Median Interquartile Range p-value
A. actinomycetemcomitans + 0.12 0.02 - 0.95
- 0.53 0.19 - 0.85 0.166
P. gingivalis + 0.43 0.21 - 1.00
- 0.31 0.03 - 0.79 0.425
P. intermedia + 0.24 0.02 - 0.76
- 0.52 0.10 - 1.19 0.178
C. rectus + 0.62 0.30 - 2.70
- 0.86 0.59 - 1.93 0.215
B. forsythus + 0.88 0.43 - 1.30
- 0.96 0.34 - 2.26 0.632
C. ochracea + 0.29 0.00 - 0.66
- 0.65 0.13 - 1.10 0.15
V. parvula + 1.32 0.43 - 4.53
- 1.83 1.17 - 3.49 0.512
Total + 9.34 4.86- 14.15
9.79 6.00- 13.39 0.583
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3.6 IMMUNOLOGY DATA
Data on a number of immunological markers were available for 28 of 29 HIV
seropositive patients, including CD4+ and CD8+ counts, activated T-cells and
P2-microglobulin. However, the date of baseline periodontal examination did not
always coincide with the date of the immunology results. Six HIV seropositive patients
had immunological results within one week of the baseline examination and twelve
patients had results, both before and after baseline examination within three months of
this visit. Four patients had a single immunology result within three months either
before or after baseline visit and five patients had no immunology results within three
months of baseline visit. Immunology results could not be traced for two HIV
seropositive patients. Only CD4+ and CD8+ T-cell counts were used for statistical
analyses because these were the most frequently performed immunological tests,
whereas [^-microglobulin, activated T-cells and immunoglobulin assays were
performed only occasionally.
3.6.1 Levels of CD4+ and CD8+ T-cells
In an attempt to provide an accurate estimate of the levels of CD4+ and CD8+ T-cells
at baseline visit the following regime was adopted. If the immunology results were
within one week of baseline, then this single value of CD4+ or CD8+ T-cells was taken
as an estimate. If either one or both results from before or after the baseline visit was
within three months, then an average of both results was taken as an estimate of levels
at baseline. If more than three months separated the baseline examination and the
immunology results, then these patients were excluded from the analysis. A total of
22 HIV seropositive patients satisfied the above criteria and details of these patients are
given in Tables 31 and 32. Median and interquartile range of CD4+ and CD8+ T-cell
counts for these patients and subgroups of CDC stage II and IV are given in Table 33.
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As would be expected the CDC stage II patients have higher counts ofCD4+ and
CD8+ T-cells than the CDC stage IV patients. The CDC stage IV group has a lower
CD4+ T-cell count and CD4+: CD8+ ratio than the CDC stage II group (p = 0.006 and
p = 0.014 respectively). The CDC stage IV group had also a tendency for a lower
CD8+ T-cell count (p = 0.070).
Table 31 Immunology Data Patient Statistics 1
HIV +
n AGE sd
male 19 36.2 8.65
female 3 27.3 3.21
Total 22 35.0 8.64
Table 32 Immunology Data Patient Statistics 2
(HIV+ only)
n % n %
homo/bi 17 77.2 CDC II 8 36.4
hetero 2 9.1 CDC IV 14 63.6
IVDA 3 13.6 smoking 11 50
non smoking 11 50
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Table 33 CDC Stage and CD4. CD8 T-Cell Counts and CD4 : CD8 Ratio
(Mann-Whitney U Test)
Marker
CD4 normal 500 - 750
CDC II 252.50
CDC IV 70.00
Median Interquartile range p-value
180.75 - 569.00
6.50 - 194.50 0.006












0.03 - 0.32 0.014
3.6.2 Attachment Loss
No correlation was found between the mean attachment loss in 22 HTV seropositive
patients at baseline visit and CD4+, CD8+ T-cell counts and CD4+: CD8+ ratio.
Immunological results were available for seven of the nine HTV seropositive patients
with widespread periodontal disease, the remaining 15 HIV seropositive patients with
immunological results having localised periodontal disease. Table 34 compares the
levels of CD4+, CD8+ T-cell counts and CD4+: CD8+ ratio for these two groups using
a Mann-Whitney U test. No statistically significant differences in CD4+, CD8+ T-cell
count or CD4+: CD8+ ratio were found between these two groups (Table 34).
3.6.3 Widespread and Localised Disease
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Table 34 Comparison of CD4. CDS T-Cell Counts and CD4 : CDS Ratio in
HIV Seropositive Subjects with Widespread and Localised
Periodontal Disease (Mann-Whitney U Test)








450.00 - 968.00 0.307





0.08 - 0.54 0.438
3.6.4 Dichotomous Clinical Indicators
Plots of CD4+, CD8+ T-cells and CD4+: CD8+ ratio against clinical indicators for the
22 HTV seropositive patients showed no correlation between these immunological
markers and clinical indicators, with the possible exception of redness. Whereas CD4+
and CD8+ counts, and percentage of sites with redness did not show any correlation,
the CD4+: CD8+ ratio tended to be weakly negatively correlated with the percentage of
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CD4+ : CD8+ ratio
Figure 21 Plot of CD4+ : CD8+ Ratio Against Percentage of Sites with
Redness in HIV Seropositive Subjects
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3.6.5 Microbiology
No correlation was found between mean levels of any of the probe species and CD4+>
CD8+ T-cells counts or CD4+ : CD8+ ratio.
3.7 ACTIVE AND CONTROL SITES
Seven HIV seropositive patients were identified as having at least one site that
experienced an increase in attachment loss of 3 mm or more between subsequent visits.
Two patients were judged to have attachment loss of this degree at different sites on
two separate occasions. Table 35 details the number of active and control sites sampled
between visits two and four, along with the number of patients contributing these sites.
Seven sites were identified from 2814 reviewed at the second visit to have increased in
attachment loss by 3 mm or more since baseline examination. Similarly, four sites from
1404 were identified at visit three and nine sites identified from 792 reviewed at visit
four. All of these sites came from homosexual or bisexual males with five of these
subjects CDC stage IV and two CDC stage II. Further details of these patients are
given in Table 36. Results of CD4+, CD8+ T-cell counts and ratio for these seven
patients are given in Table 37. All patients experiencing breakdown tended to have low
CD4+ T-cell counts.
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Table 35 Active and Control Sites
Visit
2 3 4 5
Number of patients
reviewed 18 9 5 3
Number of sites
reviewed 2814 1404 792 489
Number of patients
with active sites 4 3 2 0
Active sites
Sampled 7 4 9 0
Control sites
Sampled 4 4 2 0
Rate of occurence
of active sites 0.25% 0.29% 1.1%
(*both patients had previous occurence of active sites)
Table 36 Patient Statistics ofHIV Seropositive Subjects with Active Sites
n % n %
homo/bi 7 100 CDC II 2 28.6
hetero - 0 CDC IV 5 71.4
IVDA - 0
widespread 4 57.1 smoking 2 28.6
localised 3 42.9 non smoking 5 71.4
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Table 37 CD4. CD8 T-Cell Counts and CD4 : CD8 Ratio in HIV Seropositive
Subjects with Active Sites
Marker Median Interquartile Range
CD4 153.50 27.25 - 268.50
CD8 543.00 210.00 - 889.75
CD4:CD8 0.22 0.07 - 0.33
3.7.1 Clinical Data from Active and Control Sites
Tables 38 and 39 give the mean attachment loss and percentages of clinical indicators at
both active and control sites. The mean attachment level of active sites was 5.15 mm
(s.d 1.76) compared to 4.90 mm (s.d. 2.02) for control sites (Table 38). A Chi-square
test was used to compare the presence of these clinical indicators with the clinical
classification of active or control sites (Table 39). There was no statistically significant
differences between active and control sites with regard to dichotomous clinical
indicators, although 35% of active sites exhibited bleeding on probing compared to only
10% of control sites. Similarly, 70% of active sites had redness, whereas only 40% of
control sites exhibited redness.
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Table 38 Mean Attachment Level I^)ss of Active and Control Sites
Active Control
Number of Sites 20 10
Mean Attachment
Level Loss 5.15 4.90
(sd) 1.76 2.02
Table 39 Comparison of Clinical Indicators Across Active and Control
Sites (Chi-square Tests)
Active Control p-value
Number of sites 20 10
BOP (n) 7 1 0 307
% BOP 35 10
PLQ (n) 14 7 1.000
% PLQ 70.0 70.0
RED (n) 14 4 0.236
% RED 70.0 40.0
SUPP (n) 3 0 0.519
% SUPP 15.0 0.0
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3.7.2 Comparison of Microbiology of Active and Control Sites
To compare the microbiology of active and control sites a Mann-Whitney U test was
used. Table 40 details the median, interquartile range and p-value for the statistical test
as before for the probe species across active and control sites. C. ochracea was not
detected in either active or control sites. Of the remaining species no statistically
significant differences in the levels of any of the probe species were found between
active and control sites (Table 40).
Table 40 Comparison of Microbiology of Active and Control Sites
(Mann-Whitney)
Condition Median Interquartile p-value
Range
A. actinomycetemcomitans active 0.00 0.00 - 0.60
control 0.00 0.00- 1.25 0.408
P. gingivalis active 0.50 0.00 - 8.80
control 0.00 0.00 - 1.23 0.265
P. intermedia active 0.80 0.00 - 3.40
control 1.40 0.10-4.30 0.409
C.rectus active 0.50 0.00 - 2.80
control 0.60 0.00-1.53 0.912
B. forsythus active 0.00 0.00- 1.60
control 0.30 0.00 - 4.63 0.540
V. parvula active 2.70 0.00 - 5.80
control 0.25 0.00 - 9.68 0.611
Total active 8.00 6.00-18.30
control 7.75 3.98-21.75 0.710
(C. ochracea was not isolated from either active or control sites)
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3.8 PERIODONTAL PARAMETERS AS POSSIBLE PREDICTORS OF
HIV DISEASE PROGRESSION
In an attempt to provide some information regarding possible predictors of HTV disease
progression, cross-sectional clinical and microbiological data were used in conjunction
with a Kruskal - Wallis test, (one way analysis of variance for non-parametric data)
across the following groups, HIV seronegative, CDC stage n, CDC stage IV.
Table 41 shows that while there was no difference between the HIV seronegative group
and the CDC stage II HIV seropositive patients with regard to mean attachment loss,
CDC stage IV patients had a statistically significantly higher mean attachment loss than
any of the other groups (p = 0.036).
Table 41 Comparison of Mean Attachment Loss Across HIV Disease
Status (Kruskal-Wallis Test)
3.8.1 Attachment Loss













i.q. range = interquartile range
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3.8.2 Dichotomous Clinical Indicators
Table 42 details the differences in dichotomous clinical indicators between the three
groups. The percentage of sites exhibiting suppuration is seen to increase across the
three CDC groups, with HTV seronegative subjects having the lowest mean percentages
and the CDC stage IV patients having the highest mean percentages of sites exhibiting
suppuration. These differences were found to be statistically significant (p = 0.026). No
other differences of statistical significance were detected.
Table 42 Comparison of Clinical Indicators Across HIV Disease Status
(Kruskal-Wallis Test)
HIV - CDC II CDC IV p-value
mean % BOP 8.30 7.95 11.30
i.q. range 5.10-52.40 0.83-26.85 4.80-31.55
mean rank 30.22 23.92 29.00 0.531
mean % PLQ 60.00 57.25 63.60
i.q. range 33.30-67.90 46.40- 83.98 35.80-76.85
mean rank 26.39 32.04 29.35 0.587
mean % RED 54.20 67.30 56.50
i.q. range 34.00 - 75.30 28.40 - 92.9 43.40 - 90.70
mean rank 26.65 30.42 30.09 0.714
mean % SUPP 0.00 0.30 4.30
i.q. range 0.00- 1.40 0.00-5.15 0.30- 10.80
mean rank 23.69 27.83 36.62 0.026
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3.8.3 Microbiological Data
Differences in mean percentage of the probe species enumerated across the three
groups are given in Table 43. The mean percentage of P. gingivalis displayed a
tendency to increase throughout the groups (p = 0.055), with HIV seronegative
subjects having on average lower mean percentages of P. gingivalis than CDC stage II
HIV seropositive patients, who have in turn on average lower mean percentages of
P. gingivalis than CDC stage IV patients. The mean percentages of V. parvula were
highest for CDC stage II patients but had dropped to very low levels in CDC stage IV
patients (p = 0.037). No other differences of statistical significance were found between
these groups with respect to levels of species enumerated.
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Table 43 Comparison of Mean Percentage of Probe Species Enumerated
Across HIV Disease Status (Kruskal-Wallis Test)






































































































4.1 OBJECTIVES OF STUDY
The objectives set out at the beginning of this thesis were:
1) To establish a procedure for the enumeration of selected periodontal bacteria in
a large number of plaque samples using non-isotopic whole chromosomal DNA
probes.
2) To compare the prevalence of periodontal disease between HTV seropositive
and HTV seronegative subjects in the Edinburgh area.
3) To compare the prevalence of these selected periodontal bacteria between
HTV seropositive and HIV seronegative patients.
4) To assess the incidence of HTV-associated periodontal diseases in the
HTV seropositive group on a longitudinal basis.
5) To characterise the microbiology associated with these lesions in terms of those
species selected for enumeration.
6) To investigate whether periodontal breakdown or any of the clinical or
microbiological parameters studied could be used as predictors ofHIV disease
progression.
To discuss the fulfilment of the first objective, the advantages and disadvantages of
using whole chromosomal probes to detect periodontal bacterial DNA on nylon colony
lifts will be addressed, followed by a discussion of the modifications to the technique, as
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originally described by Gunaratnam et al (1992), that were used in this study to
improve efficiency in terms of labour, cost and time.
4.1.1 Whole Chromosomal DNA Probes
Traditional methods of identification of bacterial species in subgingival plaque samples
include the predominant cultivable microbiota technique (PCM). While PCM provides,
arguably, the widest picture of the subgingival microbiota (Dzink et al, 1985,1988;
Haffajee et al, 1988a,b; Moore et al, 1982; Tanner et al, 1979), subculture and
identification to species level of up to 50 randomly chosen colonies on a primary
isolation plate can take up to 6 - 8 weeks. Furthermore, it may result in inconclusive
biochemical tests for some isolates after a considerable investment in time and labour.
However, the development of digoxigenin-labelled whole chromosomal DNA probes,
used in conjunction with colony lifts of primary isolation plates, enables a more rapid
enumeration of a selection of periodontal species from a larger number of plaque
samples than previously possible using PCM (Gunaratnam et al, 1992). Using this
technique, enumeration of a selection of periodontal species in a subgingival plaque
sample can be completed within ten days. Although several techniques involving nucleic
acid probes are available for the identification of periodontal species in subgingival
plaque samples (see Literature Review section 1.5), the use of whole chromosomal
digoxigenin-labelled probes has several advantages.
The extraction of whole chromosomal DNA from bacteria is relatively straightforward
and protocols exist for both Gram-negative and Gram-positive bacteria (Smith et al,
1989b,c). These protocols generally take in the region of 4 - 6 hours and yields of up to
several hundred micrograms of whole chromosomal DNA are possible with some
species. Due to their size, whole chromosomal probes generally incorporate a larger
number of reporter molecules per probe than either cloned or oligonucleotide probes.
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The number of reporter molecules per probe will depend on the labelling method used
but can result in a stronger signal when hybrids are detected. Furthermore, the use of
whole chromosomal DNA probes may be considered more sensitive than either
oligonucleotide or cloned DNA probes because the entire genome of the species under
investigation is targeted, whereas oligonucleotide or cloned DNA probes target only a
small section of the DNA (Tenover, 1988; Albandar and Olsen, 1990). However, this
feature of whole chromosomal DNA probes may result in cross-reactions between the
DNA of closely related species. Gunaratnam et al (1992) reduced the occurrence of
cross-reactions observed for a selection of periodontal species by using conditions of
high stringency. These authors validated the following species P. gingivalis,
P. intermedia (homology groups 1 and 2), B.forsythus, A. actimomycetemcomitans
(serotypes a and b), C rectus, V. parvula, C. ochracea, F. nucleatum, Streptococcus
intermedius, Streptococcus sanguis I, Streptococcus sanguis II, and
Peptostreptococcus micros against 249 strains representing a total of 51 species. They
reported 100% sensitivity and 100% specificity of digoxigenin-labelled whole
chromosomal DNA probes for 12 of the 14 probes they constructed. Weak cross-
reactions were reported between the S. sanguis II probe and two strains of S. mitis,
whereas the F. nucleatum probe detected only seven of the 28 strains of F. nucleatum
used. Therefore only those species previously validated by Gunaratnam et al (1992)
were considered for use in this study and it was the intention to follow the protocol of
these authors precisely to avoid potential cross-reactions and achieve the same levels of
sensitivity and specificity. Furthermore, the use of nylon colony lifts taken from primary
isolation plates produced results comparable to those achieved using PCM. This was
considered important, as culture studies have identified the lists of currently suspected
periodontal pathogens and beneficial species. By using the colony lift technique, the
final results of this study could then be compared to other centres using DNA probes as
well as previous culture studies.
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The use of the steroid hapten digoxigenin as a reporter molecule to label whole
chromosomal DNA had several advantages over other nucleic acid labels available. The
DNA labelling procedure with digoxigenin is relatively simple and requires an overnight
reaction. Using this technique, 1 jig of template DNA produces approximately 1 (ig of
labelled DNA probe, with a molecule of digoxigenin incorporated every 20 - 25
nucleotides. However, the reaction volumes can be scaled up, so that an overnight
labelling reaction using 1 |ig of template DNA produces 5 - 6 jig of digoxigenin-
labelled DNA probe (see below). Digoxigenin is non-isotopic and therefore is less
hazardous and easier to handle than radioisotopic labels. Furthermore, digoxigenin-
labelled probes are stable for up to one year when stored at - 20°C and can be reused
several times. The probes used in this study were used up to nine times with consistent
results. Following hybridisation, digoxigenin-labelled probes are detected with anti-
digoxigenin antibody conjugated to alkaline phosphatase. The activity of alkaline
phosphatase can in turn be detected by a variety of methods, for example NBT/BCIP,
naphthol-AS phosphate and diazonium salt colour substrates or chemiluminesent
substrate (AMPPD). Usually detection is complete within eighteen hours which is
considerably faster than isotopic probes (Smith et al, 1989a). By using methods of
detection that produce a visible precipitate, the reaction can be stopped at any time
once the signals have reached a satisfactory intensity. In the present study the detection
of alkaline phosphatase enzyme activity by NBT/BCIP or colour substrates was
normally completed within one to three hours.
4.1.2 Modifications
4.1.2.1 Extraction of whole chromosomal DNA
The first method used to extract whole chromosomal DNA from subgingival bacteria
was found to be time consuming and although producing DNA of high purity, the total
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yield was generally disappointing. Modifications to this method (Dr. Sigmund
Socransky, personal communication) provided a faster extraction protocol that
improved the yields of whole chromosomal DNA from Gram-negative species. The
main differences between these methods were that the modified method achieved cell
lysis using sarcosyl rather than SDS and proteinase K as in the earlier method. The
modified method also used RNase earlier which allowed a single
phenol/chloroform/isoamyl alcohol purification and precipitation of the DNA,
immediately after CTAB/NaCl removal of cellular proteins and polysaccharides. The
modified DNA extraction protocol used with Gram-positive species required the
addition of achromopeptidase with lysozyme and a 10 min incubation at 75°C following
the addition of 2% sarcosyl before the addition of RNase. These steps were aimed at
improved lysis of the Gram-positive cell wall (Materials and Methods). These
amendments generally resulted in increases in yield of DNA from a selection of Gram-
postive species. Protein assays, absorbance spectrophotometer measurements and AGE
indicated that the DNA extracted using this method was free from contamination of
proteins, RNA or phenol (Table 5, Figure 3).
4.1.2.2 Labelling with digoxigenin
Agarose gel electrophoresis of extracted whole chromosomal DNA showed that the
DNA had been fragmented into a range of sizes but that the majority was 23.1 kb or
larger (Smith et al, 1989b). Although whole chromosomal DNA of 23.1 kb could be
used successfully labelled with digoxigenin (Boerhinger Mannheim, personal
communication) the optimum size of the DNA template for labelling with the random
priming technique was in the region of 1 - 2 kb. Shearing whole chromosomal DNA by
passing it through a 25 gauge needle four times, reduced the average size of the DNA
fragments to between 0.13 and 2.3 kb (Figure 3). The digoxigenin-labelled DNA probes
produced from this size of DNA template were also in this region (Figure 4).
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In order to produce the quantities ofDNA probe required to hybridise colony lifts
prepared from patient samples the reaction volume of the labelling reaction was scaled
up. Normally, 1 p.g of template or unlabelled DNA will produce 1 p.g of digoxigenin-
labelled DNA if the reaction is allowed to proceed for 20 hours. However, if the
reaction volumes are scaled up an overnight labelling reaction using 1 p.g of template
DNA produces 5 - 6 p.g of digoxigenin-labelled DNA probe (Materials and Methods,
Boerhinger Mannheim, 1993). This was considered an advantage given the amount and
concentration of labelled DNA required to deal with a large number of plaque samples.
The original 1 |ig of template DNA is not itself labelled with digoxigenin during the
procedure therefore the final product of a labelling reaction contains both labelled and
unlabelled DNA. The ratio of labelled to unlabelled DNA may affect the strength of the
final signal in the following ways. Unlabelled DNA would be expected to compete with
labelled DNA for hybridisation with target sequences fixed to the nylon support,
hybridise with labelled DNA in solution and be incorporated into amplification trees
with a resultant reduction in the concentration of digoxigenin at the hybridisation site
and therefore a reduction in the potential signal. If several normal volume reactions
were used to generate the amount of labelled DNA probe required then the ratio of
labelled to unlabelled would always be 1 : 1. However, the combined products of
several scaled up reactions would give a ratio of labelled to unlabelled DNA in the
region of 5 or 6 : 1. In the event, no difference between the probes constructed by
either method was observed, but the scaled up labelling reactions were used thereafter
to produce large quantities of labelled DNA required.
4.1.2.3 Colony lift protocols
Initially, the colony lift protocol as described by Gunaratnam et al (1992) was used for
■both Gram-positive and Gram-negative species. However, there was concern that in the
■present study this protocol did not consistently lyse colonies of Gram-positive species.
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Attempts were made to increase the effectiveness of the lysing stages and involved the
use of achromopeptidase and lysozyme (Materials and Methods). These additional
stages did result in an improvement in the lysis of Gram-positive species in general.
Unfortunately, the amendments to the colony lift protocol were not compatible with
Gram-negative species on mixed colony lifts. These colonies were readily dislodged
from the surface of the nylon membrane during transfer of the lift from one solution to
the next. In this respect, the original colony lift protocol was superior for Gram-
negative species as these colonies were normally adherent to the membrane surface. It
was decided that, because lysis of Gram-positive bacteria could not be consistently
achieved using the original colony lift protocol and that the extended protocol was not
compatible with the Gram-negative bacteria, S sanguis should be removed from the
study.
Following lysis, removal of cellular debris and purification, initially the DNA was fixed
to the surface of the colony lift by baking for two hours at 80°C. However, DNA can be
covalently bound to the surface of a nylon filter by the reaction of primary amino
groups on the nylon surface with DNA thymidine residues on exposure to 254 nm
ultraviolet radition for one minute (Coen, 1989; Boerhinger Mannheim, 1993c). This
more rapid method was adopted since it did not affect the signals achieved at the
detection stage.
4.1.2.4 Dispersal of plaque samples and RTF
Gunaratnam et al (1992) achieved dispersal of the subgingival plaque sample with a
Kontes sonicating tip. However, some of the subgingival plaque samples in the present
study would originate from known HIV seropositive patients and a potentially
hazardous aerosol could be produced if a sonicating tip were used, therefore it was
decided to use an alternative method of dispersal. Weiner et al (1979) proposed that an
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ultrasonic waterbath could be used to disperse plaque samples. This has the advantage
of achieving dispersal more gently, thereby preserving the viability of organisms that
may be susceptible to the effects of sonication by a tip. This method also allowed
dispersal within a closed vessel and therefore removed the potential risk of a harmful
aerosol. However,the use of an ultrasonic waterbath has some drawbacks. The
amplitude of vibration of a sonicating tip can be adjusted and therefore some control
over the amount of energy transmitted to the sample via the sonicating tip can be
exercised. The sonic energy produced by the fixed piezoelectric transducers of an
ultrasonic waterbath will vary depending on the position of the sample vessel in the
bath. An attempt to overcome this difficulty was made by observing the effects on small
silicon beads in a closed bijou placed at different positions in the ultrasonic bath. Five
positions in the bath were chosen that agitated the silicon beads to a similar degree and
a frame was constructed to hold the 5 ml of RTF in the sample bijoux just below the
surface of the water at these positions. This was used throughout the study to achieve
-consistency in the dispersal of plaque samples. Further assessment of this method of
■dispersal was made during the sonication experiment The aims of this experiment were
■to assess the effects of sonication using an ultrasonic waterbath on pure cultures of the
■species under investigation, and to provide a supply of agar plates that contained pure
■cultures of these species for colony lifting to be used as positive and negative controls
tin hybridisation experiments. The effects of sonication on bacteria in enclosed bijoux
-were assessed using dilutions in RTF of pure broth cultures of the selected species. It
■was felt that the effects of sonication on pure cultures of relatively unaggregated
■bacteria would be of interest because the CFU on the agar plates would most likely
■have originated from the free-floating bacteria in the sample solution rather than from
-he mass of plaque. Therefore the viability and vulnerability of freely-floating bacteria to
sonication, away from the protection offered by an aggregated mass of plaque, would
■letermine the bacterial growth on agar plates of dilutions of that sample. This
experiment and later observations from subgingival plaque samples, established that this
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method of plaque dispersal could be used as an alternative to a sonicating tip in an open
vessel without compromising bacterial viability or failing to disaggregate subgingival
plaque. Furthermore, a large number of samples could be dispersed at a time, thereby
reducing the time between sample collection and plating.
4.1.2.5 Selection of species for enumeration
Prior to analysis of any plaque samples, it was necessary to demonstrate the ability of
whole chromosomal digoxigenin-labelled DNA probes to detect target DNA of the
selected species on colony lifts. As mentioned above, it proved difficult to achieve
consistent lysis of S. sanguis using the colony lift protocol that was to be used for
subgingival plaque samples and it was decided to leave this organism out of the
analysis. However, control hybridisations involving F. nucleatum gave inconsistent
results although the colony lift was not thought to be at fault. There may be several
explanations why F. nucleatum proved difficult to hybridise. One may be that the
%G + C content of Fusobacteria is low being in the region of 27 - 28% which is lower
than the other species hybridised, ranging from 38 - 48% (figures from Bergey's
Manual of Systematic Bacteriology, 1984). As a result the ideal hybridisation
temperature may be lower than the 42°C used with the colony lifts. However %G + C
content is believed to have little effect on filter hybridisation in practice (Anderson and
Young, 1985). Another reason could be that the spectrophotometer reading of DNA
extracted from F nucleatum may have overestimated the total yield and have resulted in
less than 1 qg of DNA being added to the labelling reaction. In retrospect, examination
of the AGE of sheared DNA (Figure 3), the F. nucleatum signal appears weaker than
the others, although 1 pg ofDNA from each of the organisms was added. This could
have resulted in the F. nucleatum probes being weaker than the others. However, this
problem would be expected to manifest itself as the F. nucleatum probes becoming
exhausted after relatively few hybridisation reactions. In contrast, probes prepared to
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F. nucleatum were seen to work inconsistently throughout a series of hybridisation
reactions. Previous difficulties in hybridisation with this species have been reported
(Gunaratnam et al, 1992; Dr. Gillian Smith, personal communication). These problems
set against a background of taxonomic difficulties with Fusobacteria, (Dzink et al,
1990) led to the decision to drop this species from the microbiology assessment. No
problems were experienced with the remaining seven species in hybridisation and
detection procedures.
4.1.2.6 Clinical samples
At baseline examination, subgingival plaque samples were taken only from the
mesiobuccal site of all teeth present, with the exception of third molars, by Gracey
curettes. The reason for restricting samples to the mesiobuccal site at this visit was
essentially to keep the number of samples to be processed for each patient down to a
manageable level. The mesiobuccal site was considered the easiest to sample and would
provide one subgingival plaque sample per tooth. This would provide 28 samples from
a patient with a full complement of teeth and it was felt that this would allow a
reasonable estimate of the mean percentages of probe species for each patient. The
choice of Gracey curettes to sample subgingival plaque rather than paper points was in
order to keep conditions as close to the Gunaratnam study as possible.
4.1.2.7 Transport and dilution of plaque samples
RTF was chosen as the transport and dilution medium for the plaque samples as it was
easier to prepare than pre-reduced anaerobically sterilised modified Ringers solution
used by Gunaratnam et al (1992). The time from collection of the last sample to placing
TSBA plates, containing dispersed and diluted plaque samples, into the anaerobic
chamber was generally one hour. This was to ensure that loss of viability of species
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sensitive to aerobic conditions was kept to a minimum. The suitability of RTF for these
species had already been demonstrated during the sonication experiments "'hen all
dilutions were completed in RTF. Finally, dilutions of subgingival plaque samples were
completed under a continuous flow of oxygen-free nitrogen again to ensure minimum
loss of oxygen-sensitive species, as during the sonication experiment.
4.1.2.8 Prehybridisation and hybridisation of plaque samples
Although the prehybridisation and hybridisation conditions were maintained as
described by Gunaratnam et al (1992), adjustments were made to the overall procedure
by these authors, to ensure improved efficiency in terms of time, cost and labour.
Gunaratnam et al (1992) used three colony lifts per subgingival plaque sample, cut two
of these lifts into fifths and the remaining lift into quarters and hybridised each section
with one of their fourteen probes. Successful hybridisation of target DNA with the
probe used was detected with anti-digoxigenin antibody and NBT/BCIP. Brown colony
forms were enumerated on each of the sections and then these were discarded.
However, in this study it was decided to use only one nylon colony lift per site to help
keep costs down. In addition, the extra time and labour required to plate, count and
colony lift from duplicate or triplicate TSBA plates of each site sampled would have
further stretched resources. As a consequence, it was decided to limit the number of
species enumerated from each plaque sample to those given in Materials and Methods.
However simply cutting each colony lift into eight sections to accommodate these
species would have reduced the area of colony lift available for hybridisation with each
probe. It was thought this could lead to potential sources of error as it is unlikely that
one-eighth of a colony lift will be representative of the growth of the whole agar plate.
In order to hybridise a representative section of a colony lift it was necessary to
hybridise each section with more than one DNA probe. To analyse the growth
produced from each plaque sample with all eight probes, each colony lift was cut into
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quarters and each section hybridised with two probes in a sequential manner. Reprobing
sections in this way increased the amount of data recovered from each lift while still
allowing a reasonable area of each colony lift to be hybridised with each probe.
4.1.2.9 Reprobing membranes
Initially, when NBT/BCIP detection of alkaline phosphatase was used, sections of
colony lift were first hybridised, detected and stripped before being reprobed. The
reprobing protocol for NBT/BCIP detection involved firstly the removal of the brown
precipitate, followed by the removal of the digoxigenin-labelled DNA probe
(see Materials and Methods). This method required the use of heated DMF, which is
toxic, and did not result in complete colour removal (Figure 9). After stripping the
section was then prehybridised, hybridised with another probe, detected and
enumerated as before. Although the new coloured precipitate could be easily identified
from the blue-ghost colony forms from the previous detection, this method was not
ideal and an alternative was sought. Alkaline phosphatase activity can also be detected
by production of various azo dyes from the reaction of naphthol-AS phosphates with
diazonium salts in the presence of the enzyme (West et al, 1990). There are a number of
advantages of the use of naphthol-AS phosphates and diazonium salts over NBT/BCIP
to detect alkaline phosphatase. These compounds are considerably cheaper, have fast
colour development (approximately 90 mins), have very low background, are light-
stable and there is a range of colours available (Figure 5). However for detection of
bacterial DNA on colony lifts red and blue colour substrates were chosen as they are
easily distinguishable at low concentrations. Using these compounds sections of colony
lifts could be prehybridised, hybridised with the first probe and detected with red colour
substrate solution, then almost immediately hybridised with the second probe and
detected with blue colour substrate solution with no stripping procedure with DMF, or
second prehybridisation required (Figure 10). On test hybridisations and control colony
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lifts no difference in the sensitivity between the two detection methods was observed.
Therefore, although both methods allowed the hybridisation of a given area of
membrane with more than one probe, the use of colour substrates was preferred as
detections were faster and more cost effective.
4.1.2.10 Simultaneous hybridisations
A provisional protocol for simultaneous hybridisation and colour detection was
obtained from Boeringher Mannheim, although the colour detection substrates were not
yet available from the company. This protocol was adapted for the detection of three
subgingival species on nylon colony lifts using the colour substrates mentioned above.
Simultaneous hybridisation and subsequent multicolour detection represent another way
in which more information can be obtained from a limited area of colony lift. Although
the results of this small study are encouraging, many more lifts would have to be
hybridised to demonstrate the reproducibility and validity of this technique. While
simultaneous hybridisations may not be ideally suited to the enumeration of a range of
periodontal species in large number of plaque samples, it may be of benefit in other
areas of diagnostic microbiology where there is interest in only two or three species
(Tables 6 and 7, Figures 11 a,b).
In summary, a number of modifications to the procedure described by Gunaratnam et al
(1992) were adopted to fulfil the first objective. These modifications enabled the
enumeration of a selection of periodontal bacteria in a large number of subgingival
plaque samples more efficiently than previously described, without loss of sensitivity or
specificity. Furthermore, these protocols would allow a relatively large number of
plaque samples to be enumerated for each patient and an estimate of the prevalence of
each probe species within the patient groups under study.
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4.1.3 Study Design and Data Generated
Before considering the remaining objectives the design of the study and the data
generated will be considered.
4.1.3.1 Patient groups
Twenty-nine HTV seropositive and 27 HIV seronegative patients were included in this
study. Both groups had a similar mean age, although the HIV seronegative group
included more female members than the HTV seropositive group. Both HIV
seropositive and control groups had a similar number of teeth at baseline examination,
the total number of sites examined in HIV seropositive patients at this visit was 4500,
compared to a total of 4068 sites examined at baseline forHIV seronegative patients.
It could not be claimed that either of these two groups were the result of random
sampling. The HIV seropositive patients were either referred from the Royal Infirmary
ofEdinburgh or the City Hospital ofEdinburgh to the Edinburgh Dental Hospital for
treatment, or observation of specific oral complaints. A number were self-referred and
attended the Edinburgh Dental Hospital as they were unable to find a GDP to carry out
routine dental treatment because of their HIV seropositivity. While some of these
patients had oral signs ofHIV infection at baseline examination, the majority did not
(Table 10).
The 27 HIV seronegative patients responded to a poster displayed in the EDH and
therefore were limited to either the patients or technical/ administrative staff of the
hospital. In the majority of cases these patients were assumed HIV negative, however
as mentioned above, two male homosexuals were included in this group as they had
recently tested negative for HIV at the time of baseline examination. Patient volunteers
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may have been receiving treatment at any department within the hospital, although
patients currently receiving treatment in the Periodontology Department, together with
patients who had received a course of antibiotics within the previous six months, were
excluded.
4.1.3.2 Longitudinal data
This part of the study was essentially a cohort study of a group ofHIV seropositive
patients who were to be monitored at regular intervals. Unfortunately recruitment of
HTV seropositive patients into the study proved difficult The majority ofHIV
seropositive subjects in the Edinburgh area acquired HIV as a result of IVDA. When
approached, these patients were generally not interested in taking part in such a study.
The IVDA that were recruited were poor attenders at recall visits, whereas a number of
the homosexual men returned on several occasions. This potential bias should be
remembered when considering the conclusions drawn from HTV seropositive patients
on a longitudinal basis.
4.1.3.3 Clinical data
4.1.3.3.1 Measurement of attachment loss and calibration study
Measurement of attachment loss by conventional probe was considered to be an
adequate means of detecting attachment level changes of the magnitude expected in
HTV seropositive patients. Originally, it was assumed that the clinical appearance of
HIV-associated periodontal disease, i.e. necrosis, sequestration, linear gingivitis
accompanied by attachment loss ofmore than 3 mm would prompt sampling for
microbiology. Cross-sectional measurements had established inter- and intra-examiner
correlations and the likelihood of false positives (Table 3). However, longitudinal
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observations began to suggest the occurrence of subtle changes in HIV seropositive
patients i.e. "conventional" periodontal disease. Therefore a retrospective analysis of
data, collected from patients seen on a number of occasions, was undertaken to assess
measurement reproducibility on a longitudinal basis and the incidence of 3 mm
attachment loss (Table 4). The use of conventional probes in determining attachment
level loss on a longitudinal basis has been criticised as having a high false-positive rate
(Cohen and Ralls, 1988; Best et al, 1990). The false positive rate and level of
agreement between replicate measurements calculated from the cross-sectional data in
this study agreed with rates reported by Best et al (1990, Table 3). Therefore there is a
possibility that those sites designated "recently active" in the present study will contain
some false-positives due to measurement error. However, reviewing the data collected,
only a minority of sites fulfilled the sampling criteria and considerable loss of
attachment has been rare in this cohort (Table 35). This is perhaps not surprising given
the small number of patients taking part and the prospective cohort design of the study.
For these reasons the data collected so far, on a longitudinal basis, are insufficient to
determine the rate of periodontal breakdown in the HIV seropositive population at
large. However, the use of mean attachment loss as a summary statistic, calculated from
single measures of attachment loss by conventional probe, will tend to negate any
measurement error at individual sites and is a reliable indicator of the degree of
attachment loss suffered by the individual. The allocation of a patient to one examiner
for the duration of the study and the calibration of both examiners helped to ensure that
measurement of attachment loss was as consistent as possible within the design of the
study.
4.1.3.3.2 Dichotomous clinical indicators
The choice of simple dichotomous clinical indicators of periodontal disease, rather than
other semi-quantitative indices available, had the advantages of good intra- and inter-
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examiner correlation without the need for lengthy calibration of these measures as well
as reducing the time required for full mouth examination. However, the lack of any
quantitative information with regard to the clinical indicators chosen limits speculation
on the degree of influence of these factors on each other and their relationship with
periodontal disease in HIV seropositive subjects.
4.1.3.4 Microbiological data
Microbiological data were not available for all the sites sampled for a number of
reasons. One of the main considerations was to keep the lower limit of detection as low
as possible, while still being able to obtain a reasonable estimate of the total colony
count for each plate. Sites were only included in this analysis if they had between
100 and 2000 colonies on the primary isolation plate. However only one colony lift
from one dilution per site sampled was feasible, therefore if a subgingival plaque sample
was either very big or very small, the total colony count of the primary isolation plates
did not fall between the above limits and sites were lost due to over- or underdilution of
plaque samples. Other common causes of lost samples included drying out of thinly
prepared agar plates or contamination of plates with fungi. Although with experience
the number of sites that were lost due to these causes reduced, under- or overdilution of
plaque samples continued to be a problem throughout the study. It was decided
therefore that only those patients with microbiology results from at least 10% of all
sites would be used in the statistical analyses. This resulted in 43 patients from a total of
56 patients in the study. Nine patients were excluded by the 10% rule, the colony lifts




Immunological data could be traced for most patients with the assistance of the HIV
Reference Laboratory in Edinburgh. Two patients provided incorrect dates of birth and
therefore their immunological results could not be traced. The criteria set out in the
Results section for the inclusion of patients in the statistical analyses excluded a further
five patients because more than three months had elapsed between immunological
results and baseline examination for these patients. Statistical analysis was restricted to
immunological data of 22 HIV seropositive patients. The timing of immunological tests
often did not coincide with the baseline periodontal examination examination and this
should be considered when comparing immunological results against other parameters,
given the labile nature of the CD4+ T-cell counts in particular.
4.1.4 Interpretation of Results
The second and third objectives were to compare the prevalence of periodontal disease
and the prevalence of the selected periodontal bacteria between the HTV seropositive
and HTV seronegative subjects recruited into the study. Initial analysis of baseline
clinical and microbiological data centred on comparisons between the HIV seropositive
patients and the HIV seronegative controls. When mean attachment loss of each subject
in these two groups was plotted against age, it was immediately apparent that a number
ofHIV seropositive subjects had increased mean attachment loss for their age
compared to the HIV seronegative controls (Figure 16). However, when a Mann-
Whitney U test was used to compare mean attachment loss between these two groups
the HTV seropositive patients were found only to have a slight tendency for a higher
mean attachment loss compared to the HIV seronegative patients (Table 14). Plotting
the location of sites with attachment loss of 3 mm or more revealed that the HIV
seropositive patients in this sample had more sites with this degree of attachment loss
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than HIV seronegative subjects (Figures 17 and 18). Furthermore, the pattern of
attachment loss for both groups was different, with the lower incisors of the HIV
seropositive subjects experiencing severe attachment loss compared to the same region
in HIV seronegative subjects. Comparison of the prevalence of dichotomous clinical
indicators revealed that the only difference between these two groups at baseline
examination was that the HTV seropositive group had a higher mean percentage of sites
exhibiting suppuration than the HIV seronegative group (Table 19). However, this was
only a very small difference the median mean percentage of sites with suppuration in
HTV seropositive subjects was only 2.6%. Finally, the microbiological results revealed
that the only difference between these groups was that the HIV seropositive patients
had a statistically significantly higher mean percentage ofP. gingivalis than the HIV
seronegative patients. Therefore, there were only minor differences between HIV
seropositive and HIV seronegative groups with respect to prevalence and pattern of
periodontal disease and periodontal species enumerated in subgingival plaque.
Using criteria outlined by Haffajee and coworkers (1992) the incidence of widespread
and localised periodontal disease was assessed in both groups. Whereas nine HIV
seropositive patients fell into the widespread disease category, only two of the HIV
seronegative patients were considered to have widespread disease. In the absence of
figures for the prevalence of widespread periodontal disease in the general population,
these two groups were compared using a chi-square test (Table 16). This showed that
this difference in periodontal disease pattern between these two groups was very close
to statistical significance (p = 0.059). When these two groups of HIV seropositive
patients were compared, perhaps not surprisingly, the nine widespread periodontal
disease patients had a statistically significantly higher mean attachment loss than the
remaining 20 HTV seropositive localised periodontal disease patients (p = 0.001, Table
16). When the location of sites with attachment loss of 3 mm or more was compared in
HIV seropositive subjects with widespread and localised periodontal disease, it was
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evident that the distinct pattern of attachment loss observed in the HIV seropositive
patients as a group, was due almost entirely to these nine widespread periodontal
disease patients, which included the pattern of attachment loss associated with the
lower incisors of these patients (Figures 18, 19 and 20). Furthermore, these nine HIV
seropositive widespread periodontal disease patients were also found to have a
statistically significantly higher mean percentage of sites with redness and suppuration
than the localised periodontal disease patients in this group (p = 0.030, p = 0.001;
Table 20). Further evidence for the existence of a distinct subgroup of HTV seropositive
patients came from the microbiology results at baseline examination. Comparison of
these two groups revealed that the seven probe species accounted for a higher mean
percentage of the cultivable microbiota in the widespread disease patients than in the
localised disease patients. Furthermore, these seven HIV seropositive patients had a
tendency for higher mean levels of P. gingivalis, P. intermedia, C. ochracea and
V. parvula than the HIV seropositive localised disease patients (Table 29).
Interestingly, when the localised periodontal disease patients from HIV seropositive and
HTV seronegative groups were compared, no differences of statistical significance could
be found with respect to mean attachment loss (Table 18). Similarly, no differences
were found between these two groups when prevalence of dichotomous clinical
indicators was compared (Table 21). These two groups were also found to have a
similar pattern of attachment loss when sites of 3 mm or more were charted across the
mouth (Figures 17 and 20). Finally, no differences of statistical sigificance could be
found between localised periodontal disease subjects of both groups in the prevalence
of any of the probe species or total percentage of cultivable microbiota identified (Table
30).
Collectively, these results suggest that the HIV seropositive subjects in this sample
consisted of two well defined subgroups. One subgroup had widespread periodontal
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disease and differences were observed in the prevalence and pattern of periodontal
disease, clinical signs of periodontal disease and subgingival microbiota in terms of
those species enumerated, compared to the remaining HIV seropositive subjects in this
sample with localised periodontal disease. Furthermore, the HIV seropositive subjects
with localised periodontal disease were not dissimilar to the HTV seronegative localised
periodontal disease group with respect to these parameters. Therefore, the initial
differences ofmean attachment loss, percentage of sites with suppuration, location of
attachment loss and mean percentage of P. gingivalis observed between HIV
seropositive and HIV seronegative groups could all be attributed to these nine HIV
seropositive patients with widespread periodontal disease. No common factor could be
found with respect to age, sex, suspected route of acquisition of the virus, time since
diagnosis ofHIV seropositivity, CDC stage of HTV disease, CD4+, CD8+ T-cell counts
or ratio, medication related or unrelated to treatment ofHIV infection, that correlated
with the existence of widespread periodontal disease in these subjects. Why the lower
incisor region of this group had experienced severe attachment loss is also not known.
In reviewing the literature, however a number of case reports of HIV-associated
periodontal disease have described rapid attachment loss localised to the anterior teeth
(Andriolo et al, 1986; Abel and Andriolo, 1989; Levine and Glick, 1991). However,
only three of the HTV seropositive patients in this study with widespread periodontal
disease give a history of previous periodontal problems involving the lower anteriors.
The majority of widespread periodontal disease patients had no history of aggressive
periodontal destruction, i.e. HIV-P, necrotising stomatitis, therefore it is likely that
attachment loss in this group of patients proceeded insidiously, albeit at a faster rate
than others of a similar age.
In retrospect, the existence of possible subgroups within the HTV seropositive patients
was indicated earlier in the analysis of CTENP as a summary statistic for attachment
loss (Figures 12 and 13). Whereas the transformation logio (CTENP + 1) for HIV
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seronegative subjects produced a normal distribution, the same transformation failed in
the HTV seropositive subjects; the distribution produced was not normal and had at
least two distinct peaks. This appearence is often an indication that subgroups are
contained within a sample.
Reports of the prevalence for selected periodontal bacteria vary greatly for both HIV
seropositive and HIV seronegative patients at a site and subject level (Dahldn et al,
1989; Zambon et al, 1990; Savit and Kent, 1991; Asikaninen et al, 1991; Moore et al,
1984, 1985, 1991; Moore et al, 1993). Prevalence will depend on number of sites
sampled per patient, method of bacterial identification and detection limits (Mombelli et
al, 1991a,b). Tables 26 and 27 give the prevalence of the species enumerated at a
subject and site level from both groups. While the majority of these results for
prevalence of the seven probe species are comparable to results of prevalence from the
studies by Gunaratnam et al (1992) and Haffajee et al (1992), the prevalence of some
species in this study population were different. In the present study,
A. actinomycetemcomitans was found at a higher prevalence at a subject and a site level
compared to these studies, whereas the prevalence ofP gingivalis in sites fromHIV
seropositive was found to be lower than that reported by Gunaratnam et al (1992).
However, it should be remembered that although all three studies used the same method
of enumeration of subgingival bacteria, there were a number of differences in the
clinical and laboratory methods, as well as sample population that could explain these
discrepancies. As discussed above, both the transport medium and method of plaque
dispersal used in this study were different from that used by the group at Forsyth Dental
Center which could lead to differences in the viabilty of organisms following dispersal
of a plaque sample. Secondly, the patients in this study were not exclusively
periodontitis patients as was the case with the patients in the FDC studies. Furthermore,
the Edinburgh population has not been previously analysed with respect to these species
and geographic variation in the prevalence of these species should be considered as a
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possible cause of differences (Prof. T.W. MacFarlane, personal communication). This
concern confirmed the need for a separate HIV seronegative control group in this
study. Finally, a priority in the present study was to keep the lower limit of detection as
low as possible. This was achieved by reprobing sections of colony lift and lifting
primary isolation plates with total colony counts of up to 2000. This resulted in a "best"
lower limit of detection of 0.2% of the total colony count and a mean lower limit of
detection of 0.58 % for HIV seropositive patients and 0.60% for HIV seronegative
controls. This compares to a "best" lower limit of detection of 0.4% for other studies
and may account for some of the differences observed between these studies. The
detection limit of a technique will have a profound effect on the observed prevalence of
organisms at a site and subject level. Results from Savitt and Kent (1991) show a
dramatic increase in the percentage of sites positive for both P. gingivalis and
A. actinomycetemcomitans, when the sensitivity of the test was improved from 105 to
103 organisms. The data reported by these authors show an increase from an average
percentage of sites positive for P. gingivalis from 14.4 % of sites to 38.9% of sites with
the lower detection limit. Similarly, the average percentage of sites positive for
A. actinomycetemcomitans increased from 3.7% to 41.9% when the detection limit was
lowered to 103 cells. As discussed above, the increased sensitivity of the rapid
identification techniques have called into question the dependence on culture techniques
as the gold standard for bacterial identification in subgingival plaque samples. As a
consequence, currently suspected periodontal pathogens either may be more prevalent
than once thought or the list of currently suspected periodontal pathogens and
beneficial species may be inaccurate (Smith, 1992).
In this study, no correlation could be found between mean attachment loss or mean
percentage of the seven probe species and CD4+, CD8+ T-cell counts or ratio. No
differences were found with respect to dichotomous clinical indicators and CD4+,
CD8+ T-cell counts or ratio, with the possible exception of percentage of sites with
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redness and CD4+ : CD8+ ratio. A weak negative correlation was found between
CD4+ : CD8+ ratio and percentage of sites with redness, however this was not
statistically significant (Figure 21). The lack of correlation found between
immunological results and the clinical indicators and microbiological results could be
the result of the variable time lapse between immunological results and baseline
examination. Furthermore, the the lack of quantitative information provided by
dichotomous measures could result in a failure to detect an association between more
subtle clinical changes and immunological parameters.
On a longitudinal basis some differences in the clinical parameters studied was observed
in the HIV seropositive subjects. Pocket depth was seen to improve in 14 of the 18 HIV
seropositive patients at a second visit (Table 22). This was accompanied by a reduction
in the percentage of sites with bleeding on probing over the course of the first few
months and paradoxically, by an increase in the percentage of sites with plaque. The
reduction in pocket depth and bleeding on probing between baseline examination and
second visit for some of these patients may be a result of the scaling and oral hygiene
instruction given at baseline visit and an increased awareness that periodontal problems
could occur as a result ofHIV infection. However, at the end of three months patients
may have lapsed back into previous standards of plaque control resulting in higher
plaque scores (Tables 22 and 23).
The incidence of periodontal breakdown of at least 3 mm in HIV seropositive patients
seen at recall visits was extremely rare (Table 35). Only 20 sites from a total of 2814
reviewed on at least one occasion were deemed active, which gives an average rate of
breakdown across visits 2, 3 and 4 of less than 1.0% (Table 35). Interestingly, this is
well below the false-positive rate predicted for this method ofmeasuring attachment
loss (Best et al, 1990). These authors predicted that using this method ofmeasurement
at least one site in every patient would record a change of 3 mm at every follow up visit
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due to measurement error alone. Perhaps using only two calibrated examiners in this
study helped keep the false-positive rate down. If the criteria for active sites had been
2 mm or more of attachment loss then number of active sites detected in this study
would no doubt have been larger, but at the same time the false-positive rate would also
be expected to rise. Although some of these sites had the clinical appearance of
bleeding on probing, redness and suppuration, none of the sites designated active came
from areas ofHIV -G, HIV -P or NS. The incidence of these diseases in this sample of
HTV seropositive patients was restricted to three patients at baseline examination
(see below). There were no differences of statistical significance found between active
and control sites from HIV seropositive patients with regard to clinical indicators or the
species enumerated. This is perhaps not surprising given the numbers of sites available
for use in the statistical analysis, and as a consequence, the power of these tests would
be expected to be low.
The next two objectives outlined were to find the prevalence ofHlV-associated
periodontal diseases in a sample of HTV seropositive subjects and attempt to
characterise the microbiology of these lesions in the context of those species selected
for enumeration. However the incidence of these conditions in this sample ofHIV
seropositive subjects during the study was extremely low and, as discussed above
(section 4.1.3.2), the number of HIV seropositive patients recruited and the prospective
design of the study may have been contributory factors. Of 29 HIV seropositive
patients, nine had a history of periodontal treatment, however with the exception of one
patient, an accurate dental history was not available and so it was impossible to classify
previous disease experience in terms of the conditions listed above. Furthermore,
although many of these patients had clinical evidence of periodontal pocketing and
localised areas of gingival recession, it was impossible to determine if periodontal
destruction had occurred before or after HIV infection. One patient had a previous
episode ofHIV -P that progressed to necrotising stomatitis and resulted in an oro-antral
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fistula (Felix et al, 1991). At baseline examination, only 2 patients with a previous
history of periodontal disease presented with clinical signs. One patient had suspected
ANUG around the lower incisors, the other had generalised HIV -P with localised areas
of HTV -G. One patient, with no previous history of periodontal disease, presented at
baseline examination with suspected ANUG also localised to the lower incisor region.
On a longitudinal basis, 7 patients had attachment loss of 3 mm or more between
subsequent visits in 20 sites from 2814 sites reviewed on at least one occassion
(see above). None of these cases of active disease were attributed to HlV-associated
diseases as described in the literature. It is possible that three monthly recall visits with
oral hygiene instruction and scaling, if required, may have reduced the incidence of
severe HlV-associated periodontal disease in this group.
Finally, it was hoped to identify any possible predictors ofHIV disease progression in
terms of the clinical and microbiological parameters under study. Ideally, this aim would
have been satisfied by statistical analysis of longitudinal data. Due to difficulties in
recruitment of patients and patient drop-out, the majority of the data collected were
cross-sectional. In an attempt to provide some information on possible periodontal
indicators of HTV disease progression, cross-sectional data was used with a Kruskal-
Wallis test across the three patient groups that crudely divided patients into stages of
disease progression, i.e. HTV seronegative, CDC stage II and CDC stage IV. The
results of these analyses should be viewed with caution, as, ultimately, the conclusions
drawn originate from cross-sectional data. Longitudinal studies will be required to
verify any of these findings.
Mean attachment loss and the percentage of sites exhibiting suppuration were greater in
CDC stage IV subjects than either CDC stage II or HTV seronegative patients
(Tables 41 and 42). Interestingly, CDC stage II patients had a similar degree of
attachment loss to the HIV seronegative subjects, whereas CDC stage IV patients had
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on average a higher mean attachment loss. On the basis of these data, CDC IV subjects
would appear to have suffered either more episodes of active periodontal destruction or
episodes of increased severity than either CDC II or HIV seronegative subjects of a
similar age. It is tempting to speculate that increased periodontal activity occurs at or
around the time of increased immunosuppression associated with the progression of a
patient from CDC stage II to CDC stage IV. HIV disease progression from CDC stage
II to CDC stage IV is associated with increased immunosuppression which in turn leads
to increased susceptibility to opportunistic pathogens. This process may also be
presumed to occur in relation to subgingival bacteria in some patients. Indeed
increasing immunosuppression may explain the differences noted in the mean
percentage of some of the species enumerated across the three groups. The mean
percentage of P. gingivalis was observed to increase across the groups with the highest
mean percentages occuring in CDC stage IV subjects. The mean percentages of
V. parvula were highest in the CDC stage II subjects, but very low in CDC stage IV
subjects (Table 43). It may be that these fluctuations of P. gingivalis and V. parvula
confirm their description as a suspected periodontal pathogen and beneficial species
respectively. However, even if these associations are upheld in longitudinal studies, the
predictive power of mean attachment loss and levels ofP. gingivalis or V. parvula are
likely to be weak, as not all HIV seropositive patients will suffer from periodontal
disease or harbour these organisms.
4.2 SPECULATIONS ON PERIODONTAL DISEASE IN HIV
SEROPOSITIVE SUBJECTS
Results from PCM, immunofluorescence, ELISA and DNA probe studies of the
subgingival microbiota of HIV seropositive patients and HIV-associated periodontal
disease have found similar organisms present to those found in healthy sites and
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periodontal disease sites in HIV seronegative subjects (Murray et al, 1988, 1998, 1991;
Zambon et al, 1990; Lucht et al, 1990; Rams et al, 1991; Gornitsky et al, 1991; Moore
et al, 1993). Results from this study also confirm the existence of a selection of
currently suspected pathogens and beneficial species in HTV seropositive subjects.
However, several studies have also found species that are not normally considered
colonisers of the subgingival crevice in HIV seropositive patients (see Literature
Review section 1.8.2). Therefore, there are two microbiological hypotheses that could
apply to the aetiology of HIV-associated periodontal diseases. Either they could be
caused by subgingival species currently associated with conventional periodontitis, but
whose virulence is increased with the diminished immune response in HTV infection, or
be the result of infection by the unusual species found colonising the subgingival area in
HTV seropositive subjects (Robinson 1992). As discussed previously, HIV infection has
been reported to cause defects in PMNL, macrophages and B-lymphocyte function as
well as CD4+,CD8+ T-lymphocytes and cytokine production (Literature Review,
section 1.8). Similar defects in PMNL, macrophages B-and T-lymphocytes have been
reported in some patients with various periodontal diseases (Literature Review, section
1.6). Given the demonstration of both suspected periodontal pathogens and unusual
colonisers in the subgingival crevice ofHIV seropositive subjects, and the many host
cell and immune system defects that have been reported in HIV seropositive subjects, it
is perhaps not surprising that a percentage of HIV-seropositive patients should suffer
from aggressive periodontal disease. The fact that all HTV-seropositive subjects in the
present study did not exhibit severe disease may be the result of the small number seen
longitudinally, individual variation or the effects of various medications.
Periodontal destruction could occur in HIV seropositive patients in a number of ways.
Conventional periodontitis and gingivitis, in response to fluctuations in the quantity and
possibly quality of supragingival and subgingival plaque, will exist in some patients
before HTV infection. It seems unlikely that the periodontal disease process will change
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in character in the early stages of HIV infection, when the immune system and the
resident microbiota are still relatively intact As HTV disease progresses, patients may
be more likely to experience changes and imbalances in the subgingival microbiota due
to immunosuppression and treatment ofmanifestations of HTV infection. As a
consequence, they may suffer either increased frequency or severity of active
periodontal disease, although the clinical characteristics may still be similar to
conventional periodontal disease. Interestingly, depressed CD4+ : CD8+ ratio, defects
in PMNL and AMLR function as well as B-lymphocyte hyper-responsiveness have been
associated with both HIV infection and early onset periodontal disease (see Literature
Review). Furthermore, RPP has been described as an early expression of HIV disease
(Rosenstein et al, 1989; Tenenbaum et al, 1991; Levine and Glick, 1991). Finally, in a
percentage of HTV seropositive subjects, as immunosuppression increases the
subgingival crevice may be free from any effective host influence, allowing both
periodontal pathogens to increase and unusual subgingival species to colonise, giving
rise to severe periodontal diseases i.e. necrotising stomatitis and HIV-P. It is likely that
a number of these conditions coexist at different sites in the same patient
Although the results of this study indicated a tendency for mean attachment loss to
increase across CDC stages, the presence of widespread periodontal disease or the
incidence of active sites were not restricted to those patients with increased
immunosuppression. It is likely that many other factors will also play a role. Such
factors may include presence of risk factors for conventional periodontal disease,
smoking, OH status, poor dental health, previous history of conventional periodontal
disease and genetic susceptibility to periodontal disease. However, antimicrobials used
in the treatment of opportunistic infections in HIV seropositive subjects could have a
profound effect on the subgingival microbiota. This could lead to the emergence of
opportunistic periodontal pathogens, that in turn may explain the poor response to
treatment of HIV-associated periodontal diseases reported by some authors (Winkler
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and Murray, 1987; Grassi et al, 1988). Indeed, the existence of an established
protective subgingival microbiota against opportunistic and exogenous periodontal
pathogens prior to and during HIV infection and emergence of opportunistic pathogens
in an established subgingival microbiota in the presence of failing immunoregulation are
interesting possibilities to consider in this group of patients.
It seems therefore, that the ability to identify HIV seropositive subjects at risk of severe
periodontal disease will be as difficult as predicting such disease in non-
immunocompromised individuals.
Although the present study was originally designed to collect and analyse both cross-
sectional and longitudinal data, for a variety of reasons, the majority of the data
collected was cross-sectional. Longitudinal observation of HIV seropositive subjects
may offer answers to the following:
1) When does increased periodontal disease activity observed in some HTV
seropositive patients take place in relation to stage of HIV disease?
2) Is the increased activity observed in these patients related to an increase
in the number or severity of destructive phases of the disease?
3) Why should the lower incisors of these patients be the focus for severe
disease?
4) Could fluctuations in specific subgingival species be related to increased
immunosuppression?
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5) How do HIV seropositive subjects compare with subjects with early
onset periodontitis e.g. rapidly progressive periodontitis?
The development of additional naphthol-AS phosphate / diazonium salt colour
substrates to detect alkaline phosphatase activity, would allow more data to be
recovered from each colony lift if a sequential hybridisation strategy were adopted. This
would also allow more simultaneous hybridisations to be attempted as new non-isotopic
nucleic acid labels are developed.
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4.3 SUMMARY
The results of this study suggest that there exists a subgroup of HTV seropositive
patients that are at risk for severe or widespread periodontal disease. Whereas a
percentage of HIV seropositive subjects will suffer from severe, aggressive periodontal
destruction i.e. HIV-P, necrotising stomatitis, a number of these patients will develop a
form of rapidly progressive periodontal disease. One of the features of this disease may
be that the lower incisors of some subjects are at risk for attachment loss. HIV disease
progression may also be associated with fluctuations in subgingival microbiota i.e.
increasing levels of P. gingivalis and falling levels of V. parvula, but this will require
further investigation with a larger number of patients.
No clinical or microbiological features could distinguish HIV seropositive subjects and
HIV seronegative subjects with localised periodontal disease. Despite five of these HIV
seropositive subjects having full blown AIDS, increased periodontal destruction did not
appear to be a feature of their immunosuppression. It may be that other factors would
help explain absence of severe periodontal destruction in every case of HTV infection,
for example, colonisation resistence offered by an intact subgingival microbiota in
disease resistant HTV seropositive patients.
This study has confirmed that DNA probes are a simple and useful technique to
enumerate a large number of bacterial species in a large number of samples.
Development of the technique used in this study, i.e. sequential hybridisation of target
with a number of probes and detection of alkaline phosphatase with naphthol-AS
phosphates and diazonium salts, has allowed increased data recovery from a single
colony lift without necessarily incurring additional costs. In addition to sequential
hybridisation, simultaneous hybridisation with multicolour detection also provides a
way of increasing data recovery from a limited area of filter. The choice of technique
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will depend on the number of species and the number of samples under study. For a
large number of samples and species, sequential hybridisations would seem more
appropriate. However, for a small number of both, simultaneous hybridisation may be
quicker, allowing colony lifts to be hybridised without requiring to be sectioned.
Over the last five years there has been a great increase in the number of rapid microbial
identification techniques available (see Literature Review section 1.5). These
techniques, while differing in sensitivity and specificity of detection of the target
species, have allowed the analysis of a greater number of plaque samples than was
previously possible using a cultural approach. However, questions remain about the
ability of a specific microbiota to indicate/predict subject or site-specific periodontal
disease activity. The use of these techniques in studies analysing a larger number of sites
within subjects than previously, may help in clarifying the lists of currently suspected
periodontal pathogens and beneficial species, however controversy over the specific or
non-specific plaque hypothesis is unlikely to be completely resolved until periodontal
disease activity can be confidently identified using a single visit test. Microbial analysis
of plaque samples for selected pathogens or beneficial species from sites known to be
active at the time of sampling will make the determination of the contribution of each
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1. Bacteroides medium CMB
Cooked meat broth (CMB) modified by the addition of;
trypticase (BBL) 1%
protease peptone (Oxoid) 1%







Brain heart infusion broth (Difco) supplemented with;
fetal calf serum 5%
N-acetylmuramic acid 10 mg/ml
3. Campylobacter rectus
Mycoplasma broth supplemented with;
brain heart infusion 37 mg/ml
hemin 5 mg/ml
sodium formate 2mg/ml
sodium fumerate 3 mg/ml













N-acetylmuramic acid 10 mg/ml
Campylobacter rectus agar
BHI agar 52 mg/ml
yeast extract 10 mg/ml
sodium formate 2 mg/ml
sodium fumarate 3 mg/ml





(Syed and Loesche, 1972)
One litre of RTF consisted of the following;
Stock salt solution No. 1
Stock salt solution No.2
8% Na2 CO3
1% solution of dithiothreitol
(freshly prepared)








Stock salt solution No. 1 is a 0.6% solution of potassium hydrogen phosphate.
Stock salt solution No. 2 is a mixture of the following;
CTAB/NaCl
10% hexadecyltrimethyl ammonium bromide in 0.7 M NaCl
RNase A (stock solution)
10 mg/ml RNase A in 10 : 1 TE (pH 7.6) heated to 70°C for 15
min and stored in 100 ml aliquots at -20°C
1.2% sodium chloride
1.2% ammonium sulphate
0.6% potassium dihydrogen phosphate
0.25% magnesium sulphate
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4. 24: 25: 1 phenol: chloroform: isoamyl alcohol
Buffered Phenol
1) Add 250 ml 50 mM Tris base to 250 ml liquified phenol
2) Stir for 10 mins with magnetic stirrer in covered beaker
3) Let phases settle
4) Decant top phase and discard
5) Remove last traces of top phase with pipette
6) Add 250 ml 50 mM Tris HCL, pH 8.0
7) Repeat steps 2 - 6
8) Check pH of phenol phase with indicator paper (pH 8.0)
9) Add 125 ml TE buffer
10) Store at 4°C in brown glass bottle
11) Mix 25 vol buffered phenol, 24 vol chloroform and 1 vol isoamyl alcohol
5. 20 x SSC
3 M sodium chloride
0.3 M tri-sodium citrate, pH 7.0
6. De-ionised formamide
5g ofDowex MR-3 ion exchange resin added for every 50 ml of
formamide. Stirred for 30 mins at room temperature and
filtered twice through Whatman No. 1 Filter paper. Dispensed
into aliquots and stored at - 20°C.
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7. 50 x Denhardt's
1% (w/v) Ficoll
1% (w/v) polyvinylpyrrolodone
1% (w/v) bovine serum albumin, fraction V
in distilled water.
Filter sterilised and stored in 15 ml aliquots at -20°C
8. Herring sperm DNA
One gram ofHsDNA dissolved in 100 ml distilled water overnight at 4°C.
Sheared by passing through a 25 gauge needle four times, stored in 1 ml
aliquots at -20°C.
9. Nitroblue tetrazolium (stock solution)
75 mg/ml nitro blue tetrazolium salt in dimethylformamide
(70% v/v).
10. Bromo-chloro-indolyl-phosphate (stock solution)
50 mg/ml of 5-bromo-4-chloro-3-indolyl phoshate,
toluidinium salt, in dimethylformamide (100% v/v).
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11. Fast red TR (stock solution)
4-Chloro-2-methylbenzene diazonium salt hemi zinc chloride
salt, 20 mg/200 ml in dimethyformamide (100% v/v).
12. Fast Blue BB (stock solution)
4-Benzoylamino-2,5-diethoxybenzene diazonium chloride hemi [zinc chloride]
salt 20 mg/200 ml in dimethylformamide (70% v/v).
The fast blue BB salt did not dissolve completely in the dimethylformamide and
was vortexed and intermittently shaken for 5 min, followed by 5 min
centifugation and the supernatant tranfered to a fresh Eppendorf before use.
13. Naphthol-AS phosphate (stock solution)
20 mg/200 ml in dimethylformamide (100% v/v).
14. Naphthol-AS-GR phosphate (stock solution)
20 mg/200 ml in dimethylformamide (100% v/v).
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Colour Substrate Solutions
All colour substrate solutions allow 50 ml of solution for every
50 cm^ of filter.
Red
10 ml of naphthol-AS phosphate stock and 3 ml of fast red
TR stock in 5 ml of buffer 3.
Blue
10 ml of naphthol-AS phosphate stock and 15 ml of fast
blue BB stock in 5 ml of buffer 3.
Green
10 ml of naphthol-AS-GR phosphate stock and 15 ml of
fast blue BB stock in 5 ml of buffer 3.
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Appendix 2




































B) Example of a chart used to record clinical indicators.






















URB = upper right buccal quadrant
173= tooth 17 / site 3 = distobuccal
172
171
/ site 2 = buccal
/ site 1 = mesial
N
A
B
A-B
necrosis
pocket depth
level of ACJ
attachment loss
BOP
PLQ
RED
SUPP
SEQ
bleeding on probing
plaque
redness
suppuration
sequestration
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